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Ena/VASP proteins are cytoskeletal rearrangement proteins involved in processes such 
as phagocytosis, cell migration, and axon guidance in neurons. VASP contains an N-
terminal EVH1 domain which localizes it to specific sites in the cell. The VASP-
EVH1 domain recognizes the proline-rich motif (F/W)PxφP, which occurs in the 
immune cell signaling kinase IRAK1 and also as tandem repeats in the focal adhesion 
protein zyxin. Typically this motif is flanked by negatively charged amino acids that 
are necessary for a tight ( DK < 200 µM) interaction. We have examined the 
interactions between VASP-EVH1 and the binding sites in IRAK1 and zyxin and 
describe three novel observations. First, we report that the W168-P169 peptide bond in 
the IRAK1 binding site partitions into nearly equal (43% cis, 57% trans) population of 
cis and trans isomers, and that EVH1 binding to this site is specific for the trans 
isomer. We use NMR and tryptophan fluorescence spectroscopy to show that the 
prolyl isomerase cyclophilin A (CypA) isomerizes this site and accelerates binding of 
VASP-EVH1 to peptides. Second, we report that phosphorylation of two serines 
flanking the WPPPP motif in IRAK1 increases the affinity for VASP-EVH1 by a 
factor of seven. This shows that phosphoserine is an effective substitute for glutamic 
or aspartic acid in VASP-binding sequences, suggesting that phosphorylation could be 
a novel mechanism to regulate VASP localization, especially in the case of IRAK1 
 and lamellipodin, which are known to be phosphorylated. Third, we show that VASP-
EVH1 contains a noncanonical second binding site on the face opposite its primary 
binding site. We show that this site shares some binding specificity with the canonical 
(F/W)PxφP motif, and that this binding site is employed in the interaction with zyxin 
to recognize the third and fourth VASP-binding repeats of zyxin. We also show that 
this binding site is conserved in the homologous Ran-binding domain (RanBD), 
suggesting that it is widespread in EVH1 homologs. Separately, we report an NMR 
lineshape analysis-based protocol for dissecting the microscopic rate constants of a 
prolyl isomerase enzyme.  
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CHAPTER 1 
Background and Overview 
 
Conformational Selection of Proline Isomers and the Role of Prolyl Isomerases 
The peptide bond that connects amino acids in a protein is planar, as a result of 
its partial double bond character. This restricts its allowed torsion angles to only 0° 
(cis) or 180° (trans). Peptide bonds adopt the trans isomer almost exclusively, with 
the notable exception of those bonds preceding a proline residue. These so-called 
prolyl peptide bonds, by contrast, partition into an equilibrium of cis and trans 
populations in the absence of secondary structure (Fischer, 2000). This equilibrium 
typically ranges between 5-40% cis, depending on the residues immediately preceding 
and following the proline (Dasgupta et al., 2007; Pahlke et al., 2005; Reimer et al., 
1998). Bulky aromatic groups such as tryptophan, tyrosine, and phenylalanine before 
the proline induce the largest population cis (Reimer et al., 1998). In a folded protein 
on the other hand, one isomer (trans more often than not) is usually stabilized over the 
other (Reimer et al., 1998; Wedemeyer et al., 2002). Likewise, protein-protein 
interactions are frequently isomer-specific, so that only one isomer participates in 
binding (De et al., 2012). The energy barrier between prolyl isomers is considerably 
high (~80 kJ/mol), resulting in very slow (~0.0005-0.003 s
-1
 at 4° C) interconversion 
between isomers relative to other torsion angles in proteins (Figure 1.1A) (Fischer, 
2000). 
 In some proteins, such as ribonuclease A, the isomer state of a proline residue 
is crucial to the protein’s fold. In this case, a protein will fail to fold following 
synthesis on the ribosome until its proline residue is isomerized to the folding-
competent isomer (Figure 1.1B). This effect is more pronounced for proteins that 
require a cis isomer to fold, and is compounded when proteins require multiple cis 
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Figure 1.1: Cis/trans isomerization and its role in protein interactions and 
function. (A) Energy diagram portraying a typical free energy difference (ΔGC-T) 
between the cis and trans isomers of a prolyl peptide bond, and a typical activation 
energy (ΔG‡) of isomerization (based on measurements extrapolated to 25° C from  
(Reimer et al., 1998)). (B) The native fold of ribonuclease A requires two proline 
residues to adopt the cis isomer and one to adopt the trans (simplified in figure), 
requiring rate-limiting isomerization steps for the protein to fold. (C) The SH2 domain 
of Itk adopts two conformations, depending on the isomer state of a proline residue. 
The cis isomer binds to the SH3 domain of Itk while the trans isomer binds to 
phosphotyrosine-containing sequences. (D) mGluR1 adopts a cis-Pro peptide bond 
when it binds to the EVH1 domain of Homer, suggesting that binding requires a rate-
limiting isomerization step. 
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isomers (Dodge and Scheraga, 1996; Houry and Scheraga, 1996; Wedemeyer et al., 
2002). Multiple families of enzymes have evolved that catalyze this isomerization, 
collectively called peptidyl-prolyl isomerases (PPIases) (Fischer and Aumuller, 2003).  
 Conformational heterogeneity and conformational selection are recurring 
themes in the regulation of protein-protein interactions (Boehr et al., 2009). Prolyl 
isomers can be thought of as a specific kind of conformational heterogeneity. There 
are a growing number of examples of proteins that exhibit two conformations which 
are linked to the isomer state of a key proline residue. For example, the adapter protein 
Crk adopts an inhibited conformation with a cis proline residue in equilibrium with an 
open, active conformation with this peptide bond adopting the trans isomer 
(Nicholson and Lu, 2007; Sarkar et al., 2011). Likewise, the binding specificity of the 
IL-2-inducable tyrosine kinase (Itk) SH2 domain is modulated by the isomer state of a 
proline within the domain (Figure 1.1C) (Colgan et al., 2004). Prolyl isomers have 
also been found to be linked to functional conformations in the ion channel of the 5-
HT3 receptor (Lummis et al., 2005), the C-type mannose-binding protein (Ng and 
Weis, 1998), and the E. coli protein IscU (Dai et al., 2012). 
A simpler but possibly more widespread example of conformational selection 
of prolyl isomers is the recognition of short motifs by protein domains such as Src-
homology 3 (SH3), Enabled/VASP Homology 1 (EVH1), Ubiquitin E2 variant 
(UEV), GYF, and WW domains (Zarrinpar et al., 2003). Binding motifs rich in 
proline, so-called proline-rich motifs, are a common target of such domains. Proline-
rich motifs typically adopt a left-handed polyproline II helix (PPII) structure, a 
relatively rigid secondary structure with trans peptide bonds. PPII helices are 
generally solvent exposed, allowing for rapid and reversible binding, with the carbonyl 
groups of the backbone available to form hydrogen bonds (Siligardi and Drake, 1995). 
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Furthermore, the rigidity of the PPII helix lowers the loss of conformational entropy 
upon binding, allowing for tighter interactions than might be achieved by other 
exposed sequences (Kay et al., 2000). These features help to explain why proline-rich 
motifs are popular binding targets in cell signaling, which often depends on fast and 
reversible protein-protein interactions. However, the preponderance of prolines in such 
motifs presents a potential obstacle to achieving rapid protein interactions due to the 
presence of slowly-exchanging cis and trans populations (Reimer et al., 1998), which 
will not generally both be compatible with binding. In the most striking example of 
isomer selection of proline-rich motifs, the crystal structure of the EVH1 domain of 
Homer bound to a peptide from a metabotropic glutamate receptor (mGluR1) suggests 
that this interaction is specific for the cis isomer of the S1149-P1150 peptide bond in 
mGluR1 (Figure 1.1D) (Beneken et al., 2000). Less dramatically, other structures of 
proline-rich motifs bound to their binding domains show trans peptide bonds 
(pdb.org). 
 There are more examples of conformational selection of prolyl isomers that 
don’t involve binding modules that bind proline-rich motifs. A notable example is the 
conformational specificity of the Ssu72 phosphatase which dephosphorylates specific 
sites in the RNA polymerase C-terminal domain (CTD) (Krishnamurthy et al., 2004). 
Ssu72 was originally predicted to be a tyrosine phosphatase (Meinhart et al., 2003), 
but rather than recognizing phosphotyrosine it has been shown that it actually 
recognizes the cis isomer of pS5-P6, which inserts into the deep catalytic pocket of the 
enzyme the way a tyrosine sidechain would (Xiang et al., 2010; Zhang and Zhang, 
2011). The phosphorylation-specific isomerase Pin1 is able to accelerate Ssu72-
mediated dephosphorylation of the CTD in vitro (Werner-Allen et al., 2010; Xiang et 
al., 2010) and while mutations of the Pin1 homologue in yeast (Ess1) cause a 
temperature-sensitive phenotype, Ssu72 overexpression rescues the phenotype 
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(Krishnamurthy et al., 2009). 
 Yet another example of proline isomer selection is the conformational 
specificity of the SCF(TIR1)-mediated degradation of AUX/IAA proteins in auxin 
signaling in plants. The SCF ubiquitin ligase TIR1 specifically binds to the cis isomer 
of W59-P60 in the GWPPV degron motif in IAA in the presence of the signaling 
molecule auxin, targeting it for degradation (Tan et al., 2007). In a cell-free auxin 
response assay a PPIase was necessary for IAA degradation (Dharmasiri et al., 2003). 
Indeed, isomerases such as cyclophilin A (CypA) are widely involved in signaling in 
plants (Kumari et al., 2013). Presently, however, the significance of the isomer-
specificity of the TIR1 recognition of IAA proteins does not seem to be well-
appreciated (Kumari et al., 2013).  
 While most PPIases (such as the cyclophilins, FKBPs, and for the most part, 
parvulins) exhibit low sequence specificity (Schmidpeter et al., 2011; Zoldak et al., 
2009), the parvulin Pin1 is specific for phosphorylated Ser/Thr-Pro sites (Yaffe et al., 
1997).  Up- and down-regulation of Pin1 activity seems to be connected to multiple 
human diseases including asthma (Shen et al., 2009), Alzheimer’s disease, and many 
cancers, as well as aging (Lee et al., 2011). Although the role of Pin1 in accelerating 
cis-proline dephosphorylation by Ssu72 seems to be the clearest mechanism of Pin1’s 
function in the cell (Werner-Allen et al., 2010), Pin1 is also known to accelerate 
dephosphorylation by the trans specific phosphatase PP2A (Zhou et al., 2000). In 
principle, Pin1 may accelerate isomer-specific binding in addition to isomer-specific 
enzymatic reactions. Phosphorylated Ser/Thr-Pro is a common motif phosphorylated 
by the so-called proline-directed kinases (Ubersax and Ferrell, 2007), so Pin1 has a 
long list of potential targets, making it a pleiotropic enzyme.  
 Cyclophilin A (CypA or Cyp18) is an isomerase most commonly associated 
with its role in the action of the immunosuppressant drug cyclosporine. Cyclosporine 
 6 
binds cooperatively to CypA and the phosphatase calcineurin, inhibiting both enzymes 
(Liu et al., 1991). Inhibition of calcineurin activity then disrupts signaling in T-cells 
(Clipstone and Crabtree, 1992). However, the isomerase activity-or inhibition of it- is 
not important for this process because isomerase-dead CypA mutants with wild-type 
binding for cyclosporine still inhibit calcineurin with wild-type activity (Zydowsky et 
al., 1992). In a similar example of the versatility of CypA function, CypA can be 
secreted to the extracellular space where it acts as a chemokine through binding to the 
CD147 receptor. However, this function is also independent of CypA activity (Song et 
al., 2011). CypA is involved in the replication of various RNA viruses such as HCV, 
but its role is not clear as in some cases it also exhibits antiviral activity, such as in the 
case of HIV (Nagy et al., 2011).  
 CypA isomerase activity is crucial for its function as a foldase (Wedemeyer et 
al., 2002), for regulating the conformational states of Crk and Itk as described above 
(Breheny et al., 2003; Sarkar et al., 2011), and for accelerating phosphorylation by 
ERK2 (Weiwad et al., 2004). CypA isomerization also seems to be required for 
progression of cytokinesis in Jurkat cells, though it is not known what its target is in 
this process (Bannon et al., 2012). Investigations of the roles of CypA isomerase 
activity are hampered by the existence of many other isomerases with similar activities 
(Gothel and Marahiel, 1999; Schmidpeter et al., 2011; Zoldak et al., 2009). We have 
chosen CypA as an isomerase to demonstrate the role of isomerization in VASP 
(Vasodilator-stimulated phosphoprotein) binding because it is abundant in the 
cytoplasm. Nevertheless in the cell isomerization of zyxin and IRAK1 (Interleukin-1 
receptor associated kinase 1) may well be executed by another enzyme. 
Ena/VASP Function and Regulation 
Ena/VASP proteins (Mena, VASP, and Evl in mammals) are cytoskeletal 
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rearrangement proteins that play central roles in cell migration and the control of cell 
shape (Krause et al., 2003). Ena/VASP proteins control the geometry and dynamics of 
actin filaments within lamellipodia (Bear et al., 2002), and are crucial for the 
formation of filopodia in certain contexts (Lebrand et al., 2004; Mejillano et al., 2004). 
They are also important in the processes of phagocytosis (Coppolino et al., 2001), cell 
motility (Bear et al., 2000; Bear et al., 2002; Krause et al., 2003), axon guidance in 
neurons (Goh et al., 2002), and cell-cell interactions (Grevengoed et al., 2001; 
Vasioukhin et al., 2000). Notably, they are implicated in tumor development by their 
ability to increase cancer cell invasiveness (Philippar et al., 2008). Like formins, 
Ena/VASP proteins are processive actin polymerases that recruit monomeric actin to 
the growing barbed end of actin filaments (Breitsprecher et al., 2011; Hansen and 
Mullins, 2010). In addition, Ena/VASP proteins protect the barbed end of actin 
filaments from capping proteins, which otherwise halt actin polymerization upon 
binding filamentous actin (Barzik et al., 2005; Bear and Gertler, 2009; Bear et al., 
2002). This anti-capping function is not observed when VASP is in solution, but only 
when it is immobilized on beads (Breitsprecher et al., 2011), which mimics its 
punctate distribution in cells (Bachmann et al., 1999; Vasioukhin et al., 2000). 
Ena/VASP proteins also display an actin bundling activity which is necessary for 
formation of filopodia in Dictyostelium (Schirenbeck et al., 2006), as well as an anti-
branching activity (Bear et al., 2002; Skoble et al., 2001). 
There has been some debate on the significance of the processive actin 
polymerase and anti-capping activities of VASP, because the polymerase activity has 
been deemed very weak in in vitro assays (~1.5 x background spontaneous actin 
polymerization) (Breitsprecher et al., 2008; Breitsprecher et al., 2011), while the 
capping protein gelsolin prevented VASP activity in an early report (Boujemaa-
Paterski et al., 2001). This first controversy appears to be resolved by the fact that 
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VASP has a weak affinity for monomeric actin (10.3 µM) (Breitsprecher et al., 2011), 
while the concentration of actin in the cell is higher than this (~150 µM) (Koestler et 
al., 2009) and the concentration used in in vitro assays is lower (≤ 4 µM). Likewise 
weighing the evidence in the literature for the anti-capping activity of VASP against 
the early report which used a complex mixture including ActA and Arp2/3 
(Boujemaa-Paterski et al., 2001), which may have led to difficult-to-interpret results, 
has led researchers to favor the view that VASP’s anti-capping activity is functionally 
important (Bear and Gertler, 2009). 
 The domain architecture of VASP is shown in Figure 1.2. VASP contains an 
N-terminal EVH1 (Ena/VASP Homology 1) domain, a proline-rich region, and an 
EVH2 (Ena/VASP Homology 2) domain which is comprised of a G-acting binding 
motif (GAB), a filamentous F-actin binding motif (FAB), and a 15-residue repeat that 
forms a coiled coil which tetramerizes the protein (Krause et al., 2003). The EVH1 
domain contributes to the cellular localization of VASP by binding to the proline-rich 
(W/F)PxφP motif, where x is any amino acid and φ is an aliphatic residue. This motif 
most commonly occurs as the sequence “FPPPP,” and is found in various cytoskeletal 
proteins such as zyxin, lamellipodin, and vinculin (Ball et al., 2000; Niebuhr et al., 
1997). The proline-rich region of Ena/VASP proteins has multiple binding sites for the 
G-actin-binding protein Profilin (Reinhard et al., 1995), as well as binding sites for 
multiple SH3 and WW domains of various proteins, such as Abl (Gertler et al., 1996), 
Src (Gertler et al., 1996), and Fe65 (Ermekova et al., 1997). The SH3 and WW 
binding sites are generally divergent between the homologues VASP, Mena, and Evl. 
The G- and F-actin binding motifs are necessary for the actin nucleation (Walders-
Harbeck et al., 2002) and actin bundling (Bachmann et al., 1999) activities of VASP, 
respectively, while tetramerization of VASP enhances these functions (Bachmann et 
al., 1999; Walders-Harbeck et al., 2002).
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Figure 1.2: Domain architectures of the proteins VASP, zyxin, and IRAK1. 
 10 
 VASP is regulated by phosphorylation at multiple sites. PKA- and PKG-
mediated phosphorylation of Ser157, located immediately before the proline-rich 
region, changes VASP localization from primarily in stress fibers to primarily in focal 
adhesions in mouse endothelial cells (Benz et al., 2009). This may be related to the 
decreased affinity of phospho-S157 VASP for zyxin (Moody et al., 2009), which also 
appears in both stress fibers and focal adhesions (Crawford and Beckerle, 1991). 
Zyxin can obstruct its FPPPP VASP binding sites by a head-to-tail interaction with 
one of its own LIM domains, but exposes them in the presence of VASP, most likely 
because one of its LIM domains also binds VASP’s proline-rich region. However, 
phosphorylation of VASP at S157 prevents this LIM-domain interaction, keeping the 
VASP-binding sites in zyxin obstructed (Moody et al., 2009). Phosphorylation of 
VASP in the EVH1 domain at Tyr39 also influences VASP localization. This 
phosphorylation is performed by Abl tyrosine kinase in Bcr-Abl-transformed leukemic 
cells, and reduces VASP accumulation in focal adhesions (Maruoka et al., 2012). 
Remarkably, Tyr39 phosphorylation diminishes VASP binding to zyxin, despite 
Tyr39’s placement on the opposite face of the EVH1 domain from the proline-rich 
sequence binding site. VASP is also phosphorylated at S239 by both PKA and PKG, 
and at T278 by AMPK. These two sites are positioned directly after the GAB and 
FAB sites in the EVH2 domain, respectively. Phosphorylation at either of these sites 
diminishes VASP-mediated actin filament assembly (Benz et al., 2009).   
 
EVH1 and Ran-Binding Domains 
 EVH1 domains are found in Ena/VASP proteins, the related actin 
cytoskeleton-rearrangement protein WASP and its family members, the postsynaptic 
density protein Homer and its family members, and the recently-discovered related 
Sprouty and Spred families (Renfranz and Beckerle, 2002). Additionally, EVH1 
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domains have sequence and structural homology to the Ran-binding domains (RanBD) 
of the RanBP1 family (Callebaut et al., 1998). EVH1 and Ran-binding domains adopt 
a fold similar to PH domains, with a 7-strand antiparallel β-sandwich packed against a 
long C-terminal helix (Fedorov et al., 1999; Vetter et al., 1999). The EVH1 domains 
of VASP, WASP, and Homer all bind proline-rich motifs, with differing sequence 
specificities (shown in Figure 1.3), while it is not known what the Sprouty and Spred 
EVH1 domains bind (Ball et al., 2000; Beneken et al., 2000; Harmer et al., 2005; 
Niebuhr et al., 1997; Volkman et al., 2002). Ran-binding domains do not bind proline-
rich sequences but rather bind the small GTPase Ran (Beddow et al., 1995). 
There is now a wealth of crystal and NMR structures available of EVH1 
domains bound to peptides, and RanBDs bound to Ran (www.pdb.org). Although the 
binding specificity differs between domains, there are some conserved features of 
EVH1/RanBD interactions (Figure 1.3). The binding pocket that makes the most 
crucial contacts to the bound peptide is conserved throughout EVH1 and Ran-binding 
domains. Furthermore, EVH1 domains all recognize the same PPII structure despite 
the fact that the orientation of the WIP peptide bound to WASP-EVH1 is in the 
opposite orientation compared to Homer and VASP EVH1 domains (Volkman et al., 
2002). This can be explained by the rotational pseudosymmetry of the PPII structure, 
in analogy to the similar flexibility of SH3 domain proline motif recognition (Feng et 
al., 1994). Lastly, EVH1 domains employ a conserved network of aromatic and polar 
side-chains (in VASP, residues M14, Y16, W23, F79, and Q81) to directly interact 
with the carbonyl groups of their proline-rich binding motifs (Volkman et al., 2002).  
 Some EVH1 domains diverge from this framework. The most extreme 
example is the EVH1 domain of Mena, which in addition to canonical binding to 
FPPPP motifs can also bind the third LIM domain of Tes, a feature unique to 
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Figure 1.3: Conserved features of EVH1/RanBD interactions. (A) The EVH1 
domains of Mena, Homer, and N-WASP all bind proline-rich sequences (specified) in 
a conserved concave groove. Mena also binds the LIM domain of Tes at an 
overlapping site. (B) The first Ran-binding domain of RanBP2 binds a helical segment 
of Ran in this concave surface, while binding an extended sequence of Ran in a second 
binding site on the opposite face. RanBP2 residues R77, R88, and N91 participate in 
this second interaction. (Figure adapted from (Volkman et al., 2002))
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Mena (Boeda et al., 2007). Less extreme is the interaction between WASP-EVH1 and 
WIP, which wraps around the EVH1 domain to make additional contacts above and 
below the canonical binding site, utilizing residues in three distinct conserved WIP 
epitopes (Peterson et al., 2007; Volkman et al., 2002). The interaction between the 
RanBD1 of RanBP2 and Ran differs from EVH1 domain interactions in three main 
ways. First of all, the conserved binding site of RanBD1 binds a Ran sequence that 
adopts an α-helix followed by an acidic DEDDDL motif, as opposed to the proline-
rich sequences bound by WASP, VASP, and Homer. Secondly, the N-terminal 
sequence of RanBD1 extends to make significant contacts with Ran. Third, the N-
terminal sequence of Ran extends to make significant contacts with the face opposite 
the primary binding site of RanBD1, which is not contacted analogously in any EVH1 
domain architectures. Specifically, the sidechains of RanBP2 residues R77, R81, and 
N91 hydrogen bond with the carbonyl groups of the backbone of Ran residues M179, 
A181, and L182 (Vetter et al., 1999). Notably, this Ran sequence adopts a PPII helix, 
and its interaction with RanBD1 is distinctly reminiscent of the canonical mechanism 
of PPII recognition by these domains, in which sidechains hydrogen bond with the 
carbonyl groups of the PPII helix.   
 
Zyxin Function, Regulation, and Interaction with VASP 
Zyxin is a LIM domain protein that localizes primarily to focal adhesions, 
stress fibers, and adherens junctions (Beckerle, 1986; Crawford and Beckerle, 1991). 
In response to cellular mechanical stress, zyxin is phosphorylated at residue S142, 
which induces it to dissociate from focal adhesions and bind to damaged stress fibers 
(Hirata et al., 2008; Hoffman et al., 2012; Yoshigi et al., 2005). This may work by 
disrupting an inhibitory head-to-tail interaction which occurs between the proline-rich 
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region of zyxin and its LIM domains (Moody et al., 2009), which target it to cellular 
locations (Nix et al., 2001). Recruitment of VASP and the actin cross-linking protein 
α-actinin by zyxin then serves to repair and reinforce actin stress fibers (Hoffman et 
al., 2012).  
In addition to directly participating in the mechanical stress response, zyxin is 
also translocated to the nucleus in response to cyclic stretch in endothelial cells where 
it regulates transcription of a large number of stretch-sensitive genes (Nix et al., 2001; 
Wojtowicz et al., 2010). Additionally, mislocalization of zyxin by disrupting its 
interaction with α-actinin impacts cell migration and spreading (Drees et al., 1999).   
The domain architecture of zyxin is shown in Figure 1.2. Zyxin contains an N-
terminal region of undetermined structure which binds to α-actinin (Drees et al., 1999) 
as well as the cytoskeletal proteins LASP-1 and LIM-nebulette (Li et al., 2004). 
Following this sequence is a long sequence highly enriched in prolines and acidic 
residues, which contains four (W/F)PxφP VASP-binding motifs (Drees et al., 2000; 
Niebuhr et al., 1997). Lastly, zyxin has three LIM domains on its C-terminus which 
are involved in both localizing zyxin (Nix et al., 2001) and regulating its interaction 
with VASP (Moody et al., 2009).  
The appearance of four VASP binding sites in the proline-rich region of zyxin 
is reminiscent of several other VASP-binding proteins including lamellipodin, which 
contains five such sites, ActA, which contains four, and vinculin and palladin, which 
each contain two. This trend has been suggested to serve to strengthen the interaction 
with the tetrameric VASP, which in principle should bind a protein with four binding 
sites considerably tighter by the principle of avidity. Notably, in short peptide form 
none of the (W/F)PxφP motifs bind VASP-EVH1 with especially tight affinity (KD > 
60 µM) and the fourth motif has not shown any binding at all. Alternatively, four 
binding sites may instead bring together four VASP tetramers, which may function 
 15 
differently than an individual VASP tetramer (Ball et al., 2000). As mentioned earlier, 
it has been shown that VASP only exhibits its anti-capping activity when clustered on 
beads and not in solution (Breitsprecher et al., 2011). Lastly, the proximity of the 
second, third, and fourth binding sites in zyxin raise the question of whether or not 
these sites can all be simultaneously bound by separate EVH1 domains.  
Finally, it is interesting to note that VASP binds not just to the proline-rich 
region of zyxin but also to the LIM domain region (Moody et al., 2009). This not only 
allows for regulation of the interaction by either phosphorylation of VASP (Moody et 
al., 2009) or phosphorylation of zyxin by Akt (Call et al., 2011), but also changes the 
actin polymerase activity of VASP. When full-length zyxin, but not either of the 
individual regions, binds to VASP, the bundling and actin polymerase activity of 
VASP is greatly reduced (Grange et al., 2012).  
  
IRAK1 Function and Interaction with VASP 
 The IRAK (Interleukin-1 receptor associated kinase) family kinases play 
central roles in the innate immune response by participating in TLR and IL-1R 
signaling pathways (Flannery and Bowie, 2010). These signaling pathways coordinate 
such processes as the antiviral response, inflammation, and activation of the adaptive 
immune response (Martin and Wesche, 2002). Toll-like receptors recognize PAMPs 
which are common to certain pathogens but not the host, such as double stranded RNA 
(Alexopoulou et al., 2001), unmethylated CpG DNA sites (Hemmi et al., 2000), 
lipopolysaccharide (Hoshino et al., 1999), and flagellin (Hayashi et al., 2001). IL-1 
receptors on the other hand recognize cytokines such as IL-1 β and IL-18, which are 
expressed in response to TLR signaling. IL-1R and TLR signaling pathways share 
common downstream components, including the adapter MyD88, Tollip, and the 
members of the IRAK family of kinases (O'Neill, 2008). 
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 The IRAK kinases, IRAK1, IRAK2, IRAK3 (IRAKM), and IRAK4 in 
mammals, play related but distinct roles in innate immunity. Although all four proteins 
contain a kinase domain, IRAKM lacks kinase activity (Flannery and Bowie, 2010). 
IRAK1, a focus of this dissertation, is implicated in numerous autoimmune and 
inflammatory diseases including experimental autoimmune encephalomyelitis (an 
animal model of multiple sclerosis) (Deng et al., 2003), endotoxemia (Singh and Li, 
2012), atherosclerosis (Lakoski et al., 2007), and systemic lupus erythematosus (Jacob 
et al., 2009; Kaufman et al., 2013). On a cellular level, IRAK1 is important for 
production of IL-6 in response to stimulation of fibroblasts with IL-1 (Kanakaraj et al., 
1998), production of IFN-γ in response to stimulation of Th1 cells with IL-18 
(Kanakaraj et al., 1999), and production of IFN-α in response to TLR7 or TLR9 
activation (Uematsu et al., 2005).    
The domain architecture of IRAK1 is shown in Figure 1.2. IRAK1 consists of 
an N-terminal death domain which is required for recruitment to TLR and IL-1R 
signaling complexes (Lin et al., 2010; Wesche et al., 1997). This is followed by the 
undefined domain (IRAK1-UD), a proline- and serine-rich region which is involved in 
binding to various proteins including Pin1 (Tun-Kyi et al., 2011), Pellino (Lin et al., 
2008), NEMO (Conze et al., 2008), and VASP (Gan and Li, 2010). Following this 
region is a kinase domain, which is thought to autophosphorylate the proline-rich 
domain as well as additional targets (Kollewe et al., 2004; Uematsu et al., 2005). 
Finally, IRAK1 contains C-terminal domain which contains multiple TRAF6 binding 
sites (Jiang et al., 2002), and is thought to regulate IRAK1 activity by associating with 
the death domain (Nguyen et al., 2009).  
IRAK1, complexed with Tollip in the cytosol (Burns et al., 2000), is recruited 
to signaling complexes at the plasma membrane or the cytoplasmic face of endosomes 
following Toll-like or IL-1 receptor stimulation (Gottipati et al., 2008). The death 
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domain of IRAK1 participates in a helical array of the death domains of the adapter 
MyD88, IRAK4, and IRAK1 (or the partially-redundant IRAK2), the so-called 
Myddosome (Lin et al., 2010). IRAK4 next phosphorylates IRAK1 on residues T209 
and T387. This leads to activation of the kinase activity of IRAK1 and extensive 
autophosphorylation of the UD (Kollewe et al., 2004). This phosphorylation causes 
dissociation of IRAK1 from the Myddosome as well as Tollip from IRAK1 (Gottipati 
et al., 2008; Wesche et al., 1997). Depending on the signaling pathway, IRAK1 can 
then perform various functions, including phosphorylating IRF7 (Uematsu et al., 
2005), becoming sumoylated and translocated to the nucleus (Su et al., 2007), or 
forming a complex with TRAF6, IRAK4, and Pellino leading to TAK1 activation 
(Qian et al., 2001).   
 IRAK1 was recently shown to co-immunoprecipitate with VASP in human 
THP1 and MAT-2 cells. Furthermore, in murine bone marrow-derived macrophages 
(BMDM), IRAK1 is necessary for sustained PKC-induced phosphorylation of VASP 
at S157 in response to treatment with PMA, a PKC activator. This was suggested to 
influence cell migration, as IRAK1-defficient murine BMDMs migrated slower than 
wt cells in response to PMA treatment (Gan and Li, 2010). The connection between 
these two observations is not clear, however, because while human IRAK1 contains a 
VASP-binding site with the sequence LWPPPP in the proline-rich domain, mouse 
IRAK1 does not appear to contain a VASP-binding site.  
 The interaction between IRAK1 and VASP is notable in that it is the only 
known VASP-EVH1-binding motif to contain a tryptophan instead of phenylalanine, 
though tryptophan-containing sequences have been shown to bind tighter (Ball et al., 
2000; Niebuhr et al., 1997; Zimmermann et al., 2003). Furthermore, this motif does 
not contain flanking negatively charged residues, which have been shown to be 
important for tight interactions with VASP-EVH1 (Ball et al., 2000; Carl et al., 1999). 
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Rather, the VASP-binding motif in IRAK1 is flanked by serines, one of which (S173) 
is known to be phosphorylated (Tun-Kyi et al., 2011), and the other of which (S166) 
may be as well given the extensive autophosphorylation of the IRAK1-UD upon 
IRAK1 activation (Kollewe et al., 2004).   
 
Experimental Approach 
This dissertation describes, for the most part, studies of protein-protein and 
protein-peptide interactions, with a focus on proline-rich domains and sequences, 
which have relied heavily on NMR spectroscopy. This has been a successful approach 
for a few reasons. Proline isomerization, a key topic in this dissertation, occurs on the 
timescale of minutes or longer, resulting in distinct cis and trans peaks for each isomer 
in an NMR spectrum (Grathwohl and Wuthrich, 1976). Isomerization can be 
accelerated into the NMR-sensitive timescale of seconds with an isomerase enzyme 
such as CypA or Pin1, allowing for identification of pairs of isomers (Farrow et al., 
1994). Therefore, NMR provides more information about cis-trans equillibria than the 
static structures produced by X-ray crystallography. Secondly, these experiments have 
taken advantage of the utility of NMR spectroscopy to precisely measure moderate-to-
weak binding affinities ( DK >10 µM) with atomic-level information, even when the 
binding scheme being studied is significantly more complex than a simple one-to-one 
interaction (Kovrigin, 2012). We have mostly relied on protein titrations using routine 
15
N-
1
H HSQC spectra, and have aimed to extract as much information as possible 
from these experiments by paying close attention to minor details in the binding 
curves as well as to lineshapes. Lastly, we have benefitted from the sensitivity of 
NMR spectra to chemical exchange (both inter- and intramolecular) on the timescale 
of microseconds to seconds, allowing for measurements of binding rates and 
enzymatic rate constants by the analysis of lineshapes (Kovrigin, 2012; Palmer, 2004).  
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Our experiments have been limited to in vitro analysis of protein and peptide 
interactions—as such it has been important to maintain our focus on interactions that 
are deemed both biologically relevant and likely to return additional insights upon 
scrutiny of NMR data. We have largely focused on the intrinsically disordered proline-
rich domains of IRAK1 and zyxin, and the interactions between VASP-EVH1 and its 
binding site(s) in these domains. This seems an odd choice for NMR spectroscopy, as 
unstructured proline-rich regions tend to yield difficult, overlapped spectra, but we 
have benefitted from key details of the sequences of these domains. Firstly, the VASP 
binding site in IRAK1 features a tryptophan, which yields a sidechain indole amide 
peak well-resolved from the rest of the spectrum. Secondly, the zyxin sequence used 
was short enough and enriched so much in proline (which does not produce a peak in 
an 
15
N-
1
H HSQC) that overlap was not a major issue and assignments for non-proline 
residues were easily achievable. Finally, both sequences are very soluble and produce 
very sharp peaks due to their extreme flexibility and relatively fast tumbling rates. 
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CHAPTER 2 
Isomerase-Catalyzed Binding of IRAK1 to the EVH1 Domain of VASP
1
 
 
Abstract 
Interleukin-1 receptor-associated kinase 1 (IRAK1) is a crucial signaling 
kinase in the immune system, involved in Toll-like receptor (TLR) signaling. 
Vasodilator-stimulated phosphoprotein (VASP) is a central player in cell migration 
that regulates actin polymerization and connects signaling events to cytoskeletal 
remodeling. A VASP/IRAK1 interaction is thought to be important in controlling 
macrophage migration in response to PKCε activation. We show that the monomeric 
VASP-EVH1 domain directly binds to the 168WPPPP172 motif in the IRAK1 undefined 
domain (IRAK1-UD) with moderate ( transDK  = 116 ± 2 µM) affinity. We further show 
that this motif adopts distinct cis and trans isomers for the Trp168 – Pro169 peptide 
bond with nearly equal populations, and that binding to VASP-EVH1 is specific for 
the trans isomer, linking isomerization to binding. NMR lineshape analysis and 
tryptophan fluorescence experiments reveal the complete kinetics and 
thermodynamics of the binding reaction, showing diffusion-limited binding to the 
trans isomer followed by slow, isomerization-dependent binding. We further 
demonstrate that the peptidyl-prolyl isomerase (PPIase) cyclophilin A (CypA) 
catalyzes isomerization of the Trp168 – Pro169 peptide bond and accelerates IRAK1-
UD binding to VASP-EVH1. We propose that binding of IRAK1 to tetrameric VASP 
is regulated by avidity through assembly of IRAK1 onto receptor-anchored signaling 
complexes, and that an isomerase such as CypA may modulate IRAK1 signaling in 
vivo.  These studies demonstrate a direct interaction between IRAK1 and VASP, and 
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 Chapter 2 is based on a manuscript to be submitted at Biochemistry. 
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suggest a potential mechanism for how this interaction might be regulated by both 
assembly of IRAK1 onto an activated signaling complex and by PPIase enzymes.   
 
Introduction 
Toll-like receptors (TLRs) provide the first line of defense against viral, 
bacterial and fungal invaders (Moresco et al., 2011). These receptors recognize 
specific pathogen-associated molecular patterns (PAMPs) that are not normally 
present in the host, such as flagellin, double-stranded RNA, and lipopolysaccharides 
(LPS) (Carpenter and O'Neill, 2009; McGettrick and O'Neill, 2010; Uematsu and 
Akira, 2007). To date, at least 10 distinct human TLRs have been identified, some of 
which reside in the plasma membrane to detect extracellular PAMPs, while others 
localize to intracellular compartments where they detect endocytosed PAMPs 
(Casanova et al., 2011; Moresco et al., 2011). PAMP detection by TLRs triggers 
signaling cascades that upregulate the expression of type I interferons (IFNs) and 
proinflammatory cytokines to orchestrate innate and adaptive immunity. Such 
cytokines include interleukin-1 β (IL-1β) and the related IL-18, which are recognized 
by the interleukin-1 receptor (IL-1R) family of receptors. TLRs and IL-1Rs share a 
homologous cytoplasmic Toll/IL-1 receptor (TIR) domain and are therefore classified 
together as members of the Toll/Interleukin-1 family of receptors (Martin and Wesche, 
2002).   
While TLRs and IL-1Rs and their ligands are diverse, the signaling pathways 
of several of these receptors share specific components, such as the adaptor MyD88 
and the interleukin-1-receptor associated kinase 1 (IRAK1) (Martin and Wesche, 
2002). The activation of both TLR and IL-1R family members induces their 
dimerization (Qin et al., 2005; Watters et al., 2007). In mammals, the subsequent 
intracellular signaling steps include the assembly of a multi-protein complex (the 
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Myddosome) nucleated by the receptor TIR domains. A recent crystal structure 
suggests that, minimally, four MyD88 molecules bind the clustered receptor TIR 
domains and initiate a helical array onto which the death domains (DDs) of four 
IRAK4 molecules, then four IRAK1 (or IRAK2) molecules assemble (Lin et al., 
2010). Although the kinase activity of IRAK1 is involved in its subsequent 
dissociation from this receptor-initiated complex (Cao et al., 1996; Gottipati et al., 
2008), much of IRAK1 signaling function is accomplished as an adaptor protein 
through its interactions with downstream binding partners. Interactions with IRAK1 
are typically mediated through its DD, C-terminal domain, or undefined domain 
(Gottipati et al., 2008).  
The IRAK1 undefined domain (IRAK1-UD) is a 95-residue proline-rich region 
containing 27 Pro residues. To date, only a few proteins have been implicated as 
specific binding partners for this domain, namely Pin1 (Tun-Kyi et al., 2011), NEMO 
(Conze et al., 2008), and Pellino (Haghayeghi et al., 2010; Kim et al., 2011; Lin et al., 
2008). Additionally, the vasodilator-stimulated phosphoprotein (VASP) has recently 
been shown to co-immunoprecipitate and functionally interact with IRAK1 in the 
regulation of macrophage migration (Gan and Li, 2010). Cellular localization of 
VASP is mediated by an N-terminal Ena–VASP homology 1 (EVH1) domain, a 
binding module that recognizes the proline-rich motif (W/F)PxφP (Niebuhr et al., 
1997; Pistor et al., 1995; Ball et al., 2000) where x is any amino acid and φ is an 
aliphatic residue, and x and φ are frequently proline. This motif is present in the focal 
adhesion proteins Zyxin and Vinculin and the Listeria monocytogenes surface protein 
ActA, as well as in IRAK1 (Ball et al., 2002; Gan and Li, 2010). The interaction 
between VASP and IRAK1 is predicted to be mediated by the EVH1 domain of 
VASP, since the IRAK1-UD contains an EVH1 binding motif (168WPPPP172) and 
mutation of IRAK1 in this site (L167A, W168A) prevents co-immunoprecipitation 
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(co-IP) of IRAK1 and VASP (Gan and Li, 2010).  However, since co-IP can be 
mediated by additional factors, a direct interaction between VASP-EVH1 and IRAK1-
UD was not demonstrated. 
The proline content of the IRAK1-UD imparts special conformational and 
kinetic properties to this domain. In addition to disrupting secondary structure (Levitt, 
1978), proline residues tend to induce a considerable population of the cis isomer in 
their preceding peptide bond, between 5% and 40% depending mostly on the sequence 
of residues immediately preceding and following the proline (Reimer et al., 1998). 
Inter-conversion between prolyl isomers is a slow process with a time constant of 
between 100-1000 s, but prolyl isomerase enzymes have evolved that accelerate this 
isomerization (Fischer et al., 1984). One such isomerase is cyclophilin A (CypA), a 
cytosolic enzyme with specific roles in viral infectivity (Towers, 2007) and signaling 
in immune cells (Bannon et al., 2012; Colgan et al., 2004; Nicholson and Lu, 2007; 
Sarkar et al., 2011; Song et al., 2011). 
Here, we demonstrate and quantify the direct interaction between the VASP-
EVH1 domain and the 168WPPPP172 region of IRAK1-UD and show that binding is 
specific for the trans isomer of the W168-P169 peptide bond. Strikingly, at equilibrium 
the W168-P169 peptide bond is 43% cis and 57% trans, with nearly half of the protein in 
the cis conformation incapable of binding to VASP-EVH1. We speculate that this 
relatively weak interaction ( trans
DK = 116 ± 2 µM) could act as a molecular switch 
whereby this affinity of IRAK1 for VASP (a constitutive tetramer) is dramatically 
enhanced by avidity when multiple IRAK1 molecules assemble onto the activated 
Myddosome. IRAK1 could thereby recruit VASP to the plasma membrane in response 
to TLR or IL-1 receptor signaling. In a particularly novel finding, we show that the 
peptidyl-prolyl isomerase CypA accelerates the completion of the IRAK1-UD/VASP-
EVH1 binding reaction, effectively catalyzing binding through its isomerization of the 
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W168-P169 peptide bond. These studies provide the first demonstration of a direct 
interaction between IRAK1 and VASP, and suggest a potential mechanism for how 
this interaction might be regulated by both assembly of IRAK1 onto an activated 
Myddosome and by peptidyl-prolyl isomerase enzymes.   
 
Materials and Methods 
Protein and Peptide Preparation.  
All proteins were expressed as N-terminal 6X-His tagged fusion proteins in 
BL21-DE3 Escherichia coli cells. Human IRAK1-UD (IRAK1 residues 101-222) was 
encoded in a pET vector (kanamycin resistance) with a TEV protease cleavage site 
between the 6X-His tag and the protein. Human VASP-EVH1 (VASP residues 1-115) 
was encoded in a pMW172 vector (ampicillin resistance, a gift from M. Way, London 
Research Institute) with a 3Cpro protease cleavage site between the 6X-His tag and 
protein as described (Boeda et al., 2007). Human CypA (full length) was encoded in a 
pTFT74 vector (ampicillin resistance, gift from C. Kalodimos, Rutgers University) 
without a cleavage site as described (Piotukh et al., 2005). Cells were grown in 1 L 
M9 medium with 19 mM 
15
NH4Cl (or 
14
NH4Cl to produce unlabeled protein) and 
antibiotic at 37 ˚C until they reached an OD600 of ~ 0.8. Protein expression was then 
induced with 1 mM IPTG for ~ 4 hours at 37 ˚C (IRAK1-UD) or ~ 16 hours at 18 ˚C 
(VASP-EVH1 and CypA), after which cells were harvested and resuspended in 20 ml 
wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 0.1 mM TCEP, pH 
8.0) with 100 µl protease inhibitor cocktail and 1 mM TCEP added. Cells were lysed 
by freezing and thawing, adding 20 mg lysozyme, and sonicating on ice for 10 cycles. 
Cell debris was removed by centrifuging at 23,000 g followed by filtering the 
supernatant with a 0.8-µm syringe filter. The filtrate was passed through a nickel-NTA 
column which was then washed with 20 bed volumes of wash buffer. Protein was 
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eluted with 10 ml of elution buffer (50 mM Na2HPO4, 300 mM KCl, 100 mM 
imidazole, pH 8.0) and dialyzed into cleavage buffer (50 mM Tris-HCl, 1 mM TCEP, 
pH 8.0) or NMR buffer (20 mM KH2PO4, 50 mM KCl, 1 mM TCEP, pH 6.7) in the 
case of CypA. After dialysis, recombinant His-tagged 3C protease or TEV protease 
was added to the protein sample and the cleavage reaction was performed overnight at 
4 ºC. The His tag and His-tagged protease were then removed by passing the cleavage 
reaction back through a nickel-NTA column. The flow-through was dialyzed into 
NMR buffer, and concentrated with 5000 MWC centrifugal concentrators as 
necessary. NMR samples also contained 5 mM NaN3 and 7% D2O. The NMR sample 
in the 
15
N-ZZ experiment had 10 mM TCEP to prevent oxidation of the especially 
concentrated sample. Protein concentration was measured by UV absorbance using the 
theoretical extinction coefficients at 280 nm of 23,500 cm
-1
M
-1
 for wild-type IRAK1-
UD, 21,000 cm
-1
M
-1
 for VASP-EVH1, and 8,500 cm
-1
M
-1
 for CypA. Plasmids 
encoding the IRAK1-UD mutants W102G/W130G/W200G and 
W102F/W130F/W168F were generated by three sequential rounds of site-directed 
mutagenesis using the Quikchange protocol (Stratagene), mutant IRAK1-UD proteins 
were produced as above, and protein concentrations were determined using the 
adjusted theoretical extinction coefficient (5,500 cm
-1
M
-1
).   
A synthetic peptide encompassing IRAK1 residues P162-K180 (IRAK1
162-180
) 
was purchased and received as a lyophilized powder (Tufts Core Facility, Boston, 
MA). Likewise, a peptide encompassing ActA residues 333-344 (ActA
333-344
) was 
purchased from Genscript (Piscataway, NJ). Peptides were dissolved in NMR buffer. 
Peptide concentrations were determined by UV absorbance, using the theoretical 
extinction coefficient of 5500 cm
-1
M
-1
 at 280 nm for IRAK1
162-180
 and 390 cm
-1
M
-1
 at 
257 nm for ActA
333-344
. Sample pH was adjusted using NaOH and HCl before use. 
NMR Data Collection/Processing.  
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All NMR experiments were performed on a Varian Inova 600 MHz 
spectrometer equipped with a {H, C, N} Z-axis gradient probe. Unless otherwise 
stated, NMR experiments were performed at 25 ºC. All NMR spectra were processed 
and analyzed with the software nmrPipe (Delaglio et al., 1995), nmrDraw (Delaglio et 
al., 1995), and Sparky (Goddard TD, 2008). Either an exponential or phase-shifted 
sine bell window function was applied to free induction decays prior to Fourier 
transformation. The Sparky peak detection function was used to measure peak 
positions and heights.  
NMR Titration Experiments. 
Altogether, four titration experiments were carried out. Three titrations of 
15
N 
EVH1 domain (with unlabeled IRAK1-UD, IRAK1
162-180
, and ActA
333-344
) were 
performed, as well as a titration of 
15
N IRAK1-UD with unlabeled EVH1 domain. In 
each titration, the most saturated sample was prepared first and the subsequent titration 
samples were prepared by mixing a portion of the previous sample with a stock of 
labeled protein, thus keeping the concentration of labeled protein constant while 
varying the titrant concentration. All titrations were performed in NMR buffer with 5 
mM NaN3 and 7% D2O. In the titration of 
15
N EVH1 domain with IRAK1-UD, the 
concentration of EVH1 was held at 0.51 mM and the IRAK1-UD concentrations were 
0, 0.07, 0.11, 0.17, 0.25, 0.38, 0.56, 0.84, and 1.27 mM. In the titration of 
15
N EVH1 
domain with IRAK1
162-180
, the concentration of 
15
N EVH1 was held between 0.35-
0.38 mM and the peptide concentrations were 0, 0.03, 0.06, 0.12, 0.24, 0.48, 0.95, 1.9, 
and 3.8 mM. In the titration of 
15
N EVH1 domain with ActA
333-344
, the concentration 
of 
15
N EVH1 was held at 0.37 mM and the peptide concentrations were 0, 0.04, 0.08, 
0.15, 0.30, 0.61, 1.21, 2.43, and 4.86 mM. In the titration of 
15
N IRAK1-UD with 
EVH1 domain, the concentration of 
15
N IRAK1-UD was held at 0.34 mM and the 
EVH1 concentrations were 0, 0.18, 0.35, and 0.70 mM. For each titration condition, a 
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15
N-
1
H fast-HSQC (Mori et al., 1995) spectrum was recorded with a spectral width of 
8 kHz  in the proton dimension (total of 2048 complex data points) and 1.7 kHz (
15
N 
UD-perspective titration and 
15
N EVH1-perspective IRAK1-UD titration) or 1.8 kHz 
(
15
N EVH1 peptide titrations) in the nitrogen dimension (total of 256 complex data 
points).  
Quantification of Binding and NMR Lineshape Analysis. 
The peak trajectories of resolved residues in NMR titrations were used to 
determine binding constants. For a given peak, the change in chemical shift between 
the apo spectrum and a titration point spectrum spectrum for the proton and nitrogen 
dimensions, 
H   and N , were fit as a function of the apparent dissociation 
constant, AppDK , and the protein/peptide molar concentrations. For given total 
concentrations of EVH1, [EVH1
tot
], and IRAK1, [IRAK1
tot
], the concentration of 
bound complex, [EVH1:IRAK1], is given by 
          (2.1) 
 
Using chemical shift changes of 
15
N EVH1 peaks, AppDK  was determined from the 
titrations of 
15
N EVH1 with IRAK1-UD and IRAK1
162-180
 using the equation 
           (2.2) 
where i is H or N, and max  is the chemical shift difference between free and bound 
(a fitted parameter). To account for inaccuracies in the calculation of the extinction 
coefficient, the concentrations of peptide in the ActA
333-344
 titration were scaled by a 
fitted correction factor, corrL  using the equation      
(2.3) 
This was warranted given the sharp binding curves, which were very sensitive to 
stoichiometry. For each titration set, the reported AppDK  value and its error 
were 
determined by fitting each of 21 
1
H and 21 
15
N chemical shift datasets independently, 
2
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and taking the mean and standard error of the resulting fitted values. Fits were 
performed by least-squares minimization using the Solver function in Microsoft Excel.  
 Lineshape analysis of the 
15
N EVH1 peptide titrations was carried out as 
described (De et al., 2012), using the BiophysicsLab Matlab package (Kovrigin, 2012). 
Lineshapes were extracted as 1D slices in each dimension (
1
H, 
15
N) using the 
BiophysicsLab Sparky extension. To eliminate any titration-dependent variation in 
signal intensity, the area under each peak slice was normalized. The software 
calculates the populations of free and bound EVH1 domain using equation 2.1 and 
simulates lineshape data using the two-state solution to the Bloch-McConnell 
equations (McConnell, 1958) (Cavanagh J, 2007). The dissociation constant, AppDK , 
apo chemical shift, Apo , and linewidth of the apo state, 2,0
ApoR , previously determined 
by peak positions and the spectrum of apo 
15
N EVH1, were constrained while the 
dissociation rate, offk , bound chemical shift, 
Bound , and linewidth of the bound state, 
2,0
BoundR , were determined by least squares fitting. We report the average and standard 
error of the fitted parameters offk and onk  from individual fits of four lineshape 
datasets. A global fit which yielded statistically equivalent values of these parameters 
was also performed. 
Modeling the IRAK1/EVH1 complex. 
The model of VASP-EVH1 bound to IRAK1
162-180
 was built using a solution 
structure of the VASP EVH1 domain (PDB ID code 1EGX (Ball et al., 2000)) and a 
crystal structure of the complex between the Mena EVH1 domain and an ActA-
derived peptide (PDB ID code 1EVH (Prehoda et al., 1999)) with the sequence 
FPPPPT. The Mena and VASP EVH1 structures were overlaid using the “magic fit” 
function in the program Swiss-Pdb viewer (Guex and Peitsch, 1997). The IRAK1 
sequence A165-A175 was introduced into the binding site by changing the ActA 
peptide (chain B) in the complex crystal structure to the IRAK1 sequence using the 
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“mutate” and “add residue” functions in Swiss-Pdb viewer. The torsion angles of 
W168 in the IRAK1 peptide were adjusted to align the indole ring with the 
phenylalanine side chain in the ActA peptide sequence, and the torsion angles of R83 
in the EVH1 domain were adjusted slightly to accommodate the bound peptide. 
Energy minimization was performed using the GROMOS96 implementation within 
Swiss-Pdb viewer.  
Demonstration of Isomerization by Nzz Exchange Spectroscopy. 
15
N-ZZ exchange spectroscopy (Farrow et al., 1994) was performed on a 0.8 
mM 
15
N-IRAK1-UD sample, with or without 8 µM CypA in NMR buffer. Mixing 
times were 0, 0.01101, 0.02202, 0.03303, 0.04404, 0.05505, 0.082575, and 0.1101 s. 
For each spectrum, a spectral width of 8 kHz (total of 2048 complex data points) was 
used in the proton dimension, and 1.7 kHz (total of 256 data points) in the nitrogen 
dimension, with 40 transients per FID and a recycle delay of 1.0 s. To assist in 
identifying crosspeaks, the spectra with nonzero mixing time were added together 
using the NMRPipe command addNMR. To determine the rate of W168-P169 
isomerization, peak heights for autopeaks and crosspeaks corresponding to the 
sidechain of W168 were obtained using Sparky. The heights of these four peaks as a 
function of mixing time were fit to the two-state solution of the Bloch-McConnell 
equations (Cavanagh J, 2007; McConnell, 1958) by least-squares minimization with 
Microsoft Excel (Solver function). The longitudinal relaxation constants for the cis 
and trans isomers, 1,0
transR and 1,0
cisR , (determined by running the 15N-ZZ exchange 
experiment without CypA present) and the ratio of trans to cis isomer, isomK  
(determined from homonuclear TOCSY peak volumes corresponding to the cis and 
trans isomers of the W168-P169 peptide bond), were treated as fixed parameters. Fitted 
parameters included the initial intensities of autopeaks, ,0TTI  and ,0CCI , and the 
exchange rate of isomerization, exk . The mixing time dependences of all four peaks 
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were fit simultaneously. 
Tryptophan Fluorescence Experiments.  
All tryptophan fluorescence experiments were carried out using a F-7000 
fluorescence spectrophotometer (Hitachi High Technologies America, Schaumburg, 
IL). In mixing experiments, 2 ml of 100 µM (IRAK1
162-180
 experiment) or 77 µM 
(ActA
333-344
 experiment) EVH1 domain, with or without 62 nM of CypA, was 
equilibrated in a quartz cuvette, gently stirred and temperature controlled at 25 ºC. 
Peptide was then diluted from a concentrated stock into the cuvette for a final 
concentration of 53 µM (IRAK1
162-180
 experiment) or 50 µM (ActA
333-344
 experiment) 
and a time course was recorded (2 s interval, 40 minutes, or 0.5 s interval, 20 minutes). 
The fluorescence signal was measured by exciting at 294 nm and collecting at 360 nm 
(2.5 nm bandpass for excitation, 20 nm bandpass for emission) for the IRAK1
162-180
 
experiment, and exciting at 290 nm and collecting at 334 nm (2.5 nm bandpass for 
excitation, 20 nm bandpass for emission) for the ActA
333-344
 experiment. In the 
dilution experiments, 4 µl of an equilibrated stock containing 1 mM EVH1 domain 
and 1 mM IRAK1
162-180
 was diluted into 2 ml of NMR buffer (or NMR buffer with a 
catalytic quantity of CypA) in a stirred and temperature controlled (T = 20, 25, 30ºC) 
quartz cuvette. A time course was then recorded (1 s or 0.5 s interval, 15-50 minutes). 
The fluorescence signal was measured by exciting at 280 nm and collecting at 360 nm 
(1.0 nm bandpass for excitation, 20 nm bandpass for emission). Fluorescence data was 
fit following subtraction of a baseline, which was determined either from taking data 
of the EVH1 domain prior to adding peptide, or, for the dilution experiments, using 
the data from long after the exponential signal had stabilized. Data was fit to the 
exponential function, 
         (2.4) 
where finalI   and 0I   are the equilibrium and initial fluorescence intensities, 
0( ) ( )
obstk
final finalI t I I I e
  
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respectively, and 
obsk   is the rate constant given by (De et al., 2012; Hagerman and 
Baldwin, 1976; Ng and Weis, 1998)  
         (2.5) 
where 
CTk   and TCk  are the cis-to-trans and trans-to-cis rates of isomerization. The 
rates
CTk  and TCk  reflect the intrinsic isomerization rates when the experiment is 
performed in the absence of CypA, but increase linearly with the concentration of 
CypA. Equation 2.5 is an approximation that requires that the kinetics of binding be 
fast compared to the kinetics of isomerization, and that [ 1 ]freeEVH  can be treated as a 
time-independent parameter. In the dilution experiment, [ 1 ] /
free App
DEVH K  
approximates to 0 and the equation reduces to (1 1/ )obs CT TC CT isomk k k k K    .  
To measure the affinity of EVH1 binding to ActA
333-344
 using tryptophan 
fluorescence, 50 µM EVH1 with 1 µM CypA was incubated in the quartz cuvette at 25 
ºC and ActA
333-344
 was titrated in 7 µM increments. Data was collected as a time 
course to monitor stability of signal. For each titration point, a time course was 
collected (10 s, 0.1 s interval) and the average fluorescence signal at each peptide 
concentration was fit to a standard bimolecular binding curve in analogy to equations 
1 and 2. As in the NMR titration, the peptide concentration was scaled by a fitted 
correction factor to account for inaccuracies in the extinction coefficient calculation. 
All fitting of fluorescence data was performed by least squares minimization using the 
Solver function in Microsoft Excel.  
 
Results 
The undefined domain of IRAK1 is conformationally heterogeneous  
As a first step toward characterizing the IRAK1/VASP interaction, 
15
N-labeled 
human IRAK1-UD (residues 101-222, Figure 2.1A) was examined by two-
dimensional NMR spectroscopy. The 
15
N-IRAK1-UD yields a 
15
N-
1
H HSQC 
[ 1 ]
/ (1 )
free
obs CT TC App
D
EVH
k k k
K
  
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spectrum with very narrow peak dispersion, characteristic of a disordered polypeptide 
(Figure 2.1B). Furthermore, it displays a number of minor peaks at low contour level, 
which, given the 27 proline residues in this sequence, could be attributed to the cis 
isomers of the various X-Pro peptide bonds (demonstrated below). Because cis-trans 
isomerization is a slow process with an exchange time constant (τ) on the order of 
minutes in the absence of isomerase activity (Reimer et al., 1998), an equilibrium 
between cis and trans isomers generally results in two distinct NMR peaks for 
residues whose chemical environment differs for the two isomers. The four Trp indole 
NHs in this sequence give rise to six peaks (Figure 2.1C), with the two W-P motifs 
(W168-P169 and W200-P201) each giving rise to two peaks corresponding to their 
comparable cis and trans populations. Unique resonance assignments of the W168 and 
W200 indole NH peaks were obtained via mutagenesis (Figure 2.1C). Based on peak 
volumes, the equilibrium cis and trans populations of the W168-P169 peptide bond are 
nearly equal (43% cis and 57% trans by TOCSY spectra, 45% cis and 55% trans by 
HSQC), yielding an equilibrium constant of isomK  = [trans]/[cis] = 1.33. Similarly, the 
populations of W200-P201 are 35% cis and 65% trans. This is consistent with the 
intrinsic tendency of the bulky tryptophan side chain to induce a large cis population 
when preceding a proline (Reimer et al., 1998).  
By employing 3D TOCSY and NOESY experiments on the 
15
N-IRAK1-UD, 
and aided by homonuclear TOCSY and NOESY spectra of an IRAK1-derived peptide 
encompassing residues P162-K180 (IRAK1
162-180
) it was possible to determine peak 
assignments for several residues in and around the 168WPPPP172 motif (Table 2.1). 
Several residues within the A165-S173 region exhibited distinct chemical shifts for the 
two isomers of the W168-P169 peptide bond, and distinct cis (25%) and trans (75%) 
peaks were also observed for the isomers of the S173-P174 peptide bond (Appendix 
Figure 2.1). Assignments of the prolyl isomers of the W168-P169 peptide bond were  
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Figure 2.1: Conformational heterogeneity in the undefined domain of IRAK1. (A) 
Sequence of the IRAK1-UD construct used (IRAK1 residues 101-222). The backbone 
NH region of the 
15
N-
1
H HSQC spectrum of IRAK1-UD (B) shows very narrow 
chemical shift dispersion, indicating that the UD does not adopt a stable fold. The 
tryptophan sidechain indole peaks, located downfield (C) display six peaks for the four 
tryptophans in the sequence (top). The two W-P motifs in this sequence, W168 and 
W200, were identified (middle and bottom) by mutating the other tryptophans (using 
the W102G/W130G/W200G and W102F/W130F/W168F IRAK1-UD mutants, 
respectively), and the cis and trans isomers of each are labeled.    
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accomplished both by identification of characteristic through-space NOEs to proline 
protons from the preceding residue’s alpha proton ( d  for the trans isomer and d  
for the cis isomer), and by exchange cross peaks in the 
15
N-ZZ exchange experiment 
in the presence of the isomerase CypA, as described below. 
 
Table 2.1: Chemical Shift Assignments of IRAK1 Residues A165-A175 for the Cis 
and Trans Isomers of W168-P169 
Residue N NH Hα Hβ other
W168-P169 trans
A165 124.306 8.261 4.131 1.301
S166 115.062 8.066 4.299 3.769, 3.722
L167 124.392 7.934 4.14 1.23, 1.278 δCH2 0.785, 0.725
W168 122.59 7.918 4.942 3.039, 3.275 εNH 10.026
P169 - - 4.72 * δCH2 3.76,3.57
P170 - - * * *
P171 - - * * *
P172 - - * * *
S173 118.216 8.353 4.654 3.765, 3.836
P174 - - * * *
A175 126.655 8.359 4.541 1.327
W168-P169 cis        
A165 124.537 8.31 4.283 1.376
S166 115.425 8.168 4.42 3.855
L167 125.01 8.098 4.344 1.556 δCH2 0.888, 0.832
W168 123.538 8.037 4.477 3.111 εNH 10.201
P169 - - 3.26 * δCH2  3.37,3.27
P170 - - * * *
P171 - - * * *
P172 - - * * *
S173 118.228 8.326 4.669 3.829, 3.747
P174 - - * * *
A175 126.655 8.359 4.541 1.327  
 (-) indicates proline residues that do not have amide protons or routinely-observed 
nitrogen chemical shifts.  
(*) indicates chemical shifts that were not assignable due to overlap. 
 
These results, which represent the first structural information on the proline-
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rich IRAK1 undefined domain, show that this domain is conformationally 
heterogeneous. While the narrow chemical shift dispersion in the 15N-1H HSQC 
spectrum indicates rapid exchange between allowed regions of backbone 
conformational space, the additional peaks arising from cis-trans isomerization 
demonstrate that multiple sites undergo slow two-state exchange, adding to the 
conformational richness of this domain.    
Determination of the IRAK1-UD recognition sequence and isomer-specificity of 
interaction with VASP-EVH1 
 When 
15
N-IRAK1-UD was titrated with VASP-EVH1, six backbone peaks and 
one tryptophan sidechain peak move substantially. These peaks correspond to the NH 
groups of A165-A175 (proline residues in the sequence do not yield 
15
N-
1
H HSQC 
peaks) (Figure 2.2A, B). This demonstrates that binding is specific for the 
168WPPPP172 motif in IRAK1-UD and that the interaction is in fast exchange on the 
NMR timescale (Cavanagh J, 2007) (~4000 s
-1
 in this case). As described above, this 
region of the IRAK1-UD sequence exhibits distinct peaks corresponding to the cis and 
trans states of the W168-P169 peptide bond. While the peaks corresponding to the trans 
isomer of W168-P169 move significantly upon binding, the cis isomer peaks simply 
decrease in intensity as EVH1 is added, indicating that the interaction is specific for 
the trans isomer (Figure 2.2A, B). Therefore, a coupled equilibrium model that 
includes both cis-trans isomerization and binding (Figure 2.2C) is indicated for this 
system. This result is consistent with the crystal structures of both the EVH1 domain 
of Mena  (Prehoda et al., 1999) and Evl (Fedorov et al., 1999) bound to ActA peptides, 
which show a trans peptide bond between the phenylalanine and the first proline of 
the bound FPPPP sequence. 
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Figure 2.2: The IRAK1-UD/VASP-EVH1 interaction is trans-specific. (A) When 
15
N-labeled IRAK1-UD is titrated with unlabeled VASP-EVH1 domain in a series of 
15
N-
1
H HSQC spectra, peaks corresponding to the backbone and side-chain amides of 
IRAK1 residues 165-175 (excluding prolines) display different behaviors depending 
on the isomer state of W168-P169. Colors represent progression of [EVH1] with red 
being apo IRAK1-UD and blue being highest [EVH1]. Top shows a portion of the 
backbone amide region of the 
15
N-
1
H HSQC series, and bottom shows the tryptophan 
indole region of the spectra. (B) Composite chemical shift changes, 
2 2( ) (0.154 ( ))Apo ApoH H N N          , of backbone and side chain amides of 
IRAK1 residues 165-175 between the apo and final spectra of the EVH1/
15
N IRAK1-
UD titration. Black bars represent peaks corresponding to the trans isomer of W168-
P169, and grey bars represent peaks for the cis isomer, for peaks that were discernible 
in the final spectrum. (C) The coupled equilibrium model, including isomerization in 
the IRAK1 protein and trans-specific binding, used to interpret and fit binding data. 
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Determination of the thermodynamics and kinetics of the interaction between IRAK1-
UD and VASP-EVH1 
In order to measure the affinity and kinetics of binding between IRAK1-UD 
and VASP-EVH1, 
15
N-EVH1 was titrated with unlabeled IRAK1
162-180
. Use of 
IRAK1
162-180 
rather than the full IRAK1-UD was preferred due to its solubility 
(allowing saturation of 
15
N-EVH1 to be approached) and its negligible contribution to 
the molecular weight of the bound complex. This titration yielded several resolved 
peak trajectories (Figure 2.3A), indicating fast exchange on the NMR timescale as was 
observed from the 
15
N-labeled IRAK1-UD perspective (Figure 2.2). Using the peak 
assignments for VASP-EVH1 (BioMagResBank accession number 18569 (Ball et al., 
2000)), we observed that the pattern of chemical shift perturbations across the EVH1 
sequence upon adding IRAK1
162-180
 closely matches that observed for the FPPPP 
motifs in ActA binding to VASP-EVH1 (Ball et al., 2000). This was confirmed by 
titrating 
15
N-EVH1 with an ActA-derived peptide ActA
3333-344
 
(333FEFPPPPTEDEL344) and comparing chemical shift perturbations (Figure 2.3B). 
This suggests that IRAK1
162-180
 binds in the same orientation as displayed by 
published structures of Ena/VASP EVH1 domain peptide complexes (Fedorov et al., 
1999; Prehoda et al., 1999). The largest perturbations arose from residues (e.g. W23 
sidechain, K71, Y72, N73 sidechain, A75, Q81 sidechain, R83) in the binding surface 
defined by the crystal structure of the Mena EVH1/ActA complex (Prehoda et al., 
1999), as illustrated by mapping chemical shift perturbations to the EVH1 solution 
structure (Ball et al., 2000) (Figure 2.3C). Analysis of 21 
1
H and 21 
15
N chemical shift 
datasets yielded an apparent dissociation constant AppDK  of 0.203 ± 0.003 mM 
(example fits are shown in Figure 2.4A). This apparent affinity corresponds to a 
trans
DK of 0.116 ± 0.002 mM, adjusted for coupling to the cis-trans equilibrium (Figure 
2.2D) by the equation 
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Figure 2.3: Chemical shift mapping to EVH1 structure. 
15
N EVH1 domain was 
titrated with the IRAK1-derived peptide IRAK1
162-180
 and a series of 
15
N-
1
H HSQC 
spectra (A) were taken. Colors indicate peptide concentration, transitioning between 
free (red) and bound (purple) EVH1. (B) Composite chemical shift changes
 
for 
15
N 
EVH1 peaks between apo and peptide bound positions. Chemical shift changes for 
IRAK1
162-180
 titration are shown in red and changes for ActA
333-344
 titration are shown 
in blue. (C) Representation of the solution structure of the VASP EVH1 domain (PDB 
ID code 1EGX (Ball et al., 2000)) with the IRAK1 peptide-induced chemical shift 
perturbations mapped to it. For each residue, the surface representation is colored 
according to the greater of the chemical shift changes of the backbone and sidechain 
amide. Images were generated using the surface view representation and colored 
according to chemical shift perturbation using the data2bfactor.py and color_b.py 
scripts from Dr. Robert L. Campbell’s PyMol script repository at Queen’s University, 
Ontario, Canada (http://pldserver1.biochem.queensu.ca/~rlc/work/pymol/) in PyMOL 
(Delano, 2002). The peptide was modeled into the binding site by homology with the 
crystal structure of the Mena EVH1 domain bound to an ActA-derived peptide (PDB 
ID code 1EVH (Prehoda et al., 1999)). 
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          (2.6) 
where trans
DK  is the dissociation constant of the trans isomer of IRAK1 binding to the 
EVH1 domain, and isomK  is the ratio of trans to cis for the free W168-P169 peptide bond 
as determined above. Titration of 
15
N EVH1 with full-length IRAK1-UD yielded 
App
DK = 0.28 ± 0.02 mM (data not shown). This reasonable agreement further validated 
the use of the peptide. 
Lineshape analysis of the above titration data was employed to determine the 
on- and off-rates of the VASP-EVH1/IRAK1-UD interaction, as described previously 
(De et al., 2012) and in Materials and Methods. The 
15
N-EVH1 peaks that move the 
most in response to IRAK1
162-180
 binding all display a similar pattern of broadening at 
intermediate titration points before narrowing as saturation is reached (Figure 2.4B). 
This exchange broadening is dependent on the difference in chemical shift and the 
timescale of exchange between the free and bound states. Each peak that is resolved 
throughout the titration therefore potentially provides two independent measures of the 
binding kinetics via the peak lineshapes, one in the 
1
H and one in the 
15
N dimension. 
Analysis of four lineshape datasets (A75-
1
H, W23sc-
1
H, W82sc-
1
H, Q81sc-
15
N) 
yielded a offk  of 4,000 ± 200 s
-1
 and a 
onk  of 3.5 ± 0.1 10
7
 M
-1
s
-1
 (Figure 2.4B). This 
on-rate is near the diffusion limit, as is common for interactions with proline-rich 
sequences (Kay et al., 2000). Repeating this analysis with the 
15
N EVH1/ActA
333-344 
data (data not shown) yielded a substantially faster on-rate (
onk = 1.2 ± 0.1 10
8
 M
-1
s
-1
, 
offk  = 1,800 ± 200 s
-1
), however, suggesting that electrostatic steering by the negative 
charges in this ActA sequence can contribute to the binding rate. 
 
(1 1/ )App transD D isomK K K 
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Figure 2.4: Measurement of affinity and kinetics of binding between the VASP-
EVH1 domain and IRAK1
162-180
. (A) Composite chemical shift changes between 
free and bound states for selected EVH1 peaks as a function of peptide concentration 
(symbols). The data were fit (solid lines) to obtain the apparent dissociation constant 
( AppDK ) of the interaction of 0.203 ± 0.003 mM. (B) NMR lineshape analysis of 
selected EVH1 peaks in the peptide titration series. 1D slices through the centers of 
15
N EVH1 peaks were extracted along the 
15
N or 
1
H dimensions, and the data 
(symbols) were fit (solid lines) to yield on and off rates. The obtained rates were 
onk  = 
3.5 ± 0.1 10
7
 M
-1
s
-1
 and offk = 4,000 ± 200 s
-1
. 
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Demonstration of cyclophilin A catalysis of W168-P169 isomerization by NMR 
spectroscopy 
 To test whether CypA catalyzes isomerization of the W168-P169 peptide bond in 
IRAK1, we applied 2D 
15
N-ZZ NMR exchange experiments to 0.8 mM 
15
N-IRAK1-
UD in the presence of 8 µM CypA (Figure 2.5A). 
15
N-ZZ spectroscopy allows for the 
identification and measurement of conformational exchange in the range between 
about 0.1 and 10 s
-1
 (Farrow et al., 1994). Since the lower limit of this rate regime is 
approximately one to two orders of magnitude faster than typical uncatalyzed cis-trans 
isomerization rates (Reimer et al., 1998), intrinsic (uncatalyzed) cis-trans 
isomerization exchange is not detected in this experiment. If two peaks display mutual 
cross-peaks in an 
15
N-ZZ spectrum, it indicates that the same nucleus exchanges 
between two distinct states, and monitoring the cross-peak intensity as a function of 
mixing time allows for measurement of the exchange rate (Farrow et al., 1994). In the 
15
N-ZZ spectra of 
15
N-IRAK1-UD, exchange cross peaks between many pairs of cis 
and trans isomers of X-Pro motifs throughout the sequence were observed in the 
presence of but not in the absence of CypA, indicating both the general lack of 
sequence specificity of CypA activity (Schmidpeter et al., 2011; Zoldak et al., 2009) 
and the high conformational heterogeneity of the proline-rich IRAK1-UD (Figure 
2.5A). CypA-catalyzed isomerization of the 168WPPPP172 motif was quantified using 
the resolved W168 indole NH cis and trans peaks that show unambiguous exchange 
cross peaks (Figure 2.5A). Analysis of these W168 indole NH exchange cross peaks 
and auto peaks yielded the catalyzed cis-to-trans and trans-to-cis isomerization rates, 
CTk  = 0.89 and TCk = 0.72 s
-1
 (Figure 2.5B), respectively. The enzyme concentration in 
this experiment (8 µM) was chosen so that isomerization would be in this range, as 
cross peaks are too small to resolve at lower isomerization rates and the peaks would 
begin to broaden at higher rates, complicating analysis. 
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Figure 2.5: Cyclophilin A catalyzes the isomerization between cis and trans 
isomers of W168-P169 in IRAK1. (A) 
15
N ZZ-exchange spectra of 
15
N IRAK1 UD 
with a catalytic (8 µM) concentration of cyclophilin A (CypA). The red spectrum is 
taken with a mixing time of 0, while the green spectrum is a summation of multiple 
spectra with mixing times of 0.11, 0.22, 0.33, 0.44, 0.55, 0.83, and 1.10 s. The green 
spectrum shows cross peaks between pairs of peaks of cis/trans isomers in the 
sequence. Top shows a section of the backbone amide region and bottom shows the 
tryptophan indole region, featuring the W168 sidechian peaks. (B) Plot of normalized 
W168sc crosspeak intensities from the 
15
N-ZZ experiment as a function of mixing 
time. Data points are shown as symbols and fits are shown as lines. 
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Tryptophan fluorescence enables measurement of uncatalyzed prolyl isomerization 
and activation enthalpy of W168-P169 peptide bond 
In contrast to 
15
N-ZZ spectroscopy, fluorescence spectroscopy can be used to 
measure slow (τ > 10 s) processes like uncatalyzed prolyl isomerization (De et al., 
2012; Ng and Weis, 1998; Thies et al., 1999). Tryptophan fluorescence was employed 
to measure the kinetics of equilibration over the isomerization timescale, since both 
VASP-EVH1 and IRAK1
162-180
 contain tryptophan residues in or near the interaction 
interface. The exquisite sensitivity of tryptophan fluorescence to local environment 
provides the potential for measuring differences not just between free and bound 
states, but also between the cis and trans isomers of the W168-P169 peptide bond in free 
IRAK1
162-180
. Observation of the cis-trans isomerization kinetics is possible if the cis 
and trans populations can be significantly perturbed from their equilibrium values, and 
their return to equilibrium can be monitored.  The strict specificity of the VASP-
EVH1/IRAK1-UD interaction for the trans isomer of the W168-P169 peptide bond 
provides a mechanism for perturbing this equilibrium, allowing either enrichment of 
the free cis isomer by rapid mixing of the two binding partners at high concentration 
([IRAK1
162-180
] and [VASP-EVH1] ≥ AppDK ), or enrichment of the free trans isomer by 
rapid dilution of the complex to a low concentration ([IRAK1
162-180
] and [VASP-
EVH1] < AppDK ). In either case, the temporal separation of the fast binding reaction 
and slow prolyl isomerization allows detection and quantification of the slow, rate-
limiting isomerization process.  
Upon mixing IRAK1
162-180
 peptide with excess VASP-EVH1, the 57% 
population of trans conformation rapidly reaches its binding equilibrium with the 
EVH1 domain, and the free trans is depleted relative to the free cis. Subsequent 
conversion of cis to trans (toward equilibrium) provides additional trans that binds, 
generating a time-dependent fluorescence signal that can reflect both equilibration of 
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isomer populations of free peptide and the additional isomerization-dependent 
binding. The initial binding phase (to the initial 57% trans) is not observable because 
it is too fast (4000 s
-1
 as determined by NMR above) to be resolved under the 
experimental conditions, even in stopped-flow experiments (data not shown). To 
implement the mixing experiment, 2 µl of 53 mM IRAK1
162-180
 peptide was added to 2 
ml (final concentration of 53 µM IRAK1
162-180
) containing a high concentration of 
EVH1 domain (100 µM) in a quartz cuvette and a fluorescence signal time course of 
the mixture was recorded. The observed slow increase in tryptophan fluorescence was 
well fit by a single exponential with a rate constant of 0.0025 s
-1
 (Figure 2.6A, B). 
Notably, the observed change in fluorescence signal could reflect time-dependent 
binding (rate-limited by prolyl isomerizion), the isomerization of the free peptide 
itself, or a combination of both.   
Direct observation of changes in fluorescence signal due to isomerization of 
the free peptide was achieved using a dilution approach.  When pre-formed VASP-
EVH1/ IRAK1
162-180
 complex is diluted to a concentration below AppDK , the complex 
will rapidly dissociate and peptide (in the trans isomer state) will be released. The 
released peptide is far from the cis-trans equilibrium, with high trans and low cis 
populations. The return of these populations to their equilibrium values can be 
monitored by tryptophan fluorescence if the cis and trans isomers elicit different 
fluorescence signals. This approach unambiguously detects the prolyl isomerization 
kinetics independent of the binding reaction kinetics, since isomerization is temporally 
well separated from the rapid initial dissociation of the diluted complex, and 
subsequent binding is negligible in such a dilute condition. 
To implement this approach, a concentrated mixture of 1 mM VASP-EVH1 
and 1 mM IRAK1
162-180
 was allowed to fully equilibrate (≥1 hour), then 4 µl of this 
mixture was diluted into the cuvette for a final concentration of 2 µM EVH1 and  
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Figure 2.6: Tryptophan fluorescence shows cyclophilin A accelerates IRAK1-
UD/EVH1 binding and equilibration of IRAK1 isomers. (A) Mixing the peptide 
IRAK1
162-180
 with an excess of VASP-EVH1 domain yields a slow increase in 
tryptophan fluorescence signal that reflects both binding and isomerization. Including 
CypA in the mixture accelerates this equilibration. (B) Dependence of the rate 
constant of equilibration in the mixing experiment, 
obsk , on CypA concentration. (C) 
Diluting a concentrated stock of IRAK1
162-180
 mixed with VASP-EVH1to below the 
App
DK  of the interaction results in a slow decrease in fluorescence signal that simply 
reflects isomerization of the unbound peptide. As in the mixing experiment, CypA 
accelerates the equilibration of isomers. (D) Dependence of the rate constant of 
equilibration in the dilution experiment, obsk , on CypA concentration. (E) Performing 
the dilution experiment at different temperatures shows a strong dependence of obsk  on 
temperature. (F) Erying plots for the cis-to-trans and trans-to-cis rates ( CTk  and TCk ), 
used to obtain the activation enthalpy and entropy of IRAK1
162-180
 isomerization.  
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peptide, well below the AppDK . Fast dissociation of the bound trans peptide occurred in 
the dead time of the instrument, while slow equilibration of the cis and trans isomers 
of the free peptide was observed as a gradual decrease in tryptophan fluorescence 
signal over the course of an hour at 25 ˚C. This demonstrates that the trans isomer of 
the free peptide indeed produces a higher fluorescence intensity than the cis isomer, 
allowing direct detection of the isomerization kinetics. The data was well fit by a 
single exponential, yielding 
obsk  =0.00211 s
-1
 (in good agreement with the mixing 
experiment). The corresponding intrinsic cis-to-trans and trans-to-cis rates of 
isomerization are 
CTk =0.0012 s
-1
 and TCk =0.00091 s
-1
, calculated as described in 
Materials and Methods. Inclusion of 5, 10, and 20 nM cyclophilin A in the dilution 
experiment accelerated the rate constant by 2, 4 and 8-fold, displaying a linear 
dependence on CypA concentration as expected (Figure 2.6C, D). In addition to the 
ability to directly observe the isomerization process, this experiment has the important 
advantages of using ~50-fold less material than the mixing experiment, and avoiding 
the inner-filter effect (which the mixing experiment is susceptible to). 
To measure the activation enthalpy of W168-P169 isomerization, the dilution 
fluorescence experiment was performed at different temperatures (Figure 2.6E, F). 
The extraction of individual isomerization rates 
CTk  and TCk  from the measured 
exk was accomplished using the temperature dependence of isomK  determined from 
homonuclear TOCSY spectra of IRAK1
162-180
 (Appendix Figure 2.2). These rates were 
fit to the linear form of the Eyring-Polanyi equation (Connors, 1990):   
          (2.7) 
where T is temperature, R is the gas constant, Bk  is the Boltzmann constant, h is 
Planck’s constant, and TC‡
CT,H  and TC‡
CT,S  are the activation enthalpy and entropies 
of cis-to-trans (CT) and trans-to-cis (TC) isomerization. Fitting to this equation yields  
CT,TC CT,TC
CT,TC B‡ ‡ln(k /T)= - H /(R T) + ln(k /h) + S /R  
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Figure 2.7: Energy diagram describing cis and trans isomers of W168-P169 in 
IRAK1-UD. The activation enthalpy and entropy for the cis-to-trans transition, the 
difference in enthalpy and entropy between the cis and trans isomers, and the free 
energy difference for each are specified. 
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slopes that correspond to activation enthalpies of 103 and 106 kJ/mol, respectively 
(Figure 2.6F, Figure 2.7). Extrapolation to physiological temperature (37 ˚C) yields 
the population of trans (55%) and the uncatalyzed isomerization rate ( exk = 0.011 s
-1
). 
The activation enthalpies and entropies of the cis-to-trans transition and the 
differences in enthalpies and entropies between the cis and trans isomers are 
illustrated in an energy diagram (Figure 2.7). 
Tryptophan fluorescence shows that cyclophilin A “catalyzes” VASP-EVH1 
interactions  
Inclusion of CypA in the mixing experiment described earlier can be expected 
to accelerate completion of the trans-specific VASP-EVH1/IRAK1
162-180
 binding 
reaction, after the initial binding of the pre-existing trans isomer. In fact, inclusion of 
62 nM cyclophilin A in this mixing experiment accelerated the reaction approximately 
15-fold (Figure 2.6A, B).  However, since changes in the cis and trans populations 
give rise to changes in the fluorescence signal, it is difficult to distinguish between 
fluorescence signal due solely to isomerization of free peptide (which would dominate 
if binding did not give rise to substantial differences in fluorescence signal, or if 
VASP-EVH1 is not in excess) and fluorescence signal representing CypA-accelerated 
binding to VASP-EVH1. Thus, while in principle the mixing experiment should 
provide the opportunity to observe “CypA-catalyzed binding” of this trans-specific 
interaction, the contribution of isomerization of free peptide to the observed 
fluorescence signal precludes detection of a signal dependent solely on binding.  
In order to directly observe CypA acceleration of binding of VASP-EVH1 to a 
binding partner, the mixing experiment described above was performed using the 
peptide ActA
333-344
, which also partitions into cis (25%) and trans (75%) isomers 
(Appendix Figure 2.3). This sequence contains a phenylalanine instead of tryptophan 
in the binding motif, and therefore tryptophan fluorescence experiments are not 
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sensitive to prolyl isomerization of the free peptide. By contrast, Trp23 in the EVH1 
domain binding surface is shielded in the complex relative to the apo domain, so 
fluorescence experiments with this peptide are still sensitive to binding. Titrating 
EVH1 domain with this peptide shows that the tryptophan fluorescence signal of 
EVH1 increases over 34% upon binding (Figure 2.8A). Mixing ActA
333-344 
with an 
excess of EVH1 domain produced a slow increase in tryptophan fluorescence, 
following an exponential expression with a rate of 0.0038 s
-1
 (Figure 2.7B). This can 
be unambiguously interpreted as prolyl isomerization-limited binding, because the 
only tryptophan fluorescence signal arises from the EVH1 domain in this case. This 
measured rate corresponds to the intrinsic trans-to-cis (0.0012 s
-1
) and cis-to-trans 
(0.0035 s
-1
) isomerization rates according to equation 2.5. Equation 2.5 accounts for 
coupling between isomerization and binding by scaling the intrinsic trans-to-cis rate 
by the fraction of free peptide. Inclusion of cyclophilin A in the mixture accelerated 
the reaction as expected, by 10-fold (Figure 2.8B). This provides a direct example of a 
prolyl isomerase, cyclophilin A, accelerating an interaction between VASP-EVH1 and 
one of its binding partners.  
 
Table 2.2: Rates and Equilibrium/Binding Constants for IRAK1
162-180
 and ActA
333-340
  
 
 
 
 
 
 
 
 
IRAK1
162-180 ActA333-344
kCT 0.0012 s
-1
0.0035 s
-1
kTC 0.00091 s
-1
0.0012 s
-1
[trans ]/[cis ] 1.33 3.0
koff 4,000 ± 200 s
-1
1,800 ± 200 s
-1
kon 3.5 ± 0.1 x 10
7
 M
-1
s
-1
1.2 ± 0.1 x 10
8
 M
-1
s
-1
KD
trans 
116  ± 2 µM 14 ± 1 µM 
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Figure 2.8: Tryptophan fluorescence shows CypA accelerates ActA/EVH1 
binding. (A) The tryptophan fluorescence signal of the VASP-EVH1 domain 
increases upon binding ActA
333-344
, allowing independent measurement of the binding 
constant. Data is shown as symbols and a fit is shown as a solid line. (B) Mixing an 
excess of EVH1 domain with ActA
333-344
 results in a slow binding phase which can be 
accelerated with a catalytic quantity (62 nM) of CypA.  
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Discussion 
Here, we have applied biophysical methods to investigate and quantify binding 
between the EVH1 domain of VASP and the undefined domain of IRAK1. Using 
purified components, we have demonstrated that the VASP-EVH1 domain binds to the 
168WPPPP172 motif in IRAK1-UD, with specificity for the trans isomer of the W168-
P169 peptide bond. Our studies provide a quantitative thermodynamic and kinetic 
description of the coupled equilibrium between W168-P169 cis-trans isomerization and 
IRAK1-UD/VASP-EVH1 binding, and demonstrate how acceleration of isomerization 
by CypA effectively catalyzes binding. Using a combination of approaches we are 
able to report both the kinetics of isomerization and binding to the peptides IRAK1
162-
180
 and ActA
333-344
 (Table 2.2). Catalysis of the rate-limiting isomerization step in an 
isomer-specific binding reaction represents a largely overlooked function for peptidyl 
prolyl isomerase enzymes. These results offer important insights into the role of cis-
trans isomerization in innate immunity signaling, and present a physical mechanism 
for connecting IRAK1-mediated signaling pathways to VASP-mediated regulation of 
actin cytoskeletal dynamics.  
A logical mechanism of regulation of VASP binding is control of the 
oligomeric state of its binding partners, since VASP functions as a constitutive 
tetramer (Bachmann et al., 1999). Receptor oligomerization has long been understood 
to be an important mechanism in signal transduction (Lemmon and Schlessinger, 
1994; Weiss and Schlessinger, 1998), especially in the context of the immune system 
(McCulloch et al., 2006; Wilson et al., 2009). The driving force in oligomerization as 
a signal transduction mechanism is avidity, the enhancement in affinity from a 
relatively weak 1:1 interaction to an exponentially enhanced multimer/multimer 
interaction (Roitt, 2001). In some cases signal-induced oligomerization of downstream 
partners is important for transducing a signal, in a kind of “oligomerization cascade” 
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in which oligomerization of one protein induces oligomerization in a downstream 
binding partner and so on (Dong et al., 2006; Sun et al., 2004). The IRAK1:VASP 
monomer-monomer interaction quantified here is relatively weak (116 μM). IRAK-1 
tetramerizes in IL-1R and TLR signaling in response to binding to the oligomeric 
Myddosome, which may significantly increase the interaction with the tetrameric 
VASP. Interestingly, since the theoretically tightest interaction is between two 
tetramers, the fact that the WPPPP binding site partitions into 43% cis and 57% trans 
isomers means the tightest interaction would only initially arise for (0.57)
4 
= 11% of 
the total available IRAK1 tetramers. This principle can be generalized to other isomer-
specific interactions between oligomers (even a more modest 25% cis corresponds to 
(0.75)
 4 
= 32% of tetramers). An analogy can be drawn to protein folding, in which the 
isomerization of multiple proline residues in the fold of a protein can collectively 
contribute to folding kinetics (Wedemeyer et al., 2002). The Ena/VASP proteins 
are important actin-binding proteins that regulate the actin cytoskeleton by increasing 
actin filament length. This may be achieved through an anti-capping mechanism, in 
which Ena/VASP proteins supply monomeric actin to the barbed ends of actin 
filaments while preventing access of capping proteins that can terminate elongation 
(Bear and Gertler, 2009). Alternatively, this may be through the processive filament 
elongation activity Ena/VASP proteins exhibit upon clustering (Breitsprecher et al., 
2011; Hansen and Mullins, 2010). Ena/VASP proteins tend to localize at sites with 
high actin cytoskeleton dynamics, such as filapodial tips and the periphery and ruffles 
of lamellae (Rottner et al., 1999), which extend during cell spreading. Ena/VASP 
proteins are also components of the adherens junctions (Reinhard et al., 1996; 
Vasioukhin et al., 2000) and focal adhesions (Gertler et al., 1996), multi-protein 
complexes that anchor the actin cytoskeleton to neighboring cells or to the 
extracellular matrix and therefore must disassemble and reassemble dynamically in 
 62 
migrating cells, requiring concerted regulation of actin polymerization (Wehrle-Haller 
and Imhof, 2003). Ena/VASP proteins are central to cellular processes involving 
cytoskeletal remodeling, such as axon guidance (Goh et al., 2002), migration (Bear et 
al., 2000; Krause et al., 2003), and cell-cell interaction (Grevengoed et al., 2001; 
Vasioukhin et al., 2000), warranting detailed characterization of the interactions that 
localize them to specific sites. 
It was recently reported that VASP and IRAK1 co-immunoprecipitate in 
human THP1 and MAT-2 cells (Gan and Li, 2010). The same researchers also 
investigated IRAK1’s involvement in phosphorylation of VASP by PKC. They found 
that activation of PKC by PMA-stimulation of IRAK1-defficient murine bone-marrow 
derived macrophages (BMDMs) resulted in less sustained VASP phosphorylation than 
in wild-type cells, as well as impaired migration (Gan and Li, 2010). These results 
seem to collectively suggest a role for the VASP/IRAK1 interaction in macrophage 
migration. However, while human IRAK1 contains the WPPPP VASP binding motif 
we describe here, mouse IRAK1 does not contain any such motif. In fact, the 
appearance of the WPPPP binding motif in human IRAK1 is due to an Arg-to-Trp 
point mutation that occurred very recently on an evolutionary timescale (Appendix 
Figure 2.4). It is possible that this is a result of selective pressure, and indeed genes in 
the immune system tend to evolve more rapidly due to coevolution with pathogens 
(McTaggart et al., 2012). At any rate, it is not currently clear what function the direct 
interaction between VASP and IRAK1 plays.   
The localization of Ena/VASP proteins can occur in response to signals that 
trigger cytoskeletal remodeling, and this regulated spatial targeting is a critical aspect 
of directing cytoskeletal dynamics to the right place at the right time (Krause et al., 
2003). In one example, the actin cytoskeleton of helper T cells is polarized towards 
antigen-presenting cells upon T cell receptor (TCR) stimulation. This rearrangement 
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of the actin cytoskeleton is dependent on recruitment of Ena/VASP proteins to the 
TCR signaling complex via a FPPPP motif in the protein Fyb/SLAP (Krause et al., 
2000). In another example, phagocytosis relies on precisely coordinated 
spatiotemporal reorganization of the actin cytoskeleton, often initiated by stimulation 
of Fc-receptors (May and Machesky, 2001). As in T cells, Fyb/SLAP recruits 
Ena/VASP proteins to signaling complexes downstream of Fc-receptors in 
macrophages. This process was shown to be necessary for formation of the actin-based 
phagocytic cup and phagocytosis of opsonised red blood cells (Coppolino et al., 2001). 
In both cases, the interaction between Ena/VASP proteins and Fyb/SLAP is crucial to 
linking receptor activation to cytoskeletal remodeling. The interaction between VASP 
and IRAK1 appears to be another example of receptor activation leading to the 
recruitment of VASP to an activated signaling complex in order to initiate cytoskeletal 
remodeling.  
Patients with autosomal recessive deficiency of IRAK4, which acts directly 
upstream of IRAK1, show defects in neutrophil migration and phagocytosis (Bouma et 
al., 2009). TLR signaling is thought to modulate phagosome maturation, in which 
phagosomes fuse with endosomes and lysosomes to degrade engulfed pathogens, 
although reports differ on whether the effect is to enhance or impair maturation 
(Blander and Medzhitov, 2004; Yates et al., 2007). Furthermore, TLR signaling 
through MyD88 dependent and independent processes can impact gene expression to 
enhance phagocytosis (Doyle et al., 2004; Kong and Ge, 2008). Given the important 
role of VASP in the process of phagocytosis (Coppolino et al., 2001), the direct 
interaction between TLR machinery (IRAK1) and VASP as characterized here may 
serve as yet another mechanism to link TLR signaling and the reorganization of the 
actin cytoskeleton as occurs in phagocytosis.  
Our results showing that the W168-P169 peptide bond in the IRAK1-UD 
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partitions into populations of 43% cis and 57% trans and that only the trans isomer 
participates in binding to VASP provide a compelling example of the relevance of 
isomerization in the dynamics of protein-protein interactions. Our measurements of 
the binding kinetics (
onk  = 3.5 ± 0.1 10
7
 M
-1
s
-1
, 
offk = 4,000 ± 200 s
-1
) and uncatalyzed 
isomerization ( exk  = 0.0021 s
-1
) of this scheme affirm that these processes occur on 
disparate timescales and that isomerization is a rate-limiting step for binding. A 
cytoplasmic prolyl isomerase such as CypA may therefore play a role in proper 
function of VASP by “catalyzing binding” to its partners. Indeed, there is growing 
evidence that the prolyl isomerase activity of cyclophilins has specific functions in cell 
signaling, particularly in immune cells. CypA regulates a conformational switch in 
Interleukin-2 tyrosine kinase (Itk) by isomerizing a proline in the Itk SH2 domain, 
allowing inter-conversion between active and inactive states (Colgan et al., 2004). In 
another example, CypA isomerizes a conformational switch in the adaptor protein Crk, 
also accelerating conversion between inactive and active conformations (Nicholson 
and Lu, 2007; Sarkar et al., 2011). The isomerase activity of CypA has also been 
found to be required for cytokinesis in Jurkat cells (Bannon et al., 2012). CypA is 
required for efficient replication of both human immunodeficiency virus type 1 (HIV-
1) and hepatitis C virus (HCV), although it is not yet clear why (Towers, 2007). 
Interestingly, extracellular CypA is a potent chemokine through its binding to the 
receptor CD147, but this function is independent of its PPIase activity (Song et al., 
2011). 
We have employed tryptophan fluorescence to measure the intrinsic rate of 
isomerization of the W168-P169 site in IRAK1. To our knowledge this is the first 
example of an experiment that takes advantage of the intrinsic difference in tryptophan 
fluorescence intensities of the cis and trans isomers of the W-P dipeptide sequence to 
measure the kinetics of isomerization of an unstructured peptide. We have shown both 
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that the isomerase CypA can accelerate isomerization of IRAK1
162-180
, but also (using 
the tryptophan fluorescence of the EVH1 domain) that CypA isomerization of the 
related sequence in ActA can accelerate binding of ActA to EVH1. This represents a 
direct demonstration of an underappreciated role of prolyl isomerases, the acceleration 
of isomer-specific protein-protein interactions. 
Structurally, VASP recognition of the motif (W/F)PxφP is mediated by a 
hydrophobic groove in the EVH1 domain which accommodates the PPII helix adopted 
by the motif. Two sidechains, Gln81 and Trp23, are positioned to hydrogen bond with 
the carbonyl oxygens of the first proline and third residue (x) in the motif, 
respectively. Lastly, a hydrophobic pocket defined by the side chain methylenes K71, 
N73, Q81, and R83 accommodates a hydrophobic aromatic like tryptophan or 
phenylalanine, or to a smaller degree, the aliphatic leucine (Ball et al., 2000; Fedorov 
et al., 1999; Prehoda et al., 1999). Flipping the W/F-P peptide bond to the cis isomer 
while constraining the two hydrogen bonds causes the side chain of the first residue to 
flip away from the binding surface (Appendix Figure 2.5). Thus, the fact that optimal 
binding requires both that the side chain of the first residue insert into this pocket and 
the carbonyls of the second and third residues hydrogen bond to sidechains in the 
EVH1 domain can explain our result that binding is specific for the trans isomer of the 
(W/F)-P peptide bond.  
The WPPPP motif in IRAK1 is the only established biological VASP binding 
site that features a tryptophan instead of a phenylalanine. However, multiple peptide 
binding studies have demonstrated a preference of VASP-EVH1 for WPxφP over 
FPxφP motifs (Ball et al., 2000; Niebuhr et al., 1997). It should be noted that 
phenylalanine is only lower than tryptophan and tyrosine in its tendency to stabilize 
the cis isomer when preceding a proline residue (Reimer et al., 1998). Therefore, the 
principle of cis-trans isomerization as an important consideration for EVH1 binding is 
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relevant for FPxφP motifs as well as the WPxφP motif described here.  
 
Conclusions 
The VASP/IRAK1 interaction provides an intriguing example of how, in a 
binding interaction with a proline motif, the binding kinetics can be substantially 
dependent on cis-trans isomerization. Binding between tetrameric VASP and a 
multivalent binding partner such as IRAK1 assembled onto the Myddosome may be 
especially dependent on isomerization because the probability of a multivalent protein 
being all-trans ([% trans]
4
) is lower than for a single binding site. Notably, this can be 
applied to other known VASP interaction partners such as zyxin (Reinhard et al., 
1995), lamellipodin (Krause et al., 2004), and ActA (Domann et al., 1992)which have 
four to five FPxφP motifs in tandem repeat, or vinculin (Reinhard et al., 1996), which 
oligomerizes. Given the relatively weak affinity of the monomeric VASP-EVH1 for 
its substrates (19-200 μM), as well as the tendency of VASP binding sites to exist as 
tandem repeats, it seems likely that avidity is a driving force for VASP interactions. 
Therefore, we suggest that a cytoplasmic isomerase such as CypA may be necessary 
for proper function of VASP-mediated signaling processes. However, future studies 
are needed to experimentally test this prediction.  
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CHAPTER 3 
The VASP EVH1 Domain Recognizes Phosphorylated Sequences and Contains a 
Secondary Binding Site 
 
Abstract 
Protein domains that recognize phosphorylated serine or threonine residues 
include FHA, MH2, FF, 14-3-3, polo box, BRCT, WD40, and WW domains. These 
domains generally bind phosphorylated sequences with affinities many orders of 
magnitude greater than their unphosphorylated analogs. The VASP EVH1 domain is 
not considered a phosphorylation-binding domain, but rather binds the proline rich 
(F/W)PxφP motif. This motif appears in the cytoskeletal proteins zyxin, vinculin, and 
lamellipodin as well as the proteins Fyb/SLAP and IRAK1 which are involved in 
immune cell signaling. However, this core motif is generally flanked by negatively 
charged amino acids that contribute to the affinity of the interaction with VASP. We 
show that the VASP binding site in IRAK1, a relatively weakly binding site that does 
not contain negatively charged amino acids, binds VASP-EVH1 with sevenfold 
increased affinity upon phosphorylation of two flanking serine residues. We report the 
binding affinities, binding kinetics, and chemical shift perturbation profiles of a series 
of IRAK1-derived peptides, providing insights into the contacts and forces that 
determine VASP-EVH1 binding specificity. We also demonstrate that, as previously 
shown for the unphosphorylated sequence, phosphorylated IRAK1 partitions into 
nearly equally populated cis and trans isomers. Based on these results we propose that 
the VASP/IRAK1 interaction is regulated by IRAK1 autophosphorylation. Given that 
IRAK1 autophosphorylates in response to TLR/IL-1R signaling, this could serve to 
link those signaling pathways with VASP-mediated cytoskeletal rearrangement 
without requiring VASP to constitutively bind to IRAK1. We further note that serine 
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residues are enriched in VASP binding sites and propose that other VASP interactions 
may likewise be regulated by phosphorylation. Lastly, we report the observation of a 
noncanonical binding site on the opposite face of the EVH1 domain which may 
recognize a variation on the canonical (F/W)PxφP binding sequence. We propose that 
this secondary site may bind the tandem repeats of VASP interaction proteins such as 
zyxin and lamellipodin.   
 
Introduction 
IRAK1 is a Ser/Thr kinase which is activated by phosphorylation by the 
related IRAK4 upon either toll-like receptor (TLR) or interleukin-1 receptor (IL-1R) 
stimulation (Li et al., 2002; O'Neill, 2008). This is achieved by the formation of a 
helical array of the death domains of IRAK4, IRAK1 (or IRAK2), and the adapter 
protein MyD88 on the intracellular TIR (toll/IL-1 receptor) domains of the receptors, 
collectively known as the Myddosome (Lin et al., 2010). This leads to further, 
extensive phosphorylation, probably via IRAK1 itself, of the Ser/Pro rich undefined 
domain (UD) of IRAK1 (Kollewe et al., 2004). This phosphorylation is necessary for 
dissociation of IRAK1 from the Myddosome (Cao et al., 1996), as well as interactions 
with downstream binding partners including Pin1 (Tun-Kyi et al., 2011) and Pellino 
(Lin et al., 2008).  
We have previously shown that a proline-rich sequence in the IRAK1-UD 
binds to the EVH1 domain of the actin cytoskeletal rearrangement protein VASP 
(Chapter 2). The VASP-EVH1 domain binds the proline rich (F/W)PxφP motif where 
φ is an aliphatic amino acid and x is any amino acid (Ball et al., 2000; Niebuhr et al., 
1997; Pistor et al., 1995). Most commonly in actual confirmed VASP-binding 
proteins, the binding site sequence is FPPPP. Furthermore, negatively charged amino 
acids usually flank this core motif at one or more of the five positions C-terminal to 
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the motif as well as one or more of the four N-terminal to it. These negative charges 
contribute significantly to the affinity of the interaction (Ball et al., 2000; Carl et al., 
1999). In this paper, we demonstrate that the interaction between the VASP-EVH1 
domain and the 167LWPPPP172 region of IRAK1-UD is significantly strengthened by 
phosphorylation of two serine residues (S166, S173) flanking the 167LWPPPP172 
sequence ( DK  = 25 ± 2 µM vs. 203 ± 3 µM unphosphorylated). This suggests that the 
interaction is regulated by autophosphorylation of IRAK1, which can occur in 
response to TLR or IL-1 receptor signaling (Cao et al., 1996; Kollewe et al., 2004). 
Binding of IRAK1 to the constitutive tetramer (Haffner et al., 1995) VASP could be 
further enhanced by IRAK1 tetramerization, which is triggered by assembly of the 
Myddosome during TLR or IL-1 receptor signaling (Lin et al., 2010). These 
observations suggest a novel mechanism for how IRAK1 autophosphorylation might 
play an important role in regulating the connection between innate immunity signaling 
and cytoskeletal remodeling. More broadly, they suggest that localization of 
Ena/VASP proteins may be regulated by phosphorylation of serine/threonine residues 
in their binding partners, especially lamellipodin, which is involved in the formation 
of lamellipodia.  
Despite the fact that IRAK1 harbors the only WPPPP motif known to interact 
with VASP, multiple studies report that VASP-EVH1 has a significant preference for 
WPPPP over FPPPP motifs (Ball et al., 2000; Niebuhr et al., 1997; Zimmermann et 
al., 2003). We investigate the structural origin of this preference by assessing the 
differences in hydrogen bond formation and binding kinetics between WPPPP and 
FPPPP motifs. We further show that isomerization of the W168-P169 peptide bond by 
cyclophilin A, which has shown to facilitate binding to VASP-EVH1 (Chapter 2), is 
not hampered by phosphorylation of S166 and S173. Lastly, we report the observation 
of a weak secondary peptide-binding surface on the EVH1 domain, featuring an 
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arginine residue strictly conserved in the EVH1 domains of WASP, RanBP1, and 
Homer protein families.  
 
Materials and Methods 
Protein Purification and Peptide Preparation.  
Proteins were purified as previously described (Chapter 2). Briefly, proteins 
were bacterially expressed as N-terminally tagged 6X-histidine fusion proteins and 
purified using nickel-NTA columns. 
15
N-labeled Human VASP-EVH1 (VASP 
residues 1-115) (Boeda et al., 2007) was purified with the histidine tag removed using 
a protease cut site, while full-length human CypA was purified with the histidine tag 
intact (Piotukh et al., 2005). After purification proteins were dialyzed into NMR buffer 
(20 mM KH2PO4, 50 mM KCl, 1 mM TCEP, pH 6.7) and 5 mM NaN3 and 7% D2O 
were added. Protein concentration was measured by UV absorbance using theoretical 
extinction coefficients.  
Peptides encompassing IRAK1 residues P162-K180 either with the natural 
sequence (IRAK1
162-180
), with a phosphate group on Ser166 (IRAK1
162-180, pS166
), with 
phosphate groups on both Ser166 and Ser173 (IRAK1
162-180, pS166, pS173
), or a 
tryptophan-to-phenylalanine mutation (IRAK1
162-180, W168F
) were purchased and 
delivered as a lyophilized powder. Slightly longer peptides encompassing IRAK1 
residues E157-K180 with phosphorylation either at Ser163 (IRAK1
157-180, pS163
) or 
Ser173 (IRAK1
157-180, pS173
) were similarly purchased. IRAK1
162-180
, IRAK1
162-180, 
W168F
, IRAK1
157-180, pS163
, IRAK1
157-180, pS173
, and IRAK1
162-180, pS166, pS173
 were 
purchased from the Tufts University Core Facility (Boston, MA), while IRAK1
162-180, 
pS166
 was purchased from Genscript (Piscataway, NJ). Peptides were dissolved in 
NMR buffer plus 5 mM NaN3 and 7% D2O. Peptide concentration was determined by 
UV absorbance, using the theoretical extinction coefficient of 195 cm
-1
M
-1
 at 257 nm 
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for IRAK1
162-180, W168F
, and 5500 cm
-1
M
-1
 at 280 nm for the other peptides. NaOH and 
HCl were used to adjust sample pH. 
NMR Data Collection and Processing.  
NMR experiments were carried out at 25 ºC (unless otherwise stated) on a 
Varian Inova 600 MHz spectrometer  with a {H, C, N} Z-axis gradient probe. NMR 
data processing was performed using nmrPipe, apodizing with either a phase-shifted 
sine bell or exponential window function. Data analysis was performed using the 
software nmrDraw (Delaglio et al., 1995) and Sparky (Goddard TD, 2008), using the 
Sparky peak detection function to measure peak heights and positions.  
NMR Titrations.  
 Five titrations of 
15
N EVH1 domain (with the peptides IRAK1
157-180, pS163
, 
IRAK1
162-180, pS166
, IRAK1
157-180, pS173
, IRAK1
160-180, pS166, pS173
, and IRAK1
162-180, W168F
) 
were performed. NMR titrations were carried out by preparing the most saturated 
sample first and producing subsequent samples by diluting with a stock of labeled 
EVH1 domain, as described (Chapter 2). In the titration of 
15
N EVH1 domain with 
IRAK1
162-180, W168F
, the concentration of EVH1 was held between 0.33-0.37 mM and 
the peptide concentrations were 0, 0.11, 0.22, 0.43, 0.87, 1.73, 3.46, and 6.92 mM. In 
the titration of 
15
N EVH1 domain with IRAK1
157-180, pS163
, the concentration of EVH1 
was held between 0.36-0.37 mM and the peptide concentrations were 0, 0.02, 0.05, 
0.09, 0.19, 0.37, 0.75, and 1.49 mM. In the titration of 
15
N EVH1 domain with 
IRAK1
162-180, pS166
, the concentration of EVH1 was held between 0.36-0.37 mM and 
the peptide concentrations were 0, 0.03, 0.05, 0.11, 0.22, 0.44, 0.87, 1.75, and 3.49 
mM. In the titration of 
15
N EVH1 domain with IRAK1
157-180, pS173
, the concentration of 
EVH1 was held at 0.37 mM and the peptide concentrations were 0, 0.01, 0.03, 0.06, 
0.11, 0.23, 0.46, 0.92, and 1.83 mM. In the titration of 
15
N EVH1 domain with 
IRAK1
162-180, pS166, pS173
, the concentration of EVH1 was held at 0.37 mM and the 
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peptide concentrations were 0, 0.02, 0.04, 0.08, 0.16, 0.31, 0.63, 1.25, 2.50, and 5.01 
mM. In the proton dimension, a spectral width of 8 kHz (2048 complex data points) 
was used and in the nitrogen dimension a width of 1.8 kHz (256 complex data points) 
was used. Resonance assignments for the 
15
N EVH1 domain were obtained from the 
BioMagResBank (accession number 18569 (Ball et al., 2000)). 
Measurement of Amide Proton Temperature Coefficients. 
Two IRAK1
162-180 1
H-
1
H TOCSY temperature series were taken (of 4 mM 
IRAK1
162-180
 and 0.5 mM IRAK1
162-180
 with 1.5 mM EVH1 domain, at temperatures 
20, 24, 28, 32, and 36 and 20, 25, and 30 ºC respectively. Temperature coefficients 
were obtained by linear fitting of the proton chemical shift of each peak, after proper 
referencing of the spectra (Wishart et al., 1995). 
Quantification of Binding Affinities and NMR Lineshape Analysis. 
NMR lineshape analysis was carried out as described (De et al., 2012) 
(Chapter 2). The dissociation constant DK  was first measured by fitting chemical shift 
perturbation data from the 
15
N EVH1 titrations. For given concentrations of IRAK1 
peptide, [IRAK1
tot
], and EVH1, [EVH1
tot
], the change in chemical shift for each 
dimension (ΔδH and ΔδN 
) for a given titration point is proportional to the percentage 
of bound EVH1 domain, 
 
              (3.1) 
 
Fitted parameters included the chemical shift difference between free and bound Δδmax
 
, the dissociation constant DK , and for binding curves with a sharp enough shape 
( DK < 100 µM), a scaling factor to correct for small inaccuracies in the peptide 
concentration measurement, as described in Chapter 2. 21 
1
H and 21 
15
N chemical 
shift datasets were independently fit using the Solver function in Excel, yielding a 
max
2
( [ 1 ] [ 1 ]
( [ 1 ] [ 1 ]) 4 [ 1 ][ 1 ]) / (2[ 1 ])
tot tot
D
tot tot tot tot tot
D
K EVH IRAK
K EVH IRAK EVH IRAK EVH
       
   
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mean and standard error which we report as DK  and its error. We also report the 
trans
DK , the dissociation constant specifically for the trans isomer of the (W/F)-P 
peptide bond for each peptide, given by 
               (3.2) 
where isomK  is the ratio of trans to cis, determined from peak volumes in 
1
H-
1
H 
TOCSY spectra.  
NMR Lineshape analysis was carried out as described (De et al., 2012; 
Greenwood et al., 2011) using the BiophysicsLab Matlab package (Kovrigin, 2012). 
Briefly, the dependence of 
15
N EVH1 
1
H and 
15
N lineshapes on peptide concentration 
were fit to the two-state solution to the Bloch-McConnell equations (Cavanagh J, 
2007; McConnell, 1958) to extract the dissociation rate, offk of the interaction. 
Constrained parameters included the dissociation constant, DK , apo chemical shift, 
Apo ,linewidth of apo state, 2,0
freeR , and ratio of trans to cis, isomK , while the 
dissociation rate offk  and chemical shift and linewidth of the bound state, 
Bound and 
2,0
boundR , were all fitted. We report as error the standard error of multiple fits of 
independent lineshape datasets.  
 To measure the affinity of peptide binding to the weak secondary binding site, 
the 
15
N EVH1 titration 
15
N and 
1
H chemical shift data from the tightest-binding 
peptide, IRAK1
162-180, pS166, pS173
, were fit to a three-state model. This was carried out 
similarly with BiophysicsLab, but without application of the lineshape analysis 
component. Eight binding curves from residues in the primary binding site and 21 
binding curves sensitive to the secondary binding event were simultaneously fit. 
15
N 
chemical shift data was scaled by a factor of 0.154 so that 
15
N and 
1
H data would 
roughly contribute equally to the fit. Fitted parameters included the dissociation 
constants for the primary and secondary sites, a single set of bound chemical shifts for 
the primary site datasets, and two sets of bound chemical shifts for the secondary-site 
/ (1 )transD D isom isomK K K K  
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binding curves. The apo chemical shifts for all residues were determined from the apo 
spectrum and constrained in the fit. 
Electrostatic Potential Map.  
The electrostatic potential map was generated using the Adaptive Poisson-
Boltzmann Solver (APBS) plugin in Pymol (Baker et al., 2001). Dielectrics of 78 and 
2 were used for the solution and protein, respectively, and a concentration of 150 mM 
monovalent ion was used. 
Modeling the IRAK-1/EVH1 complex. 
The model of VASP-EVH1 bound to IRAK1
165-175
 was built as described 
(Chapter 2), using using the solution structure of the VASP EVH1 domain (PDB ID 
code 1EGX (Ball et al., 2000)) and the crystal structure of the Mena EVH1 
domain/ActA complex (PDB ID code 1EVH (Prehoda et al., 1999)). Briefly, the 
VASP solution structure was aligned with the Mena crystal structure and the IRAK1 
sequence was built in using the ActA peptide structure as a guide. Modeling was 
performed using Swiss-Pdb viewer (Guex and Peitsch, 1997) and the model was 
colored by chemical shift perturbation using the scripts “data2bfactor.py” and 
“color_b.py” from Dr. Robert L. Campbell’s PyMol script repository at Queen’s 
University, Ontario, Canada (http://pldserver1.biochem.queensu.ca/~rlc/work/pymol/) 
in PyMOL (Delano, 2002).  
Demonstration of Isomerization by ROESY Spectroscopy. 
1
H-
1
H ROESY spectra (mixing times of 0.04, 0.06, 0.08, 0.10, 0.15, 0.20 s) 
were acquired for a sample of 3.64 mM IRAK1
162-180, pS166, pS173
 with 10 µM CypA. 
Spectral widths of 8 kHz were used in both dimensions, with 2048 (256) directly 
(indirectly) detected data points. The heights of the W168 sidechain crosspeaks and cis 
and trans autopeaks were measured and fit to the two-state solution of the Bloch-
McConnell equations (Cavanagh J, 2007; McConnell, 1958) using the Solver function 
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in Microsoft Excel. Fixed parameters included the ratio of trans to cis isomer, isomK , 
determined from peak volumes from a 
1
H-
1
H TOCSY spectrum. The initial intensity 
of the cis and trans autopeaks, 
,0CCI  and ,0TTI ,  and the isomerization rate exk  were 
fitted.  
 
Results 
The IRAK1 VASP-EVH1 interaction is enhanced by phosphorylation of IRAK1 
 The VASP binding sites in ActA, Zyxin, Vinculin, and Lamellipodin all contain 
flanking negatively charged amino acid residues that contribute to EVH1 domain 
binding (Ball et al., 2000; Carl et al., 1999). However, the 167LWPPPP172 motif in 
IRAK1 is instead flanked by serine residues (Ser166 and Ser173). The UD of IRAK1 
is known to be hyperphosphorylated upon receptor stimulation (Kollewe et al., 2004), 
suggesting that flanking phosphoserine residues might contribute to the VASP-EVH1 
interaction with the 167LWPPPP172 motif in activated IRAK1. Ser173 has been shown 
to be phosphorylated in response to TLR7 stimulation (Tun-Kyi et al., 2011) but 
phosphorylation of Ser166 has not been investigated.  
To investigate whether potential phosphorylation of the IRAK1-UD influences 
EVH1 binding, we employed two-dimensional NMR spectroscopy with 
15
N-labeled 
VASP-EVH1 domain. We titrated 
15
N- EVH1 with a series of peptides encompassing 
residues E157-K180 or P162-K180 but with various serine residues phosphorylated in 
order to determine the impact of phosphorylation on the affinity and kinetics of 
binding (peptides are defined in Figure 3.1A). Fitting peak positions as a function of 
peptide concentration allowed for determination of the dissociation constant, DK , for 
each peptide, summarized in Table 1 (Figure 3.1B). Furthermore, we calculated the 
trans
DK , the dissociation constant specifically for the trans isomer of the (W/F)-P 
peptide bond which the EVH1 domain specifically selects. transDK  is proportional to  
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Figure 3.1: Phosphorylation of IRAK1 enhances its affinity for VASP-EVH1.  (A) 
IRAK1-derived peptides used in this study. Phosphate groups are displayed above the 
sequences.  (B) Comparison of the binding curves from six 
15
N EVH1 titrations, with 
the peptides defined in panel A. The data and fit for each peptide are averages of 42 
normalized individual binding curves and their fits. Binding curves are shown on both 
linear (left) and log (right) scales. Depending on the identity of the aromatic residue 
(phenylalanine vs. tryptophan) and the phosphorylation status of serines 166 and 173, 
the binding affinity of this sequence for VASP-EVH1 can vary over an order of 
magnitude.  
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DK  and defined by Equation 3.2. Phosphorylation of either Ser166 or Ser173 
increases the affinity more than threefold, while phosphorylation of both serines 
increases the affinity more than sevenfold. By contrast, phosphorylation of the more 
distant Ser163 resulted in a measurable but smaller increase in the binding affinity. In 
each titration, the peaks that moved the farthest upon addition of peptide broadened at 
intermediate peptide concentrations and sharpened again upon saturation (Figure 3.2.) 
This line-broadening is sensitive to the kinetics of binding, allowing determination of 
the on- and off-rates of the interaction using NMR lineshape analysis. In each case, 
phosphorylation increased the onk  rate and decreased the offk  rate, though the effect 
on the offk  rate was generally greater (Table 3.1). This suggests a combination of 
electrostatic steering (increasing onk ) and electrostatic stabilization of the complex 
(decreasing offk ).  
In order to identify EVH1 residues interacting with the phosphate groups on 
Ser166 and Ser173, a model of the complex was built using a solution structure (PDB 
ID 1EGX (Ball et al., 2000)) of the VASP EVH1 domain  and the crystal structure of 
the Mena EVH1 domain bound to an ActA-derived peptide (PDB ID 1EVH (Prehoda 
et al., 1999)), as described (Chapter 2). The differences in bound 
15
N EVH1 chemical 
shift between the titrations with phosphopeptides and the unphosphorylated IRAK1
162-
180
, given by    
              3.3 
were then mapped to the model (Figure 3.3A). The 10 peaks with the largest 
between IRAK1162-180 and IRAK1162-180, pS166 included the sidechain of W82 and 
the backbone amides of D84-V88 and K71. This implicates the sidechains of R83, 
R86 and K71, all of which seem positioned in the model to interact with a phosphate 
group on Ser166. Likewise, peaks representing the backbone amides of residues N20, 
R22, and W23 were among the five peaks with the highest difference in bound  
1 162 180 2 1 162 180 2
, , , ,( ) (0.154 ( ))
IRAK peptide IRAK peptide
H bound H bound N bound N bound    
        
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Figure 3.2: Binding kinetics derived from NMR lineshape analysis of 
15
N EVH1 
peaks in peptide titrations. 1D peak slices either along the 
15
N or 
1
H dimension were 
derived from 2D 
15
N EVH1 spectra and fit to obtain the kinetics of binding. Displayed 
are the data (symbols) and fits (solid lines) of the A75 
1
H dimension peak slices for 
the peptides IRAK1
162-180
, IRAK1
162-180, W168F
, IRAK1
157-180, pS163
, IRAK1
162-180, pS166
, 
IRAK1
157-180, pS173
, and IRAK1
162-180, pS166, pS173
.  
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Figure 3.3: Suggested basis for EVH1 phosphoserine recognition. (A) Model of 
EVH1/IRAK1 complex colored by chemical shift perturbation differences. Left, the 
surface representation of the EVH1 domain is colored by the chemical shift difference 
between the complexes with the IRAK1
162-180
 and IRAK1
162-180, pS166
 peptides, and on 
the right by the difference between the IRAK1
162-180
 and IRAK1
157-180, pS173
 peptides 
(magenta=no difference, green=highest difference). Select side chains are shown as 
sticks and similarly colored. (B) Electrostatic surface potential of the EVH1 domain. 
The peptide-binding groove as well as the surface interacting with the C-terminal 
residues of the peptide both show strong positive surface potentials (blue=positive, 
red=negative).  
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chemical shift between IRAK1
162-180
 and IRAK1
162-180, pS173
, suggesting that a 
phosphate group on Ser173 could participate in a salt bridge with the sidechains of 
K21, R22, or both, when bound to the EVH1 domain. Additionally, mapping the 
of each peptide in Figure 3.1A to the EVH1 structure allows for a rough 
visualization of the position of each modified peptide residue in the complex 
(Appendix Figure 3.1). 
 
Table 3.1: Binding rates and affinities of IRAK1-derived peptides  
‡ previously reported in Chapter 2 
We note that although phosphorylation of S166 and S173 significantly 
improves binding, chemical shifts are only marginally perturbed (at greatest,  < 
0.12 ppm). This may indicate enhancement of binding by phosphorylation is driven by 
longer-range electrostatic forces rather than specific close contacts between the 
phosphate groups and EVH1 side-chains. Lending some support to this interpretation 
is the electrostatic surface potential map (Figure 3.3B), calculated using the Adaptive 
Poisson-Boltzmann Solver program in Pymol (Baker et al., 2001). This calculation 
shows firstly that the peptide-binding groove actually possesses a positive surface 
potential. Secondly, there is an extensive positive patch poised to interact with 
residues C-terminal to the primary motif, potentially well beyond the five positions we 
have considered here. Also supporting this interpretation is the fact that, although 
there is a clear bias for negatively charged amino acids in the ~4 positions preceding 
koff (s
-1
) kon  (M
-1
s
-1
) KD (μM) KD
trans
 (μM)
IRAK1
162-180,‡
4,000 ± 200 3.5 ± 0.1 x 10
7
203 ± 3 116 ± 2
IRAK1
162-180,W168F
16,000 ± 2000 3.0 ± 0.4 x 10
7
720 ± 12 550 ± 9
IRAK1
162-180-pS163
3,200 ± 100 4.4 ± 0.2 x 10
7
127 ± 5 72 ± 3
IRAK1
162-180-pS166
2,100 ± 200 6.2 ± 0.6 x 10
7
60 ± 3 34 ± 1
IRAK1
162-180-pS173
1,500  ± 200 4.4 ± 0.5 x 10
7
60 ± 2 34 ± 1
IRAK1
162-180-pS166, pS173
900 ± 60 6.3 ± 0.4 x 10
7
25 ± 2 14 ± 1
 86 
and ~5 following the primary VASP-EVH1 binding motif in its binding partners, there 
does not seem to be a strong bias for any individual position over the others.  
We generated a sequence logo from an alignment of the VASP-EVH1 binding 
sites in ActA, Lamellipodin, Fyb/SLAP, Zyxin, Vinculin, LPP, paladin and IRAK1 
(Figure 3.4) using WebLogo 3.3 (http://weblogo.berkeley.edu/) (Crooks et al., 2004). 
This identified positions 13, 11, 4, and 12 (numbering as in Figure 3.4) as the sites 
with the highest frequency of aspartate or glutamate residues, 59%, 41%, 35%, and 
29% respectively. Interestingly, these are the positions of the negatively charged 
residues in the ActA binding sites, which are the tightest known natural binding 
sequences of VASP-EVH1 (Ball et al., 2000).  
 Lastly, this sequence logo spotlights the enrichment of serine residues within 
VASP-EVH1 binding sites at positions 1, 2, 7, and 10. This may suggest that 
phosphorylation at VASP binding sites may serve as a mechanism to regulate actin 
polymerization. Of particular note are the first, third, and fourth motifs of lamellipodin 
and the first motif of palladin, which are known to be phosphorylated 
(http://www.phosphosite.org/) (Asano et al., 2011; Carlson et al., 2011; Hornbeck et 
al., 2004; Olsen et al., 2010).  
Examining the specificity of VASP-EVH1 for tryptophan vs. phenylalanine motifs 
 IRAK1 represents the only so-far established WPxφP-containing binding partner 
of Ena/VASP family EVH1 domains, as opposed to the FPxφP motifs found in 
vinculin, zyxin, lamellipodin, and ActA. However, multiple studies have reported that 
substitution of tryptophan in place of phenylalanine in the ActA-derived motif 
332SFEFPPPPTEDEL344 enhances binding significantly (Ball et al., 2000; Niebuhr et 
al., 1997; Zimmermann et al., 2003). To investigate with atomic resolution the 
differences between WPxφP and FPxφP recognition by VASP-EVH1, we repeated the 
above NMR analysis with a peptide with Trp168 mutated to Phe (IRAK1
162-180,  W168F
)  
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Figure 3.4: Alignment and sequence logo of VASP-EVH1 binding sites. (A) 
Alignment of VASP-EVH1 binding sites. Highlighted residues indicate serines and 
threonines that are reported to be phosphorylated, and negatively charged aspartates 
and glutamates are in red. (B) VASP-EVH1 binding site sequence logo generated from 
alignment. This sequence logo shows not only an enrichment of negatively charged 
residues but also an enrichment of serine residues in positions 1, 2, 7, and 10.  
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to compare with the previously reported experiment using the wt sequence (Chapter 
2). Titrating 
15
N-EVH1 with IRAK1
162-180, W168F
 yielded peak trajectories very similar 
to the IRAK1
162-180
 titration, with a few exceptions. The binding curves generated 
from the titration yielded a weaker affinity than for the wild-type sequence ( DK = 0.72 
± 0.012 mM, vs. 0.203 ± 0.003 mM for wt, Figure 3.1B). The extent of line 
broadening was greatly reduced, indicating faster binding kinetics (Figure 3.2, top 
center). Indeed, fitting lineshapes as above yielded 
offk  = 16,000 ± 2,000 s
-1
, 
corresponding to onk  = 3.0 ± 0.4 10
7
 M
-1
s
-1
.  
The strong ring currents of the tryptophan side chain can have large effects on 
the chemical shift of nearby nuclei. As expected, then, substituting phenylalanine for 
tryptophan in the sequence of IRAK1
162-180,  W168F
 led to significant differences in the 
bound chemical shifts of 
15
N EVH1. The peaks arising from the side chains of Trp23, 
Asn73 (
1
H
δ21 
and 
1
H
δ22
), Gln81 (
1
H
ε21
), Trp82, and the backbone amides of residues 
Tyr72 and Trp89 all showed  > 0.15 ppm (Appendix Figure 3.2). Most notably, 
the side chain of Asn73 (
1
H
δ22
) showed  = 0.62 ppm. We examined the possibility 
that this large reflected a hydrogen bond with the Trp168 sidechain amide, which 
could explain the nearly 5-fold increase in affinity (by trans
DK , corresponding to a 
difference in the free energy of binding of 3.85 kJ/mol) for IRAK1
162-180
 over 
IRAK1
162-180, W168F
. To test this theory, we measured the temperature dependence of 
the chemical shift of the Trp168 indole amide peak in the presence and absence of 
excess EVH1 domain. The temperature dependence of backbone amide proton 
chemical shifts, Δδ/ΔT, is a well-established indicator of hydrogen bonding (Cierpicki 
and Otlewski, 2001), leading us to presume that tryptophan indole amides follow a 
similar trend. Generally, backbone amides with a temperature gradient more positive 
than -4.6 ppb/K have an 85% or greater likelihood of being in a hydrogen bond. 
However, sidechains amides have a moderately more positive temperature gradient 
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than backbone amides in the absence of any hydrogen bonds. We found that the indole 
peak of Trp168 in both bound and free IRAK1
162-180
 had almost identical temperature 
dependence, (-4.1 and -4.0 ppb/K, Appendix Figure 3.3) very close to that reported for 
a short unstructured (not hydrogen bonded) peptide (-4.03 ppb/K) (Merutka et al., 
1995). This led us to conclude that the Trp168 side chain does not form a hydrogen 
bond in the complex between EVH1 and IRAK1
162-180
.  
Cyclophilin A catalysis of W168-P169 isomerization is not prevented by phosphorylation 
We have previously observed that the W168-P169 peptide bond in IRAK1 is in 
equilibrium between cis (43%) and trans (57%) isomers, and that binding to VASP-
EVH1 is specific for the trans isomer (Chapter 2). We had shown that the prolyl 
isomerase enzyme cyclophilin A (CypA) catalyzes isomerization of this bond and thus 
facilitates binding to VASP. However, phosphorylation of the residue directly 
preceding proline is known to hamper CypA activity (Yaffe et al., 1997). To test 
whether phosphorylation of the flanking Ser residues S166 and S173 prevents CypA 
catalysis of isomerization of the W168-P169 peptide bond in IRAK1, we measured the 
isomerization rate of 3.64 mM IRAK1
162-180, pS166, pS173
 in the presence of 10 µM CypA 
using the 
1
H-
1
H ROESY experiment (Figure 3.5) as previously described (De et al., 
2012; Greenwood et al., 2011). This experiment produced cross peaks which were fit 
to yield an isomerization rate of 3.7 s
-1
, confirming that CypA can isomerize this 
motif. This is not surprising given that S166 is two residues from P169 rather than 
preceding it, which would likely prevent catalysis. 
Identification of a highly conserved secondary binding site on VASP-EVH1 
Interpretation of the 
15
N EVH1 phosphopeptide titration data was complicated 
by the divergence of a subset of peaks from the predominant binding behavior. Some 
peaks, most prominently corresponding to the backbones amides of S2, R48, A85, and 
the side-chains of Q37, Q58, and N63 remained relatively stationary at low  
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Figure 3.5: Phosphorylated IRAK1 can be isomerized by cyclophilin A. (A) The 
1
H-
1
H ROESY spectrum of IRAK1
162-180, pS166, pS173
 (mixing time of 100 ms) shows 
that the cis and trans isomers of W168-P169 interconvert in the presence (blue) but 
not in the absence (red) of 10 µM cyclophilin A. (B) Normalized crosspeak intensities 
as a function of mixing time are fit to obtain the isomerization rate. 
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Figure 3.6: Evidence for a weak secondary binding site on VASP-EVH1. (A) 
Examples of peaks that sense a secondary binding event in the 
15
N EVH1/IRAK1
162-
180, pS166, pS173
 titration. This is distinguished by either peaks displaying three-state 
behavior (such as R48) or by peaks remaining stationary at substoichiometric peptide 
concentrations and moving once the primary binding site is nearly saturated (such as 
S2). (B) Representative binding curves from the 
15
N EVH1/IRAK1
162-180, pS166, pS173
 
titration, fit to a three-state model. Shown in red are proton or nitrogen (scaled by the 
scaling factor 0.154) chemical shifts of residues in the primary binding site, and shown 
in blue are chemical shifts of residues sensitive to the secondary binding event or both. 
Symbols represent titration data and lines represent a global fit. (C) The secondary 
binding site mapped to the solution structure of VASP-EVH1 (Ball et al., 2000). The 
coloration of the surface view reflects the chemical shift differences between the last 
two titration points of the 
15
N EVH1/IRAK1
162-180, pS166, pS173
 titration in which only the 
occupancy of the secondary binding site significantly changes (magenta=no change, 
green=highest change). The yellow stick representation shows the position of the 
IRAK1 peptide in the primary site.  
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concentrations of peptide and began to move at the highest concentrations of peptide, 
suggesting a secondary, weak binding interaction with the peptide (Figure 3.6A). This 
necessitated careful selection of peaks that did not display this behavior for our main 
analysis. Remarkably, the extent of this secondary behavior seemed to correspond well 
with the affinity of the peptide for the primary binding site (Figure 3.7), as the tighter-
binding peptides induced larger chemical shift changes for these residues at any given 
concentration and the tightest-binding peptide yielded saturation binding curves. The 
side-chains of Q37 and Q58 showed very small chemical shift changes for the 
titrations with unphosphorylated peptides, suggesting that these residues may interact 
with the phosphate groups. 
 The titration that induced the largest chemical shift perturbations of these 
residues, with the peptide IRAK1
162-180, pS166, pS173
, produced binding curves that were 
deemed tight enough to fit to obtain the dissociation constant for the secondary 
binding site. This was performed by globally fitting 22 binding curves from peaks 
displaying three-state behavior simultaneously with eight binding curves from residues 
within the primary binding site (Figure 3.6B). This yielded a DK  of 2.15 mM for the 
secondary site and a DK  of 20 µM for the primary site, in close agreement with the 
earlier fit that simply ignored the secondary site. Because of the vastly different 
binding affinities for the primary and secondary sites, it is easy to separately determine 
the chemical shift perturbation profiles of the tight and weak binding sites by 
analyzing chemical shift differences between spectra and low concentrations and high 
concentrations of peptide, respectively. Mapping the difference in chemical shift 
perturbations between the two final IRAK1
162-180, pS166, pS173
 titration points (highest 
concentration peptide) to the structural model described above shows a unique binding 
surface on the face opposite to the primary binding site of the VASP-EVH1 domain, 
supporting the existence of a distinct, weak binding site (Figure 3.6C). This binding  
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Figure 3.7: Secondary EVH1 binding site selects phosphorylated IRAK1 
peptides. Binding curves of residues in the secondary binding site as a function of 
“free” peptide concentration (defined as the concentration of peptide not bound to the 
primary binding site, obtained from fits) for the peptides IRAK1
162-180, W168F
, 
IRAK1
162-180
, IRAK1
157-180, pS163
, IRAK1
162-180, pS166
, IRAK1
157-180, pS173
, and IRAK1
162-
180, pS166, pS173
. Data are solid symbols with lines to guide the eye. The side-chains of 
Q37 and Q58 show very small chemical shift changes for the non-phosphorylated 
peptides, suggesting that they may interact with the phosphate groups. 
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surface comprises strands 1, 2, 3, and 4, which form a concave surface similar to the 
canonical binding site on the opposite face. The large chemical shift changes for the 
sidechains peaks of R48, Q37, N63 and Q58 as well as the backbone peak of S2 may 
indicate hydrogen bonding between the peptide and these side chains. Notably, R48 
and N63 are well-conserved residues that are involved in binding of Ran to the 
homologous Ran-binding domain of RanBP2, as described in the discussion.  
 
Discussion 
Ena/VASP proteins are actin-binding proteins that serve to remodel the actin 
cytoskeleton, specifically in the processes of axon guidance (Goh et al., 2002), 
phagocytosis (Coppolino et al., 2001), cell migration (Bear et al., 2000; Krause et al., 
2003), and cell-cell interactions (Grevengoed et al., 2001; Vasioukhin et al., 2000). 
They function by increasing the length of actin filaments, either by an anti-capping 
mechanism (Bear and Gertler, 2009) or by their processive filament elongation 
activity (Breitsprecher et al., 2011; Hansen and Mullins, 2010). VASP tends to be 
localized to focal adhesions (Gertler et al., 1996), adherens junctions (Reinhard et al., 
1996; Vasioukhin et al., 2000), filapodial tips (Rottner et al., 1999), and the leading 
edge of lamellipodia (Rottner et al., 1999). This localization of VASP is mediated by 
its N-terminal EVH1 domain, a small domain with a PH fold that recognizes the 
proline-rich motif (F/W)PxφP (Ball et al., 2000; Niebuhr et al., 1997; Pistor et al., 
1995). This motif, most commonly occurring simply as the sequence FPPPP, is 
present in the focal adhesion proteins zyxin and vinculin as well as the lamellipodial 
protein lamellipodin. Most of the VASP binding sites in the proteins ActA, Zyxin, 
Vinculin, Fyb/SLAP and Lamellipodin contain two or more acidic residues flanking 
the core binding motif (Figure 3.4). Generally, 1-2 acidic amino acids are present in 
the three positions preceding the core motif, and 1-3 are present in the four positions 
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following the motif. Point mutants of the acidic residues in the ActA sequence have 
reduced binding affinity for VASP, and the positively charged EVH1 residues K21 
and R22 are implicated in recognition of the C-terminal amino acids (Carl et al., 
1999). We have shown here for the first time that phosphorylation of serine residues 
within these positions can have a similar contribution (~3 kJ/mol for each 
phosphoserine) to VASP binding. The impact of phosphorylation on VASP binding is 
a novel finding suggesting a new mechanism of regulation of VASP interactions by 
phosphorylation of its binding partners. There may be other examples of this in nature, 
as some other VASP binding sites also contain phosphorylatable residues in these 
positions (Figure 3.4). In particular, lamellipodin, a protein required for formation of 
lamellipodia, contains a C-terminal threonine and a C-terminal serine in its first and 
third FPPPP motifs. It is known that these residues can be phosphorylated during 
mitosis or through the ERK2 signaling pathway (http://www.phosphosite.org/) 
(Carlson et al., 2011; Hornbeck et al., 2004; Olsen et al., 2010).  
IRAK1 autophosphorylates multiple serine residues in its UD upon receptor 
stimulation, and in vitro kinase assays have suggested that this autophosphorylation is 
very extensive, resulting in phosphorylation of nearly all of the serines in the UD 
(Kollewe et al., 2004). Specifically Ser173 is thought to be phosphorylated in response 
to TLR7 stimulation (Tun-Kyi et al., 2011). We propose that phosphorylation of the 
IRAK1-UD in response to TLR or IL-1R stimulation may contribute to recruitment of 
VASP to the site of stimulation at the plasma membrane. Thus, the effect of 
phosphorylation on VASP-IRAK1 binding provides evidence of a potential novel 
regulatory mechanism for VASP function in cell signaling.  
Although the consensus binding motif for Mena/VASP/Evl EVH1 domains is 
frequently given by FPxφP rather than (W/F)PxφP, in agreement with other studies 
(Ball et al., 2000; Niebuhr et al., 1997; Zimmermann et al., 2003) we have shown here 
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that substitution of the larger aromatic tryptophan for the aromatic phenylalanine 
actually increases the affinity of the interaction. Our chemical shift temperature 
coefficient analysis is not consistent with a hydrogen bond between the EVH1 Asn73 
side chain carbonyl and the indole amide proton of Trp168 in IRAK1. More likely, 
tryptophan may pack more favorably than phenylalanine in the hydrophobic binding 
pocket, and/or the torsion angle strain in the conformation that allows the side chain to 
insert into the pocket may be lower for tryptophan than phenylalanine. Importantly, 
the preference for tryptophan may indicate that additional VASP binding partners 
remain to be identified, since FPxφP is widely used as the consensus sequence.  
 We have shown that the VASP-EVH1 domain contains a secondary binding 
surface on the face opposite its primary binding site which weakly binds the 
phosphorylated peptide IRAK1
162-180, pS166, pS173
 with a dissociation constant of ~2.15 
mM. The large chemical shift perturbations of the R48 and N63 sidechain peaks 
provide insight into the evolutionary origins of this binding surface. The EVH1 
domain of VASP shares structural and sequence homology with the Ran-binding 
domains of Ran-binding proteins 1 and 2 (Callebaut et al., 1998; Vetter et al., 1999), 
small proteins that bind to the Ran GTPase and inhibit guanine nucleotide exchange. 
Crystal structures show that RanBD binds the C-terminal helix of Ran in a peptide-
binding groove (Vetter et al., 1999) formed by beta strands 1, 2, 5, 6, and 7, which is 
analogous to the primary binding site of the EVH1 domains of Ena/VASP proteins 
that bind proline rich sequences (Prehoda et al., 1999), as well as Homer (Beneken et 
al., 2000) and WASP (Gan and Li, 2010; Volkman et al., 2002) EVH1 domains 
(Figure 3.8). However, Ran also wraps almost all the way around the RanBD to make 
significant contacts with the opposite face of the domain. Notably, the backbone 
carbonyls of Ran residues A181 and L182 hydrogen bond to R77 in the first RanBD  
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Figure 3.8: Comparison between the binding surfaces of the Ran-binding domain 
and the VASP-EVH1 domain. (A) Cartoon representation of the VASP-EVH1 
solution structure (Ball et al., 2000) with the secondary binding site chemical shift 
changes mapped to it (magenta=no change, green=highest change). Residues that 
show the largest chemical shift changes are shown as sticks. The primary binding site 
is identified by the stick representation of the bound IRAK1 peptide. (B) Cartoon 
representation of the core of the structure of the first Ran-biding domain of RanBP2 
(orange), bound to residues 177-211 of Ran (yellow) (PDB ID 1RRP) (Vetter et al., 
1999). The helix-binding site is analogous to the primary binding site on VASP-
EVH1, while the extended Ran sequence is bound on the opposite face, analogous to 
the secondary binding site on VASP-EVH1. RanBP2 residues R77 and N91, 
homologous to R48 and N63 in VASP, are shown as sticks. 
 98 
of RanBP2, which corresponds to R48 in VASP-EVH1 and is one of the most 
conserved residues (Callebaut et al., 1998) throughout the families of WASP and 
Homer EVH1 domains as well as Ran-binding domains. Likewise, the similarly well-
conserved N91 of RanBP2, which corresponds to N63 in VASP, hydrogen bonds to 
the backbone carbonyl of Ran residue L182. Given this strict conservation, it may be 
possible the functional significance of this binding surface is also conserved.  
Remarkably, the extent of peptide binding for this surface appears to correlate 
with the affinity for the primary site, suggesting that the sequence specificity of the 
secondary binding site has some similarities to the primary site. Specifically, it 
appears to be sensitive to the identity of the residue in position 5, selecting tryptophan 
over phenylalanine, and appears to recognize the negative charges of phosphate 
groups on either side of the (F/W)-PPPP motif. It also seems likely that the 
polyproline II helix adopted by this proline-rich sequence is an important feature of 
recognition, given that the Ran sequence P180-E186 also adopts this structure (Vetter 
et al., 1999). Given this information, it seems feasible that this binding surface may 
bind a similar motif as the canonical binding site. 
Although it is uncertain whether the weak binding surface described here has 
biological significance, the similarity between the sequence specificities of this and 
the canonical site offers an intriguing hypothesis. Many VASP-binding proteins such 
as lamellipodin and zyxin contain multiple tandem repeats of VASP-binding sites. 
Given these results it seems very plausible that such tandem repeats could be bound by 
both faces of the EVH1 domain rather than each motif being bound by a separate 
VASP molecule. Possibly depending on clustering of VASP or the binding partner 
VASP could alternate between binding stoichiometries. Further experiments in our lab 
are in progress to test this hypothesis. Interestingly, it has recently been shown that 
Abl kinase can phosphorylate VASP residue Y39, which resides within this binding 
 99 
surface, and that this phosphorylation disrupts the interaction between VASP and 
zyxin (Maruoka et al., 2012).  
In summary, we have described two previously unreported features of the 
VASP-EVH1 domain’s interactions with its target proteins: a preference for 
phosphorylated sequences, and a secondary peptide binding site. The phosphorylation 
dependence of the VASP/IRAK1 interaction described here suggests a novel 
mechanism by which VASP function can be regulated. In response to TLR or IL-1R 
stimulation, IRAK1 may autophosphorylate at the Ser166 and Ser173 residues 
flanking the VASP binding site, recruiting VASP to the periphery of the cell, which 
has been proposed to contribute to cell migration (Gan and Li, 2010). Future work, 
however, is needed to test whether TLR/IL-1R signaling and phosphorylation control 
the VASP/IRAK1 interaction in the context of the cell. The described secondary 
binding site on the domain face opposite the primary site may bind a variation on the 
canonical (F/W)-PPPP motif, and may interact with the tandem repeats of zyxin and 
lamellipodin. Future work is also needed to investigate this hypothesis. 
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CHAPTER 4 
A Noncanonical Binding Site in the EVH1 Domain of VASP is Employed in the 
Interaction with Zyxin 
 
Abstract 
VASP is a processive actin polymerase with roles in the control of cell shape and cell 
migration. Through its interaction with the cytoskeletal adaptor protein zyxin, VASP 
can localize to damaged stress fibers which it serves to repair and reinforce with the 
aid of the actin-binding protein α-actinin. VASP localization is mediated by its N-
terminal Ena/VASP Homology domain (EVH1), which binds to the motif (W/F)PxφP 
(most commonly occurring as FPPPP) found in cytoskeletal proteins such as vinculin, 
lamellipodin, and zyxin. These FPPPP motifs very frequently occur in tandem repeats 
of four or five, and zyxin contains four such sites. This may allow the tetrameric 
VASP to bind very tightly through avidity. Motivated by the observation of an 
additional non-canonical and distinct binding surface on VASP-EVH1, we asked 
whether tandem repeat sequences can also bind this second site. The sequence 
containing the EVH1-binding sites of zyxin’s proline-rich domain, zyxin41-140 was 
purified as an 
15
N-labeled 100-residue protein and assignments of most non-proline 
residues were obtained exclusively by 
15
N-separated TOCSY and NOESY 
experiments and site-directed mutagenesis. Additionally, the cis and trans isomers of 
many F-P sites were also identified using 
15
N-ZZ exchange spectroscopy in the 
presence of the prolyl isomerase cyclophilin A. Dissection of the complex binding 
scheme between zyxin
41-140
 and VASP-EVH1 was accomplished by performing 
multiple binding titrations with different Phe-to-Ala zyxin
41-140
 mutants. Small peaks 
and shoulders representing the cis isomer of F93-P94 enabled us to make inferences 
about the binding orientation. We show here that when the VASP EVH1 domain binds 
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the second (tightest binding) zyxin motif, it makes significant contacts with the third 
and fourth motifs utilizing a noncanonical binding site on the face opposite the 
primary binding site, reminiscent of the homologous Ran-binding domain’s interaction 
with Ran. We further show that this secondary-site binding is specifically reduced or 
possibly eliminated for the Y39D EVH1 mutant, which mimics Abl-induced 
phosphorylation of this secondary site in VASP-EVH1. We propose that these 
observations may account for the reported reduced binding of Y39D VASP to zyxin, 
and may aid in understanding the role of tyrosine phosphorylation of VASP in the 
regulation of cell adhesion.  
 
Introduction 
The processive actin polymerase (Breitsprecher et al., 2008; Breitsprecher et 
al., 2011) VASP (Vasodilator-Stimulated Phosphoprotein) is an important regulator of 
the organization of the actin cytoskeleton (Krause et al., 2003). VASP and its 
homologs Mena and Evl are involved in the formation of lamellipodia (Bear et al., 
2002) and filopodia (Lebrand et al., 2004; Mejillano et al., 2004), as well as the 
cellular processes of phagocytosis (Coppolino et al., 2001), cell migration (Bear et al., 
2000; Bear et al., 2002; Krause et al., 2003), and neuron axon guidance (Goh et al., 
2002). VASP functions both as an actin polymerase and as an anti-capping protein 
(Barzik et al., 2005; Bear and Gertler, 2009; Bear et al., 2002), by protecting the 
barbed end of actin filaments from capping proteins. VASP and its homologs localize 
to specific sites in the cell such as lamellipodia and filopodia as well as focal 
adhesions and sites of stress fiber damage (Hoffman et al., 2012; Reinhard et al., 1992; 
Rottner et al., 1999; Smith et al., 2010; Tokuo and Ikebe, 2004) through binding to 
proline-rich sequences with its EVH1 (Ena/VASP homology 1) domain (Ball et al., 
2000; Niebuhr et al., 1997).  
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In response to cell mechanical stress, VASP is recruited to actin stress fibers, 
which it serves to reinforce and repair. This is mediated by an interaction with zyxin, a 
cytoskeletal protein involved in the mechanical stress response (Hoffman et al., 2012; 
Smith et al., 2010). Zyxin is phosphorylated at S142 in response to mechanical 
stimulation, which disrupts an inhibitory head-tail intramolecular interaction (Call et 
al., 2011; Moody et al., 2009). Zyxin is then recruited to damaged stress fibers through 
an interaction between its LIM domains and unknown factors (Smith et al., 2013). 
Simultaneously, phosphorylated zyxin binds the proteins VASP and α –actinin with 
multiple binding motifs in its disordered N-terminus.  
The interaction between VASP and zyxin is mediated by both interactions 
between the proline-rich region zyxin and the EVH1 domain of VASP and an 
interaction between the LIM domain region of zyxin and the proline-rich region of 
VASP (Moody et al., 2009). This allows the interaction to be regulated by 
phosphorylation at several sites. First of all, zyxin can adopt an inhibited conformation 
in which its LIM domains obstruct its proline-rich region, which can be destabilized 
by phosphorylation of S142 by Akt (Call et al., 2011; Chan et al., 2007; Moody et al., 
2009). Secondly, although the LIM/VASP interaction can overcome this inhibitory 
conformation, phosphorylation of VASP at S157 by PKA prevents this (Moody et al., 
2009). Thirdly, phosphorylation of Y39 in the EVH1 domain of VASP by Abl inhibits 
its interaction with zyxin (Maruoka et al., 2012), though it is not clear why given the 
placement of Y39 far from the EVH1 binding site.  
The VASP-EVH1 domain binds the motif (W/F)PxφP, where x is any amino 
acid and φ is aliphatic (Ball et al., 2000; Niebuhr et al., 1997). This motif most 
frequently occurs as FPPPP, and very often occurs in groups of four or five, as in the 
cytoskeletal proteins lamellipodin and zyxin, and the Listeria monocytogenes protein 
ActA (Figure 4.1). This is speculated to be a mechanism to increase binding between  
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Figure 4.1: Sequences of VASP-binding proteins. The proteins ActA, Lamellipodin, 
and zyxin all contain between four and five FPxφP motifs (red, underlined) which 
bind the EVH1 domain of VASP.   
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VASP and its binding partners, by combining the individual affinities of each of the 
four EVH1 domains in a VASP tetramer (Zimmermann et al., 2002). Indeed, deletions 
of VASP’s C-terminal tetramerization domain (EVH2, or Ena-VASP Homology 2 
domain) impair its ability to bind zyxin in cell lysates (Ahern-Djamali et al., 1998) and 
to localize to focal adhesions (Haffner et al., 1995). Inconsistent with this, however are 
the facts that the EVH2 domain is dispensable for Listeria motility (Geese et al., 2002) 
and that there seems to be a linear dependence of the rate of Listeria movement on the 
number of VASP-binding sites in ActA (Smith et al., 1996). It has been proposed 
alternatively that multiple FPPPP sites can be bound by multiple VASP tetramers, 
which would allow VASP to cross-link its binding partners (Zimmermann et al., 
2002).  
We have previously observed that VASP-EVH1 contains a secondary binding 
site that binds peptides with the core motif “LWPPPP.” Interestingly, the primary and 
secondary binding sites seem to share some sequence specificity, recognizing both 
flanking negative charges and the aromatic tryptophan/phenylalanine.  However, this 
was a very weak interaction, with the tightest-binding peptide binding with a DK  of 
2.15 mM (Chapter 3). The question arose whether under certain conditions the tandem 
repeat motifs of zyxin, lamellipodin, and ActA might bind this secondary site rather 
than the primary site, by wrapping around the EVH1 domain in analogy to the 
structures of the homologous WASP-EVH1/WIP (Peterson et al., 2007; Volkman et 
al., 2002) and RanBP2-RanBD1/Ran (Vetter et al., 1999) complexes.       
Here, we provide evidence  that the third and fourth VASP-binding motifs in 
the proline-rich region of zyxin bind to the secondary site of EVH1 domain in the 
context of the full proline-rich sequence of zyxin (zyxin
41-140
), but only weakly in a 
short peptide. Furthermore, we show that the phosphomimetic EVH1 mutant Y39D 
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demonstrates reduced or abolished binding at this secondary site. This secondary site 
may contribute to the overall affinity between zyxin and VASP, which could explain 
the effect of Y39 phosphorylation on cellular localization of VASP.        
 
Materials and Methods 
Protein purification 
Human VASP-EVH1 domain (residues 1-115) and full-length human CypA were 
produced as described (Chapter 2), as bacterially-expressed 6X-His fusion proteins. 
The Y39D EVH1 mutant was similarly produced using site-directed mutagenesis. A 
pDEST17 plasmid (ampicillin resistance) encoding human zyxin residues 41-140, plus 
an N-terminal 6X-His fusion and a TEV cleavage site, was produced using the 
GATEWAY cloning system. The zyxin
41-140
 sequence was amplified from a RFP-
zyxin expression vector purchased from Addgene (Addgene plasmid 26720 (Bhatt et 
al., 2002)). Various Phe-to-Ala mutations (F71A/F104A , F71A/F104A/F114A , and 
F71A/F104A/F93A ) were introduced by site-directed mutagenesis. Zyxin
41-140
 was 
grown in BL21-DE3 E. coli cells in 1 L M9 minimal media with 19 mM 
15
NH4Cl (or 
14
NH4Cl to produce unlabeled protein). Cells were grown to an OD600 of ~0.8 at 37 ˚C, 
the temperature was reduced to 17 ˚C, and protein expression was induced overnight 
with 1 mM IPTG. Cells were spun down and resuspended in 20 ml denaturing buffer 
(20 mM NaH2PO4, 500 mM NaCl, 6 M GuHCl, pH 8.0). Cells were then lysed by 
sonicating for 15 cycles (10 s on, 20 s off). The sonicate was centrifuged at 23,000 g 
and the supernatant was filtered with a 0.8 µM syringe filter to remove cell debris. The 
filtrate was then passed through a nickel-NTA column and the beads were washed 
with 40 ml of pH 8 wash buffer (20 mM NaH2PO4, 500 mM NaCl, 8 M urea, pH 8.0) 
and 20 ml of wash buffer at pH 6.0. Protein was then eluted with wash buffer at pH 
4.0 and dialyzed into TEV cleavage buffer (50 mM Tris, 0.1 mM TCEP, pH 8) or 
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NMR buffer (20 mM KH2PO4, 50 mM KCl, 1 mM TCEP, pH 6.7). To cleave the 6X-
His tag, TEV protease was added and the protein was allowed to cleave at 4 °C for 1-2 
days. The His tag was then removed with nickel resin as described (Chapter 2)  and 
protein was dialyzed into NMR buffer. The other proteins were purified using native 
preps as described (Chapter 2), and dialyzed into NMR buffer following cleavage and 
removal of His tag. NMR samples also contained 5 mM NaN3, 0.05% protease 
inhibitor cocktail (EDTA-free, Sigma), and 7% D2O. Unlabeled zyxin
41-140
 proteins 
used in the 
15
N-EVH1 titrations had the His tag intact in order to measure protein 
concentration by absorbance (using tyrosine residues between the tag and cleavage 
site), and CypA had the His tag intact due to the absence of a cleavage site. NMR 
samples were concentrated with 3000 MWC centrifugal concentrators. Protein 
concentration was determined by UV absorption at 280 nm, using the theoretical 
extinction coefficients of 21,000 cm
-1
M
-1
 for VASP-EVH1, 8,500 cm
-1
M
-1
 for CypA, 
and 5.96 cm
-1
M
-1
 for uncleaved zyxin
41-140
. The concentration of cleaved 
15
N zyxin
41-
140
, which does not have any UV absorbance, was determined by including a fitted 
correction factor in the binding curve fitting procedure.  
Peptide production 
Synthetic peptides encompassing the third and fourth binding motifs of zyxin, zyxin
99-
123
 and zyxin
99-123, F104A
 were purchased from Genscript (Piscataway, NJ). Peptides 
were dissolved in NMR buffer and their pHs were adjusted using NaOH. Peptide 
concentration was determined using the theoretical extinction coefficients of 390 and 
195 cm
-1
M
-1
 at 257 nm. 
NMR data collection and processing 
NMR experiments were carried out at 25 ºC using a Varian Inova 600 MHz 
spectrometer with a {H, C, N} Z-axis gradient probe. Spectra were processed with 
nmrPipe and analyzed with Sparky. Prior to Fourier transformation, 
15
N zyxin
41-140
-
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perspective data were processed with a phase-shifted sine bell window function and 
15
N EVH1 data were processed with an exponential window function. Peak positions 
and volumes were measured using the Sparky peak detection function.  
Resonance assignments 
15
N-separated 3D TOCSY and NOESY spectra were taken on 
15
N zyxin
41-140
 using 
mixing times of 70 and 100 ms, respectively. Sequential assignments for residues 69-
126, excluding prolines, were obtained from H
N
(i)-H
α
(i-1) NOESY connectivities and 
additional insights from site-directed mutagenesis and binding titrations. Assignments 
for the cis isomers of various X-Pro sites in the sequence were obtained by the 
15
N-ZZ 
exchange experiment described below. Resonance assignments for the EVH1 domain 
were obtained from the BioMagResBank, accession number 18569 (Ball et al., 2000), 
and incongruent assignments or residues near the N-terminus were clarified by 3D 
TOCSY and NOESY spectra of 
15
N EVH1. 
15
N-ZZ exchange experiments 
15
N-ZZ exchange spectra were taken of 
15
N zyxin
41-140
 in the presence of 5 μM CypA. 
Mixing times of 0, 22, 44, 110, 220, and 440 ms were taken. Comparison of spectra 
with longer mixing times to the 0 ms spectrum allowed for identification of exchange 
cross peaks, which identify pairs of peaks representing cis and trans isomers of the 
F71-P72, F93-P94, F104-P105, and F113-P114 peptide bonds.   
NMR titration experiments 
Three 
15
N EVH1-perspective HSQC titration experiments were performed. In each 
experiment the sample with the highest concentration of zyxin construct was produced 
first, and subsequent samples were produced by mixing part of the previous sample 
with a part of a stock of 
15
N EVH1. The experiments were: EVH1 domain titrated with 
wt zyxin
41-140
, zyxin
99-123
, and zyxin
99-123, F104A
. In the wt zyxin
41-140
 titration, the 
concentration of 
15
N EVH1 was held at 0.37 mM and the zyxin
41-140
 concentrations 
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were 0, 0.101, 0.201, 0.403, and 0.805. In the zyxin
99-123
 titration the concentration of 
15
N EVH1 was held at 0.3 mM and the zyxin
99-123
 concentrations were 0.13, 0.27, 
0.54, 1.08, 2.17, 4.33, and 8.67 mM. In the zyxin
99-123, F104A
 titration the concentration 
of 
15
N EVH1 was held at 0.18 mM and the zyxin
99-123, F104A
 concentrations were 0, 
0.12, 0.24, 0.49, 0.97, 1.95, 3.90, and 7.79 mM. Four 
15
N zyxin
41-140
 -perspective 
HSQC titration experiments were performed, with the mutants F71A/F104A , 
F71A/F104A/F114A , and F71A/F104A/F93A and wt zyxin
41-140
 . In the wt zyxin
41-140
 
titration EVH1 domain was continually added from a stock to the NMR sample, 
diluting the 
15
N zyxin
41-140
 further for each sample. In the other titrations, the most 
concentrated sample was produced first and subsequent samples were produced by 
mixing with a more concentrated stock of 
15
N zyxin
41-140
, so that the concentration of 
15
N zyxin
41-140
 increased as the concentration of EVH1 decreased.  For the wt zyxin
41-
140 
titration the concentrations of EVH1 were 0, 0.02, 0.03, 0.05, 0.13, 0.22, 0.47, and 
0.79 mM. For the F71A/F104A zyxin
41-140
 titration the concentrations of EVH1 were 
0.09, 0.18, 0.35, and 0.71 mM. For the F71A/F104A/F114A zyxin
41-140
 titration the 
concentrations of EVH1 were 0.08, 0.16, 0.32, and 0.64 mM. For the 
F71A/F104A/F93A zyxin
41-140
 titration the concentrations of EVH1 were 0.08, 0.16, 
0.32, and 0.64 mM. Four spectra were taken of 
15
N zyxin
41-140
 constructs with either 
54 µM EVH1 Y39D (wt zyxin
41-140
 ) or 94 µM EVH1 Y39D (zyxin
41-140
  
F71A/F104A, F71A/F104A/F114A, and F71A/F104A/F93A). Additionally, four 
spectra with equivalent concentrations of zyxin and wt EVH1 domain were taken. The 
15
N-EVH1 perspective spectra were taken with spectral widths of 8 kHz in the proton 
dimension (2048 complex data points) and 1.8 kHz in the nitrogen dimension (256 
complex data points). The 
15
N- zyxin
41-140
 perspective spectra were taken with spectral 
widths of 6 kHz in the proton dimension (2048 complex data points) and 1.4 kHz in 
the nitrogen dimension (256 complex data points).  
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Quantification of binding 
15
N and 
1
H chemical shift perturbation datasets were globally fit to either two- or 
three-state models. 
15
N EVH1/ zyxin
99-123
 titration data was fit to a three state model 
allowing for the zyxin
99-123
 peptide to bind either at the primary or secondary site, with 
distinct chemical shifts for each case. However, key primary-site residues such as 
Q81sc were deemed to only be sensitive to binding at the primary site and thus only 
had chemical shift parameters for the free and primary-site-bound states.  Fitted 
parameters included the chemical shifts of the bound states and dissociation constants 
for the two sites, primary
DK  and 
secondary
DK . From the 
15
N EVH1/ zyxin
99-123
 dataset, three 
binding curves for the primary binding site and 20 binding curves for the secondary 
site were globally fit. From the 
15
N EVH1/ zyxin
99-123, F104A 
dataset, five primary site 
binding curves and 27 secondary site binding curves were fit. F71A/F104A and 
F71A/F104A/F114A 
15
N zyxin
41-140
/EVH1 titration datasets were fit to a three state 
model allowing for EVH1 to bind with either 1:1 or 1:2 stoichiometries. 
F71A/F104A/F93A
15
N zyxin
41-140
 was modeled to only bind EVH1 domain in a 1:1 
complex. Peaks of residues near the third and fourth motifs were modeled to have 
distinct chemical shifts in the 1:1 and 1:2 complexes, while peaks of residues near the 
second motif were modeled to be insensitive to this. Fitted parameters included the 
chemical shifts of the bound states and dissociation constants for the 1:1 and 1:2 
complexes, 1DK and
2
DK  . Fitting was accomplished by minimizing the sum of squares 
of the residuals using the BiophysicsLab Matlab package. 
 
Results 
Assignment and characterization of the proline-rich region of zyxin 
In order to investigate whether VASP uses the secondary site in its EVH1 
domain to interact with its binding partners, we chose to study its interaction with the 
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proline-rich domain of zyxin. Residues 41-140 of zyxin (Figure 4.2A), which contain 
all four of its FPxφP motifs (M1, M2, M3, M4), was cloned and bacterially expressed 
and purified as an 
15
N-labeled protein. The
15
N-
1
H HSQC of zyxin
41-140
 (Figure 4.2B) 
shows very narrow peak dispersion characteristic of a disordered sequence undergoing 
rapid sampling of conformational space. Thanks to the relatively small number of 
residues that give rise to peaks (66, excluding prolines and the N-terminal residue), 
however, nearly all the peaks in the spectrum are resolved from each other.  
It was possible to assign residues 69-126 (excluding prolines) with primarily 
3D TOCSY and NOESY spectra, using H
N
(i)-H
α
(i-1) NOESY connectivities 
(Appendix Table 4.1). For residues isolated by proline residues which do not have NH 
protons, assignments were aided by site-directed mutagenesis and process-of-
elimination. Comparisons of HSQCs of the mutants F71A/F104A , 
F71A/F104A/F114A , and F71A/F104A/F93A (described below) and wt zyxin
41-140
 
allowed for identification of peaks that responded to these mutations, likely to 
correspond to residues near the site of mutation. Furthermore, assignments were 
carried out after titration data and 
15
N-ZZ exchange experiments (described below) 
were underway, allowing for attention to be focused on peaks that responded to EVH1 
binding or isomerization, and were thus likely to be near EVH1 binding sites.  
A small subset of peaks in the zyxin
41-140
 HSQC had much smaller (~1/4X) 
peak volumes, suggesting that they represented the slowly-exchanging cis isomers of 
the various X-Pro sites in the sequence. To further understand this, the 
15
N-ZZ 
exchange experiment was performed on 
15
N zyxin
41-140 
in the presence of 5 μM 
cyclophilin A (CypA), a prolyl isomerase that can accelerate proline isomerization 
into the NMR-sensitive timescale of seconds (Figure 4.2C). Indeed, this experiment 
produced exchange cross peaks between the minor peaks and other, larger peaks, 
which, remarkably, in every case corresponded to residues close to one of the four  
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Figure 4.2: HSQC and 
15
N-ZZ spectra of the proline-rich region of zyxin. (A) The 
sequence of zyxin
41-140
 contains many prolines and four VASP-binding sites (red, 
underlined). The four amino acids to the left of residue P41 are a consequence of 
cloning. (B) The 
15
N-
1
H HSQC spectrum of 
15
N zyxin
41-140
 shows narrow peak 
dispersion but nearly all peaks are resolved. (C) The 
15
N-ZZ experiment performed on 
15
N zyxin
41-140
 in the presence of 5 μM CypA allows for identification of cis and trans 
isomers of each of the four Phe-Pro sites in the sequence. Mixing times of 0 ms (red) 
and 220 ms (green) are shown.  
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Phe-Pro motifs in the sequence. This can be attributed to the tendency of 
phenylalanine to induce a relatively large population of cis when preceding a proline 
residue (Reimer et al., 1998). Thus, assignments for the minor cis isomers were 
possible by observing cross peaks in the 
15
N-ZZ exchange spectra, and confirming 
their identities by observing H
N
(i)-H
α
(i-1) NOESY connectivities when possible 
(Appendix Table 4.1). The dominance of Phe-Pro motifs in producing cis populations 
can be explained by the intrinsic tendency of bulky amino acids such as phenylalanine 
to induce a large percentage of cis isomer. Because we have previously shown that the 
interaction between VASP-EVH1 and its (W/F)PXφP binding motifs is specific for 
the trans isomer of the (W/F)-P peptide bond (Chapter 2), it was of particular 
importance to account for the cis/trans equillibria of these sites. 
Zyxin induces chemical shift changes at a unique binding interface on VASP-EVH1. 
  Having purified and characterized the proline-rich region of zyxin that harbors 
its VASP-binding sites, we next attempted to characterize its interaction with VASP-
EVH1. As a first step, 
15
N  EVH1 domain was titrated with unlabeled zyxin
41-140
 and a 
series of HSQC spectra were taken. Remarkably, zyxin
41-140
 induced severe 
broadening in all EVH1 peaks so much that below a ratio of 1:4 zyxin
41-140
 to EVH1, 
only two peaks corresponding to glycines in the flexible tail preceding Met1 of EVH1 
were discernible. This may be a result of formation of an ensemble of high molecular-
weight complexes where multiple EVH1 domains bind to the four motifs in zyxin
41-140
 
and potentially the primary and secondary binding sites in EVH1 are similarly 
occupied by multiple zyxin
41-140
 molecules. This prevented in-depth analysis, but it 
was still possible to analyze the chemical shift perturbation pattern induced by zyxin
41-
140
. The composite chemical shift perturbations at a ratio of 1:4 zyxin
41-140
 to EVH1 
were extrapolated based on the binding curve of Gly-2 (not shown). Although this 
analysis assumes a simple 1:1 complex, which later experiments show is not an 
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appropriate assumption, it nevertheless produced a chemical shift perturbation profile 
that matched the previously reported (Chapter 2) profile of ActA
333-344
-induced 
chemical shift changes quite well (Figure 4.3A). The primary difference between these 
profiles is that a number of key residues are sensitive to binding to zyxin
41-140
 but not 
ActA
333-344
. These residues, which include S2, R48, N63 and A65, map to the 
previously-characterized (Chapter 3) secondary site (Figure 4.3B).  
EVH1 binding to zyxin motif M4 is sensitive to sequence and isomer state at motif M2 
 In order to identify the residues in zyxin that contact the secondary binding site 
in the EVH1 domain, 
15
N zyxin
41-140
 was titrated with unlabeled EVH1 domain. As 
opposed to the 
15
N  EVH1 perspective titration, line-broadening only incrementally 
affected the spectra, and most peaks remained resolved throughout the titration. Peaks 
corresponding to residues within the first, second, and fourth binding motifs all moved 
significantly at early titration points, while peaks of residues in the third binding motif 
only started to move at very high concentrations of EVH1 (Figure 4.4A, left). This 
was unexpected, as it has previously been reported that a peptide containing only the 
fourth binding motif did not demonstrate detectable binding to EVH1 domain, while 
the third motif binds with moderate (197 μM) affinity (Ball et al., 2000).  
 Interestingly, the very different shapes of binding curves corresponding to each 
motif seem to suggest that it is possible for four EVH1 domains to bind each of the 
four FPPPP motifs in zyxin at once, overcoming any steric clash (Figure 4.4A). 
However, the unexpected preference of the EVH1 domain for motif M4 over motif 
M3 suggested that the fourth binding motif is bound very differently in the context of 
the full sequence and focused our attention on it. Specifically, we asked whether 
binding of motifs M1, M2, or M3 at the EVH1 domain’s primary site allowed motif 
M4 to bind at the EVH1 domain’s secondary site. We selected motif M2 as the motif 
most likely to participate in this kind of interaction, based on the number of residues 
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Figure 4.3: Zyxin
41-140 
induces chemical shift changes in the secondary binding 
site of VASP-EVH1. (A) Composite chemical shift changes of 
15
N EVH1 residues 
upon binding zyxin
41-140
 (blue) or the peptide ActA
333-344
 (red). Certain EVH1 
residues, such as S2, R48, N63, and A65, are only sensitive to binding to zyxin
41-140
. 
(B) Mapping chemical shift changes to the structure of VASP-EVH1 shows that 
zyxin
41-140
 induces chemical shift perturbations for residues in the primary binding site 
but also for residues on the opposite face of the EVH1 domain. ActA
333-344
 by contrast 
only influences residues in the primary binding site (Data from Chapter 2). Green = 
highest chemical shift perturbation, white = no perturbation. 
 
 
 
 119 
 
 
Figure 4.4: 
15
N zyxin
41-140
/EVH1 titration data shows isomer specificity of 
interaction at motif M2. (A) Above, various zyxin
41-140
 mutants are represented by 
either “M1-M4” for motifs 1-4, or “-” for a Phe-to-Ala mutant at a given motif. 
Binding curves for (left to right) wt, F71A/F104A, F71A/F104A/F114A, and 
F71A/F93A/F104A 
15
N zyxin
41-140
 titrated with EVH1 domain are shown. Motifs M1-
M4 are represented by yellow, red, green and blue symbols, respectively, in the 
binding plots. Binding at the third and fourth motifs persists when these motifs are 
mutated.  (B) Features of binding titration data for residues at motif M2. Peaks for the 
trans isomers of F93, G90 and G91 all move with increasing [EVH1] while the cis 
isomers remain stationary and decrease in intensity. For the I100 peak on the other 
side of motif M2, the cis isomer moves in a very distinct trajectory. Mutating F93 to 
alanine (rightmost column) does not abolish binding entirely, and the cis isomer is no 
longer observable. The I100 peak moves along a similar trajectory as the cis isomer in 
the other titrations for this mutant. 
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between motifs M2 and M4 (19). Therefore, in an effort to simplify the complex 
binding interaction between these proteins, the 
15
N zyxin
41-140
/EVH1 titration was 
repeated with the zyxin mutants F71A/F104A , F71A/F104A/F114A , and 
F71A/F104A/F93A. These titrations did not suffer significantly from line-broadening 
and the F71A/F104A mutant showed peak trajectories for residues near motifs M2 and 
M4 that were on the whole very similar to the wt titration.   
 Binding curves for all four zyxin
41-140
 titrations are shown in Figure 4.4A. 
Interestingly, while mutation of motif M1 (F71A) seems to prevent binding at this 
motif, significant chemical shift changes for residues at the other three motifs persist 
when they are mutated. The most drastic mutation, F93A, resulted in weaker binding 
curves and reduced chemical shift perturbations for residues in motif M2, while 
mutating motif M4 (F114A) does not substantially change the binding curves or 
chemical shift changes.  
 Small features of these titrations lend insight into the binding orientation of 
these proteins (Figure 4.4B). The previously-demonstrated (Chapter 2) trans isomer-
specificity of binding at the EVH1 domain primary site resulted in very different 
behavior for the peaks corresponding to the cis and trans isomers of F93-P94. While 
the trans peaks moved substantially, the cis peaks of G90, G91, and F93 only 
decreased in intensity upon addition of EVH1 domain. In contrast, the peak 
corresponding to I100 showed a minor population, most likely corresponding to the cis 
isomer, that moved in a very different direction rather than remain stationary. 
Meanwhile, residues in the third and fourth motifs showed minor population peaks 
that became resolved upon titration of EVH1 and lagged behind, and in some cases 
moved in slightly different (such as I113), or substantially different (such as S116) 
directions (Figure 4.5). This “lagging” behavior was most pronounced for residues in 
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the third motif, and most pronounced in the triple mutant F71A/F104A/F114A. 
Importantly, these minor population peaks were distinct from the peaks of the cis 
isomer of F114-P115, which unexpectedly moved comparably to the trans peaks. 
Remarkably, when motif M2 was mutated (F93A), the peaks for these M3 and M4 
residues followed these minor-peak trajectories rather than the trajectories of the 
previous major populations, and there was no longer evidence of a minor population, 
with a few small exceptions. Thus, the binding trajectories of residues in motifs M3 
and M4 are surprisingly sensitive to factors that influence EVH1 binding (the 
sequence and the isomer state of F93-P94) at motif M2. Furthermore, motif M2 seems 
to have some affinity for EVH1 even when F93 is mutated to alanine or when the F93-
P94 peptide bond is cis, but it seems to bind in a distinct orientation, based on the 
behavior of the I100 peak. 
 In order to quantitatively interpret the binding curves obtained from these 
titrations, we noted that peaks for residues in motifs M3 and M4 displayed clear three-
state behavior, in which they shift trajectories or even begin moving back towards the 
Apo chemical shift as the EVH1 domain concentration is increased. This was not 
observed for residues in motif M2, and the extent of this was nearly completely 
abolished in the F71A/F104A/F93A mutant. We interpreted this as evidence that the 
EVH1 domain can bind in multiple stoichiometries, which is not surprising given the 
multiplicity of binding motifs. Fitting the binding curves to models (Appendix Figure 
4.1) allowing 1:1 and 1:2 complexes yielded good fits, and the binding constants listed 
in Table 4.1. Fitting the binding curves from the wt zyxin titration was not attempted 
due to the complexity of the binding scheme.   
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Figure 4.5: 
15
N zyxin
41-140
/EVH1 titration data show multiple populations in slow 
exchange for zyxin’s third and fourth FPxφP motifs. Each column represents a 
different zyxin
41-140
 construct (wt, F71A/F104A, F71A/F104A/F114A, and 
F71A/F93A/F104A as represented by colored boxes above). The F104, I113, and 
F114 peaks (top three rows) show a trailing minor population that is not present for the 
F71A/F104A/F93A mutant (fourth column). Both cis and trans peaks of F114 and 
I113 (middle two rows) move upon addition of EVH1 domain. Finally, both S103 and 
S116 (bottom row) show clear three-state behavior that is abolished in the 
F71A/F104A/F93A titration. 
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Table 4.1: Dissociation constants of EVH1 binding to zyxin constructs 
 
 
 
 
 
The phosphomimetic Y39D EVH1 mutant is impaired in binding at the secondary site 
It has been reported that phosphorylation of Y39 by Abl reduces VASP 
accumulation in focal adhesions, and that mutation of Y39 to aspartic acid reduced 
VASP binding to zyxin. Because Y39 is located within the secondary binding site we 
have described, we wondered whether Y39 phosphorylation inhibits binding at the 
EVH1 secondary site. Furthermore, we reasoned that adding EVH1 Y39D to 
15
N-
labeled zyxin
41-140
 would help to map the zyxin residues that interact with the 
secondary site.  
The phosphomimetic Y39D EVH1 mutant was produced as an unlabeled 
protein and added to zyxin
41-140
 as before. Because of low protein yield, only one 
spectrum was taken for each 
15
N- zyxin
41-140
 construct: wt zyxin
41-140
 with 54 µM 
EVH1-Y39D, and the mutants F71A/F104A , F71A/F104A/F114A , and 
F71A/F104A/F93A with 94 µM EVH1-Y39D. Plots of the chemical shift perturbation 
profiles of these spectra compared to the analogous wt-EVH1 profiles are shown in 
Figure 4.6A. The largest differences between the wt-EVH1 and EVH1-Y39D 
perturbation profiles are seen for the triple mutants F71A/F104A/F114A, and 
F71A/F104A/F93A. In these cases, EVH1 Y39D induces significantly smaller 
chemical shift perturbations for residues spanning motifs M2, M3, and M4. The 
largest differences are seen for residues near mutated motifs, i.e. M4 for the  
construct
zyxin
99-123
141 µM 4.2 mM
zyxin
99-123, F104A
125 µM 2.5 mM
zyxin F71A/F104A 33 µM 226 µM
zyxin F71A/F104A/F114A 14 µM 135 µM
zyxin F71A/F104A/F93A 93 µM -
1
DK
2
DK
primary
DK
secondary
DK
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Figure 4.6: Chemical shift perturbation profiles of wt and Y39D EVH1 domain, 
and example peaks. (A) Bar charts representing the composite chemical shift 
perturbations () induced by adding either wt (blue bars) or Y39D (red bars) EVH1 
domain to the four zyxin
41-140
 constructs (wt, F71A/F104A, F71A/F104A/F114A, and 
F71A/F93A/F104A) represented by colored boxes above each charts. The position of 
the colored boxes reflects the position of each motif in the sequence. In the triple 
mutants, there is a significant decrease in chemical shift perturbation values for 
residues 100-123 for Y39D relative to wt EVH1 domain. (B) The Y39D EVH1 mutant 
induces chemical shifts that often correspond to the minor, slowly-exchanging 
population seen previously (left, I113 peak as example). The I100 peak, which 
exhibited a strikingly different peak trajectory for the F71A/F93A/F104A mutant, 
simply does not move when EVH1-Y39D is added to this mutant (center). The S116 
peak, which previously displayed three-state behavior, moves in the direction of the 
final chemical shift when EVH1-Y39D is added.
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F71A/F104A/F114A data and M2 for the F71A/F104A/F93A data, and M3 for both. 
Remarkably, in almost all cases peaks that had shown a lagging population in the wt-
EVH1 spectra adopted the chemical shift of that lagging population at the 
corresponding EVH1 concentration. The I100 peak no longer moved at all in the 
F71A/F104A/F93A/EVH1-Y39D spectrum, indicating that the alternative orientation 
for that residue could not be adopted for Y39D EVH1. Lastly the S116 peak, which 
had shown three-state behavior in the wt EVH1 titraion, moved towards its final, 1:2 
peak position for this Y39D mutant (Figure 4.6B).  
Collectively, these data suggest strongly that the Y39D mutation disrupts 
binding at a distinct secondary EVH1 site, which is employed primarily at a 
stoichiometry of 1:1. This distinct site seems to bind residues 100-123, and seems to 
compete with the primary site, as the effects of the Y39D mutation are most 
pronounced at mutated motifs that can no longer bind the primary site. Figure 4.7 
suggests a model of the multi-state binding scheme for VASP-EVH1 and the three 
zyxin
41-140
 mutants used in this study (F71A/F104A, F71A/F104A/F114A, and F71A/ 
F93A/F104A) that accounts for most of our observations. This model defines two 1:1 
complexes between the EVH1 domain and zyxin
41-140
, either with the primary EVH1 
site bound to motif M2 and the secondary EVH1 site bound to motif M4, or visa-
versa, with the first binding orientation dominating. When the F93-P94 peptide bond 
adopts the cis conformation, or when F93 is mutated to alanine, the equilibrium is 
shifted towards this second orientation. As EVH1 domain concentration is increased, 
the equilibrium is shifted towards a 1:2 zyxin:EVH1 complex, where motifs M2 and 
M4 are both bound in the primary EVH1 domain site. The Y39D mutation in the 
EVH1 domain disrupts the secondary binding site interaction, causing the chemical 
shifts of the two possible 1:1 complexes to collectively resemble those of the 1:2 
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Figure 4.7: Suggested model of EVH1/ zyxin
41-140
 binding. This model describes the 
binding scheme between EVH1 and the three mutant zyxin
41-140
 constructs used in this 
study (F71A/F104A, F71A/F104A/F114A, and F71A/ F93A/F104A). The EVH1 
domain is shown as an orange box with primary (rounded) and secondary (triangular) 
binding sites on opposite faces. Zyxin
41-140
 is shown a flexible black line with four 
binding motifs (M1-M4, yellow, red, green, blue). This model defines two 1:1 
complexes in equilibrium, and a 1:2 complex where both M2 and M4 are bound by the 
primary EVH1 binding site. The impacts of various mutations in both the EVH1 
domain and zyxin
41-140
 on the equilibrium of binding orientations are specified. 
Additionally, the impact of the isomer state of F93-P94 on the binding orientation is 
shown. 
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complex. 
Zyxin motifs M3-M4 as a short peptide only bind the secondary EVH1 site with low 
affinity  
In order to examine the specificity of zyxin motifs M3 and M4 for the 
secondary vs. primary binding sites in the EVH1 domain, we titrated 
15
N EVH1 
domain with a peptide corresponding to residues 99-123 of zyxin (zyxin
99-123
) or a 
mutant that abolished binding at the third motif (zyxin
99-123, F104A
). The long sequence 
was used because these were the residues that seemed to respond to the Y39D 
mutation in the earlier analysis. Fitting the data from both titrations to a three-state 
model (Appendix Figure 4.2) yielded the dissociation constant for the secondary and 
primary sites for each peptide (Table 4.1). Strangely, the F104A mutant peptide bound 
to the primary site with identical affinity as the wild-type peptide and slightly higher 
affinity to the secondary site. This experiment helped to better map the secondary site, 
since peaks sensitive to weak secondary binding continue to move at 
EVH1concentrations where the primary site is saturated (Figure 4.8). This experiment 
showed only very weak binding to the secondary site (2.5-4.2 mM), and tighter 
binding to the primary site than reported in (Ball et al., 2000) (~125-141 µM). 
Therefore, we concluded that binding at motif M2 is an important prerequisite for 
binding in the secondary site of the EVH1 domain. 
 
Discussion 
This work highlights the utility of NMR titration analysis for the study of 
complex protein-protein interactions involving several binding sites. The 
15
N-
1
H 
HSQC of the intrinsically disordered proline-rich sequence zyxin
41-140
 yields residue-
specific data that can be used to simultaneously track four distinct binding events. This 
provides the opportunity to address the question of whether four EVH1 domains can 
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simultaneously bind the four binding motifs in zyxin. Furthermore, measurement of 
binding in the context of the full-length sequence allows for detection of secondary 
contacts with residues very far in sequence from a primary binding motif. Lastly, the 
site specificity of NMR analysis allows unambiguous decoupling of primary and 
secondary binding events.    
 Additionally, this work provides an example of the usefulness of identification 
and interpretation of cis/trans equillibria. The trans-specificity of the EVH1/FPPPP 
interaction made it possible to interpret the minor lagging population seen for peaks of 
motif M3 and M4 residues as a cis population. This in turn provided evidence that 
binding of motif M2 in the primary EVH1 domain site is important for a secondary 
interaction involving motifs M3 and M4.   
 EVH1 domains consist of two antiparallel β-sheets which share two strands (1 
and 2), forming a sandwich, packed against a long C-terminal helix. The canonical 
(primary) binding site is a concave surface formed by one of the sheets (Figure 4.8). 
The secondary binding site we define here, on the other hand, is a rather similar 
concave surface formed by the other sheet, on the opposite side of the domain. The 
residues most sensitive to the secondary interaction include the very N-terminal 
sequence of the protein (M0-C7) as well as the side-chains of R48, and N63, which are 
all in close proximity to each other.   
 EVH1 domains all share a conserved primary binding site which binds proline 
rich sequences adopting a polyproline type II (PPII) structure. However, secondary 
interactions with additional epitopes have been reported, including for the VASP-
EVH1 domain itself. The WASP-EVH1 domain binds the protein WIP making 
contacts in its conserved canonical binding site, but also additional sites both above 
and below (Volkman et al., 2002). Similarly, the VASP-EVH1 domain recognizes the 
epitope 343EL344 in ActA using residues Q31 and A32, relatively far from the primary  
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Figure 4.8: Tyr39 is located centrally in the secondary EVH1 binding site. (left) 
The first Ran-binding domain of RanBP2 (orange) binds Ran (cyan) using a similar 
secondary binding surface as the site we describe, employing residues R77, R81, and 
N91 which correspond to R48, R52, and N63 in VASP-EVH1. (right) VASP-EVH1 
residue Y39 is located centrally in the secondary binding site. EVH1 is colored 
according to chemical shift perturbations induced at high concentrations of the zyxin
99-
123
 peptide (white = no perturbation, green = highest perturbation). Key residues are 
shown as sticks. The ActA sequence FPPPP (yellow) is shown bound in the primary 
site. (Model produced as in Chapter2). 
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binding site (Ball et al., 2000). While none of these secondary EVH1 sites are quite as 
distant as the binding surface described here, the homologous Ran-binding domain 
(RanBD) does seem to utilize this site.  
EVH1 domains share structure and sequence homology with RanBDs 
(Callebaut et al., 1998). The crystal structure of the first RanBD of RanBP2 bound to 
the nuclear transport protein Ran demonstrates that key features of the secondary 
binding interaction of VASP -EVH1 are conserved for Ran-binding domains (Vetter et 
al., 1999). In this structure, there are multiple significant contacts between RanBD1 
and Ran besides contacts to the “primary” site, which binds an α-helical segment of 
Ran rather than the PPII structure that EVH1 domains bind. In particular, the N-
terminal sequence of Ran binds to the face of RanBD1 that corresponds to the 
secondary binding site we have described (Figure 4.8). The sidechains of RanBP2 
residues R77, R81, and N91 (corresponding to VASP-EVH1 residues R48, R52, and 
N63) hydrogen bond with the backbone carbonyl groups of residues M179, A181, and 
L182 in Ran. Interestingly, these Ran residues adopt a PPII structure, and the 
recognition of their backbone carbonyl groups by RanBP2 is very reminiscent of the 
conserved mechanism by which EVH1 domains recognize their proline-rich motifs in 
the primary binding site.   
In an alignment of EVH1 and Ran-binding domains, the residues R48 and N63 
are very well-conserved (Callebaut et al., 1998). Given the degree of conservation of 
these residues, it is tempting to speculate that this secondary binding site is utilized by 
proteins such as WASP and Homer as well. On the other hand, R48 may play a 
structural role, as it forms a salt bridge with E3 in VASP, possibly contributing to the 
stability of the β sheet. This and the very weak binding affinity of the secondary site 
for motifs M3 and M4 in isolation (zyxin
99-123
) suggest that it is also possible that this 
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binding site in VASP is only vestigial.  
 Some support for the biological relevance of the secondary binding interaction 
described here comes from the recently reported impact of phosphorylation of VASP-
EVH1 by Abl tyrosine kinase (Maruoka et al., 2012). In Bcr-Abl-positive leukemic 
cells, Abl phosphorylates Y39 of VASP, which is centrally located in the binding site 
we describe (Figure 4.8). This may regulate the interaction between VASP and zyxin, 
since the phosphomimetic mutant Y39D has a reduced ability to bind zyxin in cell 
lysates. Furthermore, overexpression of either the Y39D or Y39F mutants, but not wt 
VASP, impairs adhesion of K562 cells to fibronectin, implying a cycle of 
phosphorylation and dephosphorylation is important for proper regulation of VASP. 
We have provided evidence that the Y39D mutant of VASP-EVH1 retains wt binding 
affinity for its primary site but that it is incapable of binding in the secondary site. 
Taken together, this data suggests that the secondary binding site is crucial for the 
interaction with zyxin in the cellular context.  
 Because we have focused our attention on motifs M2 and M4, it may be quite 
possible that motif M1 may similarly recruit other sites in zyxin to the secondary 
EVH1 site, or that it itself might interact with the secondary site. Indeed, when we 
produced a truncated version of zyxin that did not contain the fourth binding motif, 
(zyxin
41-108, F104A
) and added it to 
15
N-labeled EVH1 domain, the secondary site 
responded similarly to the longer zyxin
41-140
 construct (data not shown). This suggests 
that either motif M3 is more central to the secondary interaction, or alternatively that 
additional binding orientations involving motif M1 remain to be characterized. Future 
work should also be done to assign the EVH1 Y39D mutant in order to confirm that it 
is impaired for binding in the secondary site as the data suggests.  
In conclusion, we have identified and characterized a noncanonical binding site 
on the VASP-EVH1 domain and shown that it binds the third and fourth VASP-
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binding motifs of zyxin. We show that this interaction occurs in the context of the full 
VASP-binding region (zyxin
41-140
) but only very weakly for a shorter sequence 
(zyxin
99-123), suggesting that binding of zyxin’s motif M2 at the primary site of the 
EVH1 domain is important for this secondary interaction. We further show that the 
Y39D mutant, which mimics the effect of Abl-mediated phosphorylation of Y39 
(Maruoka et al., 2012), shows impaired or abolished capacity to participate in this 
secondary interaction. However, we have not shown whether or not disruption of this 
secondary binding interaction is enough to significantly decrease the overall affinity of 
VASP-EVH1/zyxin binding in vitro, which could help explain the reported cellular 
impact of Y39 phosphorylation. Future work should address this question.  
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CHAPTER 5 
Complete Determination of the Pin1 Catalytic Domain Thermodynamic Cycle by 
NMR Lineshape Analysis
2
 
Abstract 
The phosphorylation-specific peptidyl-prolyl isomerase Pin1 catalyzes the 
isomerization of the peptide bond preceding a proline residue between cis and trans 
isomers. To best understand the mechanisms of Pin1 regulation, rigorous enzymatic 
assays of isomerization are required. However, most measures of isomerase activity 
require significant constraints on substrate sequence and only yield rate constants for 
the cis isomer, cis
catk and apparent Michaelis constants, 
App
M
K . By contrast, NMR 
lineshape analysis is a powerful tool for determining microscopic rates and 
populations of each state in a complex binding scheme. The isolated catalytic domain 
of Pin1 was employed as a first step towards elucidating the reaction scheme of the 
full-length enzyme. A 24-residue phosphopeptide derived from the amyloid precurser 
protein intracellular domain (AICD) phosphorylated at Thr668 served as a 
biologically-relevant Pin1 substrate.  Specific 
13
C labeling at the Pin1-targeted proline 
residue provided multiple reporters sensitive to individual isomer binding and on-
enzyme catalysis. We have performed titration experiments and employed lineshape 
analysis of phosphopeptide 
13
C-
1
H constant time HSQC spectra to determine cis
catk , 
trans
catk , 
cis
DK , and 
trans
DK  for the catalytic domain of Pin1 acting on this AICD substrate. 
The on-enzyme equilibrium value of [E·trans]/[E·cis] = 3.9 suggests that the catalytic 
domain of Pin1 is optimized to operate on this substrate near equilibrium in the 
cellular context. This highlights the power of lineshape analysis for determining the 
microscopic parameters of enzyme catalysis, and demonstrates the feasibility of future 
                                                 
2
 Reprinted with kind permission from Springer, Journal of Biomolecular NMR, 2011, volume 51, 
pages 21-34, "Complete determination of the Pin1 catalytic domain thermodynamic cycle by NMR 
lineshape analysis" by Alexander I. Greenwood, Monique J. Rogals, Soumya De, Kun Ping Lu, Evgenii 
L. Kovrigin, and Linda K. Nicholson. 
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studies of Pin1-PPIase mutants to gain insights on the catalytic mechanism of this 
important enzyme. 
 
Introduction 
Peptidyl-prolyl isomerases, or PPIases, are enzymes that catalyze the 
isomerization of the peptide bond preceding a proline residue (Fischer and Aumüller, 
2003). The peptide bond between the amide nitrogen and the carbonyl carbon of the 
preceding residue is typically in the trans (ω = 180) configuration (Fanghanel, 2003). 
However, in the case of the peptide bond preceding a proline residue, the cis isomer (ω 
= 0) often exists in equilibrium with trans (Fanghanel, 2003). In the absence of stable 
tertiary structure, such as in short peptides, the population of the cis isomer can be 
between approximately 5% and 40%, depending on sequence (Reimer et al., 1998). 
Structure or protein-protein interactions can stabilize one isomer preferentially, often 
leading to nearly either 0% (Ramelot et al., 2000) or 100% cis (Sarkar et al., 2011). 
Prolyl isomerases can be important for facilitating catalysis by isomer-specific 
enzymes, and are thought to play an important role in facilitating binding by proteins 
which recognize only one of the isomers. The importance of this activity is highlighted 
in the example of dephosphorylation of the Ser(P)
5
-Pro
6
 motif in the heptad repeats of 
the C-terminal domain (CTD) of RNA polymerase II (Meinhart and Cramer, 2004; 
Xiang et al., 2010). This dephosphorylation is performed by the Proline-directed 
phosphatase Ssu72 which binds specifically to the lower populated cis isomer of the 
substrate (Werner-Allen et al., 2011; Xiang et al., 2010) . Because phosphorylation 
and dephosphorylation of the CTD occur on the same timescale as transcription 
(milliseconds to seconds) (Skinner et al., 2004), isomerization by the PPIase Pin1 is 
necessary to allow Ssu72-mediated dephosphorylation to proceed to completion on the 
proper timescale. This principle applies similarly to trans-specific phosphatases such 
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as PP2A (Zhou et al., 2000), though the impact of Pin1 activity is presumably most 
pronounced if there is a substantial population of cis isomer to be converted. 
Pin1 is the only PPIase in humans that is specific for pSer/pThr-Pro motifs (Lu 
et al., 1996; Ranganathan et al., 1997). While uncatalyzed inter-conversion between 
cis and trans isomers occurs naturally with a half-life on the order of 100 s (Grathwohl 
and Wüthrich, 1981), the presence of Pin1 can speed this exchange by orders of 
magnitude into the more biologically relevant timescale of milliseconds.  Notably, 
aberrant function of Pin1 is implicated in cancer (Lu et al., 2006), asthma (Anderson, 
2005), and Alzheimer’s disease (AD) (Pastorino et al., 2006). Although Pin1 is a 
much-studied enzyme, we lack a detailed understanding of the actual significance of 
its isomerase activity towards its most-studied substrates, such as the microtubule-
associated protein Tau or the amyloid precursor protein (APP), which are involved in 
Alzheimer’s disease. In the case of APP, Pin1 knockout shifts the proteolytic 
processing fate of APP towards the amyloidogenic pathway in cell culture and mouse 
models (Pastorino et al., 2006). This may contribute to Pin1’s established protective 
role against neurodegeneration (Meraz-Rios, 2010; Pastorino et al., 2006). Pin1 binds 
to and specifically catalyzes isomerization of the pT668-P669 motif in APP in vitro 
(Pastorino et al., 2006), suggesting that the mechanism of Pin1’s action on APP 
processing in vivo involves isomerization at this motif (Iijima et al., 2000; Lee et al., 
2003). Pin1 is comprised of two domains with similar specificity, a catalytic PPIase 
domain (hereafter referred to as Pin1-PPIase) and a type IV WW binding domain 
(Verdecia et al., 2000). While essential for Pin1 function in vivo (Lu et al., 2002), the 
WW domain does not improve catalytic function in vitro on phosphopeptide substrates 
(Eckerdt et al., 2005; Peng et al., 2009; Rippmann et al., 2000). Hence, as an important 
step toward understanding a key molecular switch involved in the development of AD, 
focus on the isolated Pin1-PPIase domain avoids substrate competition with the WW 
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domain and provides the opportunity to obtain a complete description of its catalytic 
reaction scheme. 
Assays of isomerase activity (Fischer et al., 1984; Fischer et al., 1983; Lin and 
Brandts, 1985) commonly employ an isomer-specific protease such as chymotrypsin, 
which only cleaves after aromatic residues following a residue preceded by a trans 
peptide bond (Xaa-trans-Xaa-Yaa-Xaa, where Yaa is aromatic and Xaa is any amino 
acid). By coupling the reversible isomerization reaction with the essentially 
irreversible cleavage of the peptide bond, assays can indirectly measure conversion of 
cis to trans by a PPIase by monitoring the cleavage reaction. This is accomplished by 
incorporating the chromogenic compound p-nitroanilide (pNA) after the cleavage site 
(most commonly Xaa-Pro-Phe-pNA) and monitoring the change in fluorescence upon 
release of the pNA. This approach therefore does not allow for much variation in the 
sequence of the substrate C-terminal to the isomerized proline residue. Furthermore, it 
can only report on the cis-to-trans rate constant, cis
catk , and an “apparent” Michaelis 
constant, App
M
K , which is a composite of the binding constants for the trans and cis 
conformers. Other problems with this type of assay include the tendency of proteases 
to degrade the isomerase, and the likely possibility that cleavage of the substrate 
affects the value of App
M
K . Other approaches have employed solvent jumps to perturb 
the equilibrium of cis and trans populations of substrates and monitor the return to 
equilibrium via UV absorption, exploiting the small differences in UV absorption 
between the cis and trans isomers (Garcia-Echeverria et al., 1992; Garcia-Echeverria 
et al., 1993). This, however, imposes similar restriction on substrate sequence because 
a UV-absorbing residue such as pNA must be located close to the isomerized peptide 
bond.  
NMR provides direct observation of cis and trans isomers, which due to their 
slow timescale of interconversion can be identified as distinct resonances. NMR is 
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therefore another popular tool used for the study of prolyl isomerization, and had in 
fact been used to measure intrinsic uncatalyzed isomerization in short peptides prior to 
the discovery of prolyl isomerases (Grathwohl and Wüthrich, 1981). Unlike most 
other approaches, NMR experiments have the ability to measure isomerization at 
chemical equilibrium, removing the need to perturb the cis-trans equilibrium and take 
time-resolved datasets. CPMG (Korzhnev and Kay, 2008) or R1ρ (Massi et al., 2004) 
experiments can measure the catalyzed rate of exchange as well as the rates and 
populations of on-enzyme motions. EXSY (Landrieu et al., 2000) and ROESY 
(Pastorino et al., 2006) experiments have been used to measure the rate of 
interconversion between two slowly-exchanging states. However, even in routine 
HSQC (Mulder et al., 1996) spectra, the supreme sensitivity of NMR line shapes to the 
kinetics and equilibria of individual reaction steps in a complex multi-state scheme is 
apparent. For complex systems in which multiple states are at equilibrium, NMR 
lineshape analysis provides a powerful tool with which to determine the microscopic 
kinetic rates and equilibrium constants connecting the different states in the reaction 
scheme, complementing these techniques.  
The detailed analysis of NMR line shapes is a well-established but 
underutilized tool for examining protein interactions and motions that occur within the 
microsecond to millisecond timescale (Gunther and Schaffhausen, 2002; Kern et al., 
1995; Kovrigin and Loria, 2006). The processes of ligand binding and release, 
conformational exchange, and enzymatic turnover can all occur on this timescale 
(Mittermaier and Kay, 2009a).  While classically applied to 1D NMR spectra, 
lineshape analysis is easily applied to 2D spectra by peak slice extraction. NMR 
lineshape broadening and changes in chemical shift in both dimensions of a series of 
HSQC spectra can yield information about kinetics, populations, and unobservable 
chemical shifts on a residue-specific basis (Gunther and Schaffhausen, 2002). Because 
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lineshape analysis uses data taken at multiple concentrations of interacting proteins, it 
is especially applicable to complex models with three, four, or more states (Gunther 
and Schaffhausen, 2002). Software has been developed to fit lineshape data to 
multiple, arbitrarily complex models, allowing easy comparisons between models 
(http://lineshapekin.net/, http://biophysicslab.net/). Simultaneously fitting data from 
multiple peaks can allow a global understanding of complex physical processes to 
emerge. In addition to ligand binding and protein dynamics (Craven et al., 1996; 
Johnson et al., 1998), lineshape analysis is applicable to the study of catalyic 
mechanisms and enzyme function, such as that of PPIases (Kern et al., 1995). The 
advantages of NMR lineshape analysis over standard biochemical isomerase assays lie 
in the ability to use the natural substrate sequence and the convenience of performing 
experiments at chemical equilibrium.  
Here we present the complete characterization of the reaction scheme of Pin1-
PPIase acting on the pT668-P669 motif in APP using NMR lineshape analysis. A 
specifically isotopically labeled (
13
C- and 
15
N) APP-derived phopshopeptide 
(pAPP659-682, corresponding to residues 659-682 of APP phosphorylated at T668) 
was titrated with unlabeled Pin1-PPIase, and the induced line broadening was fit to a 
four-state model (Figure 5.1A). NMR titration experiments using 
15
N-labeled Pin1-
PPIase and unlabeled pAPP659-682 allowed the measurement of the apparent 
dissociation constant App
D
K  for the binding reaction, which was used as a constraint in 
the lineshape analysis. This App
D
K  was in close agreement with that measured for full-
length Pin1, indicating that the isolated Pin1-PPIase domain accurately represents the 
function of the intact enzyme under these conditions. Using lineshape analysis, the 
microscopic rates ciscatk  and 
t
cat
ransk  of catalysis as well as isomer-specific dissociation 
constants s
D
ci
K  and s
D
tran
K were determined. Moreover, 
1
H-
1
H ROESY exchange 
experiments were employed to measure the overall rate of exchange exk  for both Pin1- 
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Figure 5.1: Models used to interpret NMR data. (A) Four state model for lineshape 
fitting of 
13
C-pAPP659-682 peptide isomerization data. This model describes four 
states: the cis and trans isomers of the peptide in the free state, and the cis and trans 
isomers bound to the enzyme. B) Three state model of PPIase catalysis for PPIase-
perspective data. This model describes Pin1-PPIase catalysis as a three-state process in 
which the PPIase can bind to either the cis or trans isomer of the pAPP659-682 
peptide. (C) Two-state approximation for PPIase-perspective titration data. 
Interpretation of peak positions with this model requires the approximation that 
exchange between the two bound states in the three-state model occurs on the fast 
chemical shift timescale. In this model the relative populations are described by a 
single parameter, the apparent dissociation constant App
D
K .  
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PPIase and full-length Pin1, providing independent validation of the lineshape-derived 
fitted parameters and further supporting the accurate representation of Pin1 catalytic 
function by the isolated PPIase domain. Interestingly, the on-enzyme equilibrium of 
cis and trans substrate was found to be skewed slightly in favor of trans, suggesting 
that Pin1 may be optimized to operate on this substrate slightly off-equilibrium.  
Materials and Methods 
Protein expression and purification 
A pET vector [GE Health Sciences] imparting kanamycin resistance was used 
for recombinant Pin1-PPIase expression. This vector encodes a protein consisting of 
an N-terminal His tag and a TEV cut site followed by the PPIase domain of Pin1 
(residues 46-163). Protein was expressed in BL21 star E. Coli [Invitrogen] cells grown 
in 1 L of either LB [BD] or M9 minimal media (using 19 mM 
15
NH4Cl [Isotec]) with 
50 μg/ml kanamycin [IBI Scientific]. Cultures were grown at 37°C to an O.D.600 ~0.6, 
and expression was induced with 1 mM IPTG [CalBioChem] at 15°C for ~20 hours. 
Cells were then pelleted and resuspended in lysis buffer (50 mM Tris-Hcl 
[Mallinckrodt Baker], 200 mM NaCl [Mallinckrodt Baker], 10 mM Imidazole [Alfa 
Aesar], pH 8.0, plus 100 µl protease inhibitor [Sigma], 1 mM DTT [Gold 
Biotechnology]). Cells were then lysed by freezing and thawing on ice, adding 1 
mg/ml lysozyme [EMD], and sonicating (10 cycles). Cells were then centrifuged at 
23,000 g and the supernatant was filtered with a 0.8-μm syringe filter [Corning]. 
Filtrate was then applied to a nickel-NTA column [Qiagen] and washed with 20 bed 
volumes wash buffer (50 mM Tris-Hcl, 200 mM NaCl, 18 mM Imidazole, pH 8.0). 
Protein was then eluted with elution buffer (50 mM Tris-Hcl, 150 mM NaCl, 300 mM 
Imidazole, pH 8.0) and dialyzed into cleavage buffer (50 mM Tris-Hcl, pH 8.0). 
Recombinant His-tagged TEV protease was then added and the Pin1-PPIase was 
cleaved from the His-tag overnight at 4°C. The His-tagged TEV was then removed by 
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putting the cleavage reaction through a second Nickel-NTA column, and the flow-
through containing pure Pin1-PPIase was dialyzed into NMR buffer (10 mM HEPES 
[Fisher, sodium salt], 1 mM DTT, pH 6.9). NMR samples also included 5 mM NaN3 
[Fisher], 1 mM TCEP [Thermo Scientific], and 7% D2O [Cambridge Isotope 
Laboratories]. Protein was concentrated with VivaSpin-20 5000 MWC centrifugal 
concentrators [GE]. The concentration of Pin1-PPIase was measured by the UV 
absorbance spectrum, using the theoretical extinction coefficient at 280 nm of 7210 
cm
-1
M
-1
. Protein purity was verified by SDS-PAGE. The pH of buffers and samples 
was adjusted using HCl [Mallinckrodt Baker] and NaOH [Sigma]. All peptides were 
synthesized using solid-phase F-moc chemistry at the Tufts University Core Facility, 
purified, and delivered as a lyophilized powder. Peptides were dissolved in NMR 
buffer (plus NaN3, TCEP and D2O), de-salted using a PD MiniTrap gravity column 
[GE], and their pH adjusted with NaOH before use. 
NMR experiments/Data processing 
NMR experiments were performed at 25°C on a Varian Inova 600 MHz 
spectrometer equipped with a {H,C,N} Z-axis gradient probe. Spectra were processed 
and analyzed using the software tools nmrPipe (Delaglio et al., 1995), nmrDraw 
(Delaglio et al., 1995), and Sparky (Goddard, 2008). Free induction decays were 
apodized using an exponential function to preserve the natural lorentzian lineshape, 
except for the ROESY data for which a phase-shifted sine bell function was used, and 
zero filled prior to Fourier transformation. Peak heights and positions were measured 
using the peak detection modules of nmrDraw or Sparky, respectively.  
In titration experiments to measure App
D
K , 12 mM pAPP659-682 was added to 
0.25 mM 
15
N-labeled Pin1-PPIase, and the peptide was reverse titrated from ~12 mM 
to ~0.8 mM by diluting with 
15
N-labeled Pin1-PPIase. Titration points were taken at 
peptide concentrations of 12, 7, 4, 2, 0.8, and 0 mM. The concentration of peptide was 
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measured by UV absorbance based on the theoretical extinction coefficient of 1,209 
cm
-1
M
-1 
at 280 nm. At each concentration, a two-dimensional 
15
N-
1
H fast HSQC 
spectrum (Mulder et al., 1996) was taken with a spectral width of 1.7 kHz (8 kHz) in 
t1 (t2), and a total of 512 (2048) complex data points. A total of 40 scans were 
acquired per FID with a 1.0 s delay, for a total time per spectrum of 7 hrs.  
For lineshape analysis titration experiments, ~1.0 mM unlabeled Pin1-PPIase 
was added to 0.7 mM labeled peptide and the protein was reverse titrated from 1.0 
mM to 0.06 mM by diluting with labeled peptide. Titration points were taken at 
enzyme concentrations of 1, 0.5, 0.25, 0.1, 0.06, and 0 mM. At each concentration, a 
two-dimensional 
13
C-
1
H constant-time (constant time delay of 27 ms) HSQC spectrum 
(Vuister and Bax, 1992) was taken with a spectral width of 5.5 kHz (8 kHz) in t1 (t2), 
and a total of 256 (2048) complex data points. A total of 88 scans were acquired per 
FID with a with a repetition delay of 1.0 s, for a total time per spectrum of 7.5 hrs. 
Constant-time spectra were taken to prevent splitting in the carbon dimension. 
Wrapping the alpha and delta peaks in the 
13
C dimension allowed for a smaller 
window with still well-resolved peaks. The 
13
C time domain was extended to 512 
points by mirror-image linear prediction prior to zero filling. 
For rate measurements, 3 mM of peptide was dissolved in NMR buffer and a 
catalytic amount of Pin1-PPIase (50 μM) was added. The rate of interconversion 
between the cis and trans isomers was measured by taking a series of ROESY (Bax 
and Davis, 1985) spectra with varying mixing times. The rate measurement was taken 
with mixing times of 0, 0.01, 0.02, 0.04, 0.06 0.08, 0.10, 0.15, and 0.20 s. Spectral 
widths used were 6 kHz in both dimensions, using a total of 192 complex data points 
in t1 and 2048 in t2. A total of 52 scans per FID were acquired with a recycle delay of 
1.0 s, for a total acquisition time of 64 hrs.  
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Data fitting 
ROESY peak heights for autopeaks and crosspeaks corresponding to the amide 
proton of E670 were obtained using Sparky processing software after baseline 
correction using a Gaussian fit (Goddard, 2008). Peak heights were fit to the two-state 
solution to the Bloch-McConnell equations (Cavanagh, 2007; McConnell, 1958)  by 
least-squares minimization using the Solver function in Microsoft Excel. Fixed 
parameters included the transverse relaxation constants for the cis and trans isomers, 
2,0
transR  and 2,0
cisR  determined independently by running the ROESY experiment without 
enzyme present, and the ratio of trans isomer to cis isomer, eqK , determined 
independently by comparing peak volumes of the two isomers. The cis autopeak was 
broadened significantly relative to the trans autopeak upon addition of Pin1-PPIase 
due to the high rate of isomerization. To accommodate this, the data was fit using an 
additional fitted parameter, 0
tcI , which scales the intensity of the trans-to-cis cross-
peak. Other fitted parameters included the initial intensities of autopeaks, 0
ttI  and 
0
ccI , 
and the overall rate of isomerization, exk . Errors were determined by Monte Carlo 
analysis, using the noise of the spectrum as experimental error and fitting in Matlab 
2010a. 
Lineshape fitting was performed using the BiophysicsLab Matlab package 
(Kovrigin, E.L., manuscript in preparation, http://biophysicslab.net). BiophysicsLab 
fits data extracted as 1D slices from Sparky (Goddard, 2008) using a custom Python 
extension BiophysicsLab 1DNMR. 
1
H-dimension slices from cis and trans peaks of the 
13
C-labeled phosphopeptide were extracted separately and normalized by the area 
under each peak to correct for broadening in the 
13
C dimension. Cis and trans datasets 
were then added together (weighting appropriately) before lineshape fitting. Data was 
fit to the four-state reaction scheme in Figure 5.1, which considers both the free and 
bound states of both isomers.  
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Fitted parameters included the on-enzyme equilibrium constant (
d
eq
boun
K ), the on-
enzyme catalysis rate from trans-to-cis ( t
cat
ransk ), and the chemical shifts of the proline 
resonances in the bound peptide ( νtransbound  
and νcisbound ). Constrained parameters included 
the apparent dissociation constant ( p
D
Ap
K ), the equilibrium constant for the cis and trans 
isomers of the free peptide (
eq
K ), the intrinsic (uncatalyzed) rate from trans-to-cis 
( int
tck ) obtained by measuring isomer-specific binding kinetics (unpublished data), the 
chemical shifts ( νtransfree and ) and linewidths ( 2,0
freeR ) of the proline resonances in the 
free peptide, and the small 
1
H-
1
H J-couplings between proline ring protons ( i
HHJ ). 
Because the parameters 
eq
K , νtransbound , ν
cis
bound
 and 2,0
freeR  are intrinsic to the free peptide, 
and easily measured using only the apo spectrum, these parameters were fit once from 
the apo spectrum and held constant during lineshape fitting. The numerous couplings 
between proline protons, i
HHJ , are available in the literature (Aliev and Courtier-
Murias, 2007) and thus held constant.  The parameters p
D
Ap
K  and inttck  were not deemed 
to be reliably extractable parameters from the lineshape titration data, and so were 
obtained using independent experiments (enzyme-perspective titration, below, and 
binding kinetics, data not shown). Likewise, the  contributions to the apparent 
transverse relaxation rates of resonances from the bound peptide not due to exchange 
( 2,0
boundR ) and the reverse binding rate constants 
cis
offk  and 
trans
offk  were not deemed to be 
reliably extractable parameters, so rather than fitting for them they were constrained 
and  systematically varied to assess the impact of their values on the results and 
quality of the fit, as discussed in results and discussion as well as the appendix 
(Appendix Table 5.1).  
BiophysicsLab fits titration lineshape data with the Bloch-McConnell 
equations in the following way: the population column vector P (equation 5.1A), 
which describes the populations of the four states ( ip ; free cis, free trans, bound cis 
and bound trans), is calculated for each spectrum using the thermodynamic parameters 
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p
D
Ap
K , 
eq
K , and 
d
eq
boun
K , and the total enzyme/peptide concentrations at each titration point 
(Appendix Equations 5.1-5.3). The rate matrix, which describes the equilibrium rate 
equations for the four species, is then calculated for each spectrum using the 
calculated population of free Pin1-PPIase ( freePPIase ) (equation 5.1B). The first-order 
rates for binding and isomerization are featured in the diagonal and off-diagonal 
elements of the rate matrix. The chemical shifts ( i ) of each of the four states appear 
as the diagonal elements of a square matrix (equation 5.1C, term 2). Likewise, the 
apparent transverse relaxation rates of resonances not due to exchange (
2,0
i
R ) appear in 
a second matrix (equation 5.1C, term 1), and the frequency variable   appears in a 
third (equation 5.1D). The simulated spectrum is given by equation 5.1E in the 
absence of three-bond proton coupling. To account for the small scalar coupling 
between proline ring protons, the final simulated spectrum was expressed as a sum of 
lorentzians that took the form of equation 5.1E with various small offsets in   
according to the scalar coupling constants reported in the literature (Aliev and 
Courtier-Murias, 2007) (Appendix equations 5.4 and 5.5 and Appendix Table 5.2). 
This classical approach is justified if scalar couplings are small compared to natural 
linewidths and exchange rates, as they are here (discussed in detail in Appendix). 
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Fitting was performed using the truncated Newton interior-point method (Kim 
et al., 2007) in Matlab 2010a. The quality of the fit was assessed by calculating the 
sum of squares of residuals, which are normalized by the square of the RMS noise of 
each spectrum. Fit results were insensitive to the starting values of fit parameters, 
indicating that in all cases a true minimum was reached. As errors we report the 
variations in the fitted parameters from varying p
D
Ap
K within its standard deviation of 
measurement of 0.3 mM. Uncertainty in p
D
Ap
K
 
was deemed the largest single source of 
uncertainty in the fit, as varying other constrained parameters or the experimental data 
itself within their uncertainties did not impact the fit as much (Appendix Table 5.1).  
 
Results and Discussion 
Measurement of p
D
Ap
K  by NMR titration experiments 
The Pin1-PPIase/pAPP659-682 interaction from the substrate perspective is 
represented by a four-state binding scheme (Figure 5.1A) that is described by seven 
independent rate, equilibrium, or binding constants. In order to minimize the number 
of fitted parameters in the linshape analysis, the overall apparent binding constant 
( p
D
Ap
K ) of Pin1-PPIase and pAPP659-682 was measured using a chemical shift 
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perturbation approach in an independent experiment. Since the binding of Pin1-PPIase 
to the pAPP659-682 peptide is very weak ( p
D
Ap
K ~ 1 mM), it was not possible to reliably 
measure the binding constant from substrate-perspective titration data due to the 
limited solubility of Pin1-PPIase. Therefore, the apparent affinity was measured from 
the perspective of the 
15
N-labeled Pin1-PPIase domain. Pin1-PPIase exchanges 
between three states (free, cis-bound and trans-bound) during catalysis (Figure 5.1B).  
However, approximation of the Pin1-PPIase interaction with the peptide substrate as a 
two-state (free and bound) exchange process with an equivalent p
D
Ap
K  (Figure 5.1C) is 
reasonable if exchange between the bound cis and bound trans states is fast on the 
chemical shift timescale.  A series of 
15
N-
1
H HSQC spectra of 0.25 mM 
15
N-labeled 
Pin1-PPIase was acquired while titrating with unlabeled pAPP659-682 peptide 
(soluble up to at least 12 mM). Backbone amide resonances moved progressively 
during the titration and followed a single trajectory rather than splitting into two peaks 
(Figure 5.2), justifying the two-state approximation (Figure 5.1C). The chemical shifts 
of selected residues were fit to the equation for fast exchange ( Δωon offk k ) 
between two states:  
         (5.2) 
 
where [P] refers to the PPIase enzyme concentration, [L] refers to the pAPP659-682 
peptide concentration, and  Δω is the composite chemical shift perturbation which is 
given by (Ayed et al., 2001; Mulder et al., 1999) 
         (5.3) 
Residues that provided the best fits were in close agreement with each other, yielding 
a p
D
Ap
K of 1.3 ± 0.3 mM, where error is the standard deviation across 10 individually fit 
peak walks (Figure 5.3A). A global fit of the same 10 residues also yielded an  
          2K P L (K P L )  4 P L  
Δω   Δω
2[ ]
App App
D Dmax
P
     

2 2Δω (ω ω )  (0.154 (ω ω ))Apo ApoH H N N    
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Figure 5.2: Chemical shift perturbation of 
15
N-labeled Pin1-PPIase upon titration 
with unlabeled pAPP659-682 peptide. Overlay of 
15
N-
1
H HSQC spectra of 0.25 mM 
Pin1-PPIase with varying amounts of unlabeled pAPP659-682 peptide, from 0 mM 
(red) to 12 mM (purple). Expanded regions (above) show example peak trajectories 
used in the determination of p
D
Ap
K . 
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Figure 5.3: Overall binding constant of Pin1 for pAPP659-682 is approximately 
independent of the presence of the WW domain. To measure the apparent ligand 
binding affinity, p
D
Ap
K , 
15
N-labeled PPIase domain (A) or full-length Pin1 (B) were 
titrated with the APP-derived phosphopeptide pAPP659-682 and a series of 2D 
15
N–
1
H HSQC spectra were acquired. The chemical shift perturbation, Δω (see main text), 
is plotted for a subset of residues that were used to determine p
D
Ap
K  for each protein. 
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identical p
D
Ap
K of 1.3 mM. This dissociation constant represents a weighted sum of the 
binding affinities for each isomer, cis and trans, of the substrate peptide:  
         (5.4) 
 
where 
eq
K =13.6 ± 0.7 is the ratio of free trans isomer to free cis isomer, as determined 
from the ratio of [trans peak/cis peak] volumes in a 
13
C-
1
H HSQC spectrum of 
pAPP659-682 (error is standard deviation across three sets of peaks). The p
D
Ap
K of 1.3 
mM provides a useful constraint on the fitted parameters s
D
tran
K and s
D
ci
K  accessible from 
lineshape analysis as described below. 
In order to assess the pertinence of using the isolated PPIase domain as a 
model to study Pin1 activity, this analysis was repeated with labeled full-length Pin1 
(Figure 5.3B). In this case, individual fitting of 7 residues yielded a ,App P
D
Piase
K of 2.2 ± 
1.3mM, while a global fit yielded ,App P
D
Piase
K = 1.5 mM. Because the corresponding values 
in full-length-Pin1 and isolated PPIase are within error of each other, as well as the 
close correspondence of the globally fit values, we concluded that Pin1-PPIase 
binding to pAPP659-682 is essentially independent of the presence of the WW domain 
under the experimental conditions used. 
Lineshape analysis yields kinetic rates and equilibrium constant for Pin1-PPIase 
isomerization of pAPP659-682 
The kinetic rates and equilibrium constants describing catalysis by the Pin1 
PPIase domain acting on the pT668-P669 motif were next extracted from the 
lineshapes of nuclei on the pAPP659-682 phosphopeptide substrate. Although 
measuring dynamics from the perspective of a saturated enzyme provides a wealth of 
information about enzyme function and mechanisms, the acquired data can be 
ambiguous to interpret. Enzyme-perspective dynamics can represent substrate 
turnover, but they can also represent numerous other exchange processes, related or 
1
1
eqApp
D
eq
trans cis
D D
K
K
K
K K



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not related to catalysis (Bosco et al., 2010). Furthermore, depending on the catalytic 
mechanism and the timescale of substrate binding, resonances from enzyme nuclei 
may not be sensitive to the actual process of substrate turnover.  For these reasons, we 
sought to measure catalysis by the Pin1 PPIase domain primarily by considering the 
lineshapes of nuclei on the substrate, which exchange between four states (free cis, 
free trans, bound cis and bound trans, Figure 5.1A). This approach provides the most 
direct measure of the actual catalytic activity, although it does not by itself provide 
information about the various residues and motions in the enzyme that contribute to 
catalysis as enzyme-perspective analysis can (Labeikovsky et al., 2007). We utilized a 
specifically labeled phosphopeptide, identical to pAPP659-682 but 
13
C and 
15
N labeled 
at Pro669 (
13
C-pAPP659-682). A constant-time 
1
H-
13
C HSQC of 
13
C-pAPP659-682 
contains peaks corresponding to the alpha proton as well as the two beta, two gamma, 
and two delta protons of the proline ring (Figure 5.4). Each proton yielded two peaks, 
a large peak corresponding to the trans isomer and a smaller peak corresponding to the 
cis isomer. With the exception of the gamma protons, which have overlap in their 
trans isomer peaks, and the delta protons, which have overlap in their cis isomer 
peaks, these peaks are well-resolved from each other. The generally large chemical 
shift differences between the cis and trans isomer resonances (e.g. ~0.5 ppm in the 
1
H 
dimension for the alpha proton) ensure that their linewidths are particularly sensitive 
to catalyzed exchange between the two states on the second-to-millisecond timescale. 
Furthermore, the presence of five sets of well-resolved peaks associated with the 
major trans population (H, H1, H2, H1, H2) allows for a global analysis, which 
can yield a much more reliable fit than analysis of a single pair of resonances.  
The four-state binding scheme for the Pin1-PPIase/pAPP659-682 interaction 
(Figure 5.1A) is described by three independent equilibrium or binding constants (the 
ratio of the trans to cis isomers of the free peptide, 
int int/
eq ct tc
K k k
 
, the on-enzyme  
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Figure 5.4: 
13
C–1H constant-time HSQC spectrum of specifically labeled 13C-
pAPP659-682 peptide. A 
13
C–1H constant-time HSQC (constant time delay of 27 ms) 
of the APP-derived phosphopeptide 
13
C-pAPP659-682, specifically 
13
C labeled on 
Proline 669, yields a spectrum with peaks corresponding to the proline sidechain 
protons in both the trans and cis conformations. Both negative (alpha, delta protons) 
and positive (gamma, beta protons) peaks are shown in black. The alpha proton peaks 
are split in the carbon dimension due to coupling with the 
13
C-labeled carbonyl 
carbon. The trans peaks of the gamma protons were found to overlap, and therefore 
were not considered in the lineshape analysis. (inset) Delta proton peaks. 
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equilibrium constant, /
bound c
eq
is tran
cat cat
s
K k k , and the overall apparent binding constant p
D
Ap
K  , 
as defined in Equation 5.4) as well as four independent rate constants (the uncatalyzed 
and catalyzed conversion rates from cis-to-trans, 
int
ct
k  and 
s
cat
ci
k , and off rates for the cis 
and trans isomers, 
cis
off
k  and 
trans
off
k ). In order to determine these microscopic rates and 
equilibria, lineshape analysis was performed on a series of constant-time 
13
C-
1
H 
HSQC spectra of 
13
C-pAPP659-682 with varying concentrations of unlabeled Pin1-
PPIase. Resonances corresponding to the trans isomer typically showed a small 
upfield shift and modest, progressive broadening (Figure 5.5). In all cases, the peaks 
corresponding to the cis isomer broadened substantially upon addition of even low (60 
µM) concentrations of enzyme. This can be expected because, in the limit of slow 
exchange, exchange broadening preferentially affects the minor exchanging 
component as it has a shorter lifetime (faster rate constant) (Wang and Palmer Iii, 
2003). Because of this, essentially only the apo peak positions for cis peaks impacted 
the fit. Constant-time HSQC spectra were utilized to eliminate splitting in the carbon 
dimension, and to provide resolution of peaks that would otherwise be overlapped in 
the 
1
H dimension. However, use of constant-time 
13
C evolution precluded lineshape 
analysis in this dimension, since this mode of evolution provides no encoding of 
exchange processes into the 
13
C lineshapes. 
Proton dimension peak slices were extracted using the BiophysicsLab Sparky 
extension (Kovrigin, E.L., http://biophysicslab.net). To allow simultaneous 
visualization and analysis of data from both the trans and cis peaks, peak slices from 
each isomer of a given nucleus were added together in Matlab to generate a single 1D 
1
H spectrum containing both isomer peaks. The resulting 1D 
1
H spectra were then fit 
to a four-state model that considered the bound trans and bound cis states as well as 
apo trans and cis states (Figure 5.1A). The on-enzyme apparent transverse relaxation 
rate in the absence of exchange ( 2,0
boundR ) was constrained to be 20 Hz, the average  
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Figure 5.5: NMR lineshape fitting of 
13
C-pAPP659-682 peptide titration data. 
Individual 
1
H lineshapes for five well-resolved 
13
C-bonded protons of Pro669 (A-F) 
were globally fit using lineshape analysis. Stack plots show extracted 1D slices 
(frequency axis expressed in ppm) from 2D 
13
C-
1
H constant-time HSQC spectra of 0.7 
mM 
13
C-pAPP659-682 peptide with varying concentrations of unlabeled Pin1-PPIase, 
from 0 mM (black dots) to 1 mM (magenta dots). The corresponding best-fit globally 
analyzed lineshapes are shown as solid lines in matching colors. Close proximity of 
cis-Pro669 αH to the water resonance detracted from its inclusion in the stack plot (A); 
lineshapes of trans-Pro669 αH are shown in more detail (B). 
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value for aliphatic protons in the enzyme. The theoretical value of the transverse 
relaxation rate for a 
13
C-attached proton in a 16 kDa complex was also calculated to be 
17 Hz using Stokes’ law and Figure 1.6 in (Cavanagh, 2007). Because varying this 
constrained parameter within a range of ± 4 Hz did not impact the result or quality of 
the fit substantially (Appendix Table 5.1), this approach was deemed valid. Because in 
general these 
1
H lineshapes exhibited small splitting due to J-coupling between the 
proline ring protons, each peak was modeled as a superposition of lorentzians, using 
the literature scalar coupling values between the ring protons of L-proline as reported 
by (Aliev and Courtier-Murias, 2007) (detailed in Appendix). In order to obtain 
consistent results, it was necessary to simultaneously consider all five groups of peaks 
in a global fit. The obtained rate, equilibrium, and dissociation constants are presented 
in the top section of Table 5.1, while constrained global parameters and nucleus-
specific parameters are presented in the bottom section.  
 
Table 5.1: Summary of fitted and constrained parameters 
Fit 
parameters 
on-enzyme 
trans/cis 
(mM)  (mM) 
on-enzyme     
 kex (s
-1
) 
 
3.3 ± 0.5 1.6 ± 0.4 0.4 ± 0.1 1100 ± 90 
 
 
Constrained 
parameters 
free trans/cis 
a
  (mM) 
b
 
Uncatalyzed   
kex (s
-1
) 
c
 
 (s
-1
) 
d
  (s
-1
) 
d
 
13.6 ±  0.7 1.3 ± 0.3 
0.0085 ± 
0.0008 
≥ 4,000 ≥ 20,000 
Nucleus-
specific 
parameters 
Proline 
Protons 
Δω trans 
(ppm) 
Δω cis (ppm)  (s-1) JHH (rad/s) 
Hα -0.073 -0.197 75.5 46.9 
Hβ1 -0.079 -0.477 87.7 77.0 
Hβ2 -0.036 -0.434 109.4 73.9 
Hδ1 -0.022 0.357 99.4 61.1 
Hδ2 -0.044 -0.143 95.1 65.2 
a Determined from peak volumes 
b Determined from NMR titration of enzyme 
c Determined form binding kinetics (data not shown) 
d Assuming a diffusion-limited on-rate of  ≥ 107 M-1s-1 
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The value obtained for the on-enzyme rate of exchange, bound cis
ex
tran
cat c
s
at
k k k   , was 
1500 ± 100 s
-1
, in very close agreement with the rate of conformational exchange 
during catalysis of a model peptide (1200 ± 200 s
-1
) as detected by Labeikovsky et. al. 
(Labeikovsky et al., 2007). Furthermore, since that study showed similar motions in 
the free enzyme, this measurement seems to suggest that the rates of Pin1 catalysis are 
dictated by intrinsic motions that are largely independent of the actual substrate. The 
ratio of bound trans to bound cis 
d
eq
boun
K
 
was found to be 3.9 ± 0.8, which may indicate 
a role for the enzyme in restoring equilibrium to this substrate when it is skewed 
slightly towards the cis isomer, as discussed later. Determination of this ratio allows 
for the separation of the apparent p
D
Ap
K  into the isomer-specific binding constants s
D
tran
K = 
1.5 ± 0.4 mM and s
D
ci
K  = 0.4 ± 0.1 mM, using equation 5.4 and the definition 
/bound c
eq
is tran
cat cat
s
K k k . Errors were obtained by propagating the errors in p
D
Ap
K , 
d
eq
boun
K
 
and 
eq
K .  
The dissociation rates 
s
off
ci
k  and 
t
off
rans
k
 
were found to have only a small effect on 
the fit unless they were constrained to be below 1,000 s
-1
, which reduced the quality of 
the fit (Appendix Table 5.1). This observation suggests that
s
off
ci
k  and 
t
off
rans
k  are 
sufficiently fast as to have no significant impact on lineshapes. This interpretation is 
consistent with the enzyme-perspective data, which indicated fast exchange. Assuming 
diffusion-limited on-rates of greater than 10
7
 M
-1
s
-1
, we can only bracket 
s
off
ci
k   and 
t
off
rans
k  
as greater than 4,000 s
-1
 and 20,000 s
-1
, respectively. 
The best global fit of the data yielded rather large chemical shift changes for 
the bound cis populations of the beta protons and one of the delta protons, on the order 
of 0.4 ppm. While not unusual for chemical shift changes due to protein-ligand 
interactions, these were significantly larger than those for the trans peaks. This may 
reflect a distinct environment for the cis isomer in the active site of the enzyme, 
possibly involving closer interactions with the proline ring than for the trans isomer. It 
should be noted that in the fitting these three chemical shift changes diverged to even 
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larger values when left unconstrained, and that the values presented reflect the upper 
or lower allowed limits in the fit. Loosening the limits, however, did not result in a 
substantially improved fit. Therefore, the reported bound chemical shifts for the cis 
isomer, while approximate, clearly indicate a significant change in chemical 
environment upon binding to the active site.  
 In order to construct the energy diagram of Pin1-PPIase catalysis, free energies 
for each of the four states in the model were calculated using the equations 
         (5.5A) 
         (5.5B) 
where bindG is the Gibbs free energy of binding for each isomer, Bk  is the Boltzmann 
constant, T  is temperature, DK is the dissociation constant for each isomer, 
cis transG G   is the difference between the Gibbs free energies of the cis and trans 
isomers, and 
eqK  is the ratio of free trans and cis populations. Activation energies 
were calculated using the Eyring equation: 
         (5.6) 
where iG   refers to the activation barrier (catalyzed or uncatalyzed) for either the cis 
(i=ct) or trans (i=tc) isomer, h is Planck’s constant, and ik  is the measured rate of 
exchange (catalyzed or uncatalyzed) between cis and trans (i=ct) or between trans and 
cis (i=tc). The values obtained for the peptide bond torsion barrier on (55.4 kJ/mol) 
and off (84.8 kJ/mol) the enzyme are in good agreement with published measurements 
and estimates for these values (Kofron et al., 1991; Park et al., 1992; Schutkowski et 
al., 1998).  
Measurement of overall cis/trans exchange by ROESY 
As a validation of the best-fit parameters, the catalyzed rate of exchange 
between the cis and trans isomers was measured by 
1
H-
1
H ROESY experiments. A 
catalytic amount of PPIase (50µ M) was added to a 3 mM sample of unlabeled 
( )bind B DG k T ln K  
( )cis trans B eqG G k T ln K   
( )i BB i
k T
G k T ln
h k
  

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pAPP659-682 and 
1
H-
1
H ROESY spectra were taken with a series of mixing times. In 
the absence of Pin1, the cis and trans conformations of the amide backbone resonance 
of E670 are resolved and do not detectably exchange in a ROESY spectrum. Upon 
addition of Pin1, chemical exchange crosspeaks appear and vary in intensity as a 
function of mixing time. The intensities of auto-peaks (cis and trans,  ( )ccI t  and 
 ( )ttI t ) and cross-peaks (trans-to-cis and cis-to-trans,  ( )tcI t  and  ( )ctI t ) were obtained 
and fit to the two-state solution of the Bloch-McConnell equations (Cavanagh, 2007; 
McConnell, 1958) to extract out the rate of isomerization (Figure 5.6A). All four 
curves for cross- and auto-peaks were simultaneously fit to obtain rates.  The value of 
ex cis trans trans cisk k k    = 41 ± 1 s
-1
 was obtained and found to be in excellent 
agreement with the value of 47 s
-1
 predicted by the measured microscopic rates, using  
the reversible Michaelis-Menten equation  
 
           (5.7) 
 
When this analysis was repeated with full-length Pin1 (Figure 5.6B), a value of exk  = 
28 ± 1 s
-1
 was obtained. Although this is modestly lower than the value for the isolated 
PPIase domain, we concluded that there is no drastic difference in catalysis of 
pAPP659-682 by Pin1-PPIase and full-length Pin1 under the conditions of the 
experiment, validating our approach of focusing on the isolated catalytic domain. 
 
A complete description of the Pin1-PPIase thermodynamic cycle for catalysis of a 
biological substrate 
Taken together, the results obtained here provide a complete kinetic and 
thermodynamic description of the Pin1-PPIase cycle for isomerization of a 
phosphopeptide corresponding to the Pin1-targeted motif in the intracellular domain of 
   
[ ]
( )
1
trans cis tot
cat cat
ex trans cis
D D
trans cis
D D
k k E
k
trans cisK K
K K
 
 
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APP. The kinetic rates for each individual step and the corresponding equilibrium 
constants have been determined (Figure 5.1A, Table 5.1).  A diagram mapping the 
corresponding relative free energies of each state (Figure 5.7) illustrates that the 
modest binding energies for each isomer (19.2 kJ and 16.1 kJ for the cis and trans 
isomers, respectively), combined with the more favorable binding to the syn transition 
state (49 kJ/mol, or 11.6 kcal/mol) result in a lowering of the activation barrier by 29.4 
kJ (7.0 kcal/mol) relative to the uncatalyzed reaction.  This enzymatic reduction of the 
N-C’ torsion barrier is comparable to that reported for other PPIase enzymes such as 
FKBP and CypA (Dugave and Demange, 2003; Fischer et al., 1993; Kofron et al., 
1991; Lu et al., 2007; Park et al., 1992).  Overall, these results provide the microscopic 
constants associated with the multi-state thermodynamic cycle of the Pin1 catalytic 
domain, and demonstrate that these parameters that quantitatively describe the activity 
of Pin1 on this important biological target are similar to those for other well-studied 
PPIase enzymes acting on their biological substrates. 
Implications of intK  for function of Pin1 
The internal equilibrium constant, intK , of an enzyme is defined as the ratio of 
bound substrate to bound product at equilibrium ( int ([ ] / [ ] )eq eqK ES EP . The catalytic 
efficiency of an enzyme is highly dependent on the relationship between the value of 
intK and the conditions under which the enzyme operates. For an enzyme that operates 
near equilibrium of its substrates and products, the optimal value of intK is 1 (Burbaum 
et al., 1989). However, for an enzyme that operates far from equilibrium, the optimal 
value of intK is correspondingly skewed. Specifically, if the ratio of substrate to 
product is much lower than the equilibrium value ([ ] / [ ] [ ] / [ ]eq eqS P S P ) the optimal 
value of intK is correspondingly increased ( intK >> 1). There is still a limited 
understanding of the role of Pin1-catalyzed isomerization of many of its substrates, 
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Figure 5.6: ROESY measurement of Pin1-PPIase isomerization rate. In order to 
measure isomerization rates, a series of 
1
H-
1
H ROESY spectra of 3.0 mM pAPP659-
682 were taken in the presence of 50 µM PPIase (A) or full-length Pin1 (B). Shown 
are the normalized cross-peak build-up curves Itc/Itt as a function of mixing time tmix. 
The rate of isomerization was determined by fitting auto- and cross-peaks, yielding a 
kex = kcistrans + ktranscis of 41 ± 1 s
-1
 for the PPIase domain and 28 ± 1 s
-1
 for full-
length Pin1. 
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Figure 5.7: Free energy diagram of Pin1-PPIase catalysis. The binding, 
equilibrium, and rate constants obtained by lineshape fitting (Table 5.1) were used to 
calculate the energy diagram of the PPIase-pAPP659-682 isomerization reaction. The 
determined equilibrium and binding constants were used to elucidate the 
thermodynamic cycle of PPIase binding to the cis and trans isomers of pAPP659-682. 
The measured rates of isomerization were used to determine the activation barriers 
between the two states either on or off the enzyme.  
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such as the AICD of APP (Pastorino et al., 2006). An important factor when 
considering a mechanism of Pin1 function is the value of intK .  For example, if Pin1 
exhibits a significantly skewed intK for the pAPP659-682 it may indicate that Pin1 is 
optimized to operate far from equilibrium in its isomerization of this substrate. This in 
turn would have implications for the role of isomerization in the biological system, i.e. 
whether Pin1 serves to restore equilibrium to a population of substrates abnormally 
enriched for the cis isomer or the trans isomer. The measured value of intK for the 
pAPP659-682/Pin1-PPIase complex is 3.9, which may suggest Pin1 is optimized to 
restore equilibrium to the AICD under conditions where it is slightly skewed towards 
the cis isomer. Pin1 has evolved under selective pressure from multiple substrates (Lu 
and Zhou, 2007), so it should not be assumed that Pin1 is optimized for its catalysis of 
the AICD; however, this result is suggestive because evidence exists that implicates 
the cis isomer of the pT668-P669 motif in the AICD in amyloidogenic processing of 
APP (Iijima et al., 2000; Lee et al., 2003; Ramelot and Nicholson, 2001), and Pin1 
protects against this (Pastorino et al., 2006). Future work on other substrates such as 
the heptad motifs in the CTD of RNA Polymerase II (Buratowski, 2003) should 
provide insights into the significance of the value of intK .  
 
Concluding Remarks  
During the past twenty years, the power of NMR spectroscopy for elucidating 
the detailed motions of proteins has dramatically increased, with decisive 
contributions from Lewis Kay and his research group (Grishaev et al., 2008; Hansen et 
al., 2008a; Hansen et al., 2008b; Religa et al., 2010; Sprangers and Kay, 2007; 
Vallurupalli et al., 2008). Particularly important is the development of methods to 
detect and characterize microsecond to millisecond timescale motions via CPMG 
(Hansen et al., 2008a) or R1 (Massi et al., 2004) relaxation experiments that yield 
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dispersion profiles that can be fit to reveal rates, populations and chemical shifts 
associated with exchange processes.  These methods have opened important windows 
into motions that occur on the timescale of many biological processes, and have 
greatly enhanced our understanding of relationships between internal protein motions 
and function (Mittermaier and Kay, 2009b).  While the interpretation of relaxation 
dispersion profiles has been extended to three-state (Sugase et al., 2007) and four state 
(Li et al., 2008) exchange processes, the complexity of the exchange reaction remains 
the major limitation of these methods.  Here we have applied classic lineshape 
analysis as a complementary approach for measuring exchange processes ( exk  < 10
5
 s
-
1
) that offers the advantage of being based on the convenient and sensitive HSQC 
experiment (Mulder et al., 1996). 
This study highlights the ability of NMR lineshape analysis to provide a 
quantitative description of functional motions during catalysis for the four-state 
reaction scheme of Pin1-PPIase acting on a biological substrate involved in the 
pathogenesis of Alzheimer’s disease. Lineshape analysis of the 13C-Pro-labeled 
substrate yielded individual kinetic rates, equilibrium constants, and an overall 
catalytic rate that was independently verified using ROESY exchange spectroscopy. 
Importantly, since 
13
C-labeled proline yields a very characteristic spectrum with many 
well-resolved alpha, beta, delta, and gamma proton peaks, this labeling strategy 
coupled with lineshape analysis is applicable to the study of any prolyl isomerase and 
any peptide substrate.  Our results support the interpretation of CPMG-derived 
chemical exchange occurring in and near the active site of Pin1-PPIase saturated with 
an optimized peptide substrate as on-enzyme isomerization of the substrate 
(Labeikovsky et al., 2007). These results further suggest that, since similar on-enzyme 
exchange rates were observed for distinctly different substrates, the intrinsic motions 
of Pin1-PPIase pre-determine the approximate timescale of this exchange and 
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substrate-specific variations in overall catalytic rate are governed by their relative 
affinities.  Of particular interest for future lineshape analysis studies is the 
characterization of specific Pin1-PPIase mutants to gain an in-depth understanding of 
the Pin1 catalytic mechanism.  
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CHAPTER 6 
Perspectives, Additional Observations, and Future Plans 
 
Role of Isomerization in VASP Binding Interactions  
 In Chapter 2, we demonstrated that the interaction between the VASP-EVH1 
domain and (W/F)PPPP motifs is specific for the trans isomer of the (W/F)-P peptide 
bond. Furthermore, we showed that the prolyl isomerase cyclophilin A was able to 
accelerate binding between VASP-EVH1 and such motifs. Tetrameric VASP may 
exhibit very tight binding through avidity to the tandem repeat motifs of zyxin, 
lamellipodin, and ActA. IRAK1 tetramerizes in response to IL-1R and TLR signaling, 
raising the possibility that the VASP/IRAK1 interaction is regulated by IRAK1 
tetramerization. An intriguing implication of our work was that, if the interaction 
between VASP and IRAK1 is enhanced by avidity, then VASP will preferentially 
select IRAK1 tetramers that adopt the trans peptide bond for each of the four 
monomers. As this only occurs for rather minor fraction (%trans
4
, or 11%) of the total 
IRAK1 tetramers, this would predict an increased importance for an isomerase such as 
cyclophilin A to accelerate VASP binding.  
 These two predictions, that tetramerization of IRAK1 can regulate its 
interaction with VASP, and that isomerization would then be a major rate-limiting step 
in this binding interaction, can be tested with purified components in vitro. Full length 
His-tagged VASP expresses well in E. coli, though in our hands usage of Bl21 Rosetta 
cells and cobalt resin are important. Furthermore, we have cloned expression vectors 
encoding fusion constructs designed to produce either dimer or tetramer IRAK1-UD. 
These constructs have N-terminal 6X His tags followed by a TEV protease cleavage 
site and either the sequence 
GHMGGRMKQLEDKIEELLSKIYHLENEIARLKKLIGERGGSA (GCN4_pIL, 
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dimer) or the sequence GRMKQIEDKLEEILSKLYHIENELARIKKLLGER 
(GCN4_pLI, tetramer), followed by the UD of IRAK1 (residues 102-222). These 
GCN4 sequences are known to form leucine zippers of defined oligomeric states 
(Harbury et al., 1993). In our hands, it is necessary to purify these fusion proteins 
using a denaturing prep (described for zyxin
41-140
 in Chapter 4) for purity as well as to 
prevent degradation.   
In our hands, we have not been able to detect binding of these fusion constructs 
to VASP by fluorescence spectroscopy under dilute (< 10 µM) conditions. However, 
multiple controls remain to be performed. The sequences of the fusion constructs may 
require a flexible linker in between the IRAK1 sequence and the GCN4 sequence to 
oligomerize properly. We have not been able to obtain unambiguous evidence for 
these constructs forming dimers and tetramers, either by cross-linking experiments or 
by analytical ultracentrifugation (AUC). Unless their oligomeric state is confirmed, it 
will be difficult to interpret even a positive result of tight binding, so this is an 
important goal. 
Because both VASP and these IRAK1-UD fusion proteins contain multiple 
tryptophan residues, tryptophan fluorescence titration data will require large baseline 
subtractions. Likewise, given the difference in tryptophan fluorescence signal for the 
cis and trans isomers of the W168-P169 peptide bond observed in Chapter 2, 
fluorescence binding kinetics data would be difficult to interpret. Therefore, if the 
issues in the previous paragraph are resolved, it may be worthwhile to perform surface 
plasmon resonance (SPR) rather than tryptophan fluorescence to measure binding 
affinities and rates.  
 
Role of Phosphorylation of VASP Binding Partners 
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 In Chapter 3, we have shown that phosphoserines flanking VASP-binding 
motifs can have a similar effect as negatively charged amino acids in increasing the 
affinity of sequences for VASP-EVH1. In our example, the VASP-binding motif in 
the UD of IRAK1, the motif is flanked by two serines. While studies have identified 
one of these serines (S173) as being phosphorylated in response to TLR stimulation 
(Tun-Kyi et al., 2011), it is unknown whether the other (S166) is phosphorylated at all. 
Given the extensive phosphorylation of the IRAK1-UD in response to IRAK1 
activation (Kollewe et al., 2004), it is reasonable to expect that S166 is 
phosphorylated. However, future experiments should be performed to ascertain this. 
This may require raising an antibody against this modification, as S166 is contained 
within a sequence of IRAK1 that is not very amenable to mass spectrometry analysis 
(personal communication: Greg Finn, Harvard University). The question further 
remains of how important phosphorylation of IRAK1 is for it to interact with VASP. 
To address this, it will be informative to test whether mutating these serines to alanine 
impairs the ability of IRAK1 to co-IP with VASP in cell culture. It will be particularly 
interesting whether or not TLR stimulation enhances this interaction, as we predict, 
and whether or not mutation of the serine residues abolishes this enhancement. We 
have produced a double mutant S166A/S173A IRAK1 expression construct and are 
pursuing these experiments currently. 
 Our results further suggest that the interaction of VASP with the proteins 
lamellipodin and palladin likewise may be regulated by phosphorylation. While it 
would be trivial for us or others to test whether phosphorylated peptides derived from 
these proteins bind VASP-EVH1 tighter than their non-phosphorylated counterparts in 
vitro, the most pressing question is what the role of phosphorylation of these proteins 
is in the cellular context. Given that the VASP-binding sites in lamellipodin are 
phosphorylated in response to Erk2 signaling and during mitosis 
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(http://www.phosphosite.org/) (Asano et al., 2011; Carlson et al., 2011; Hornbeck et 
al., 2004; Olsen et al., 2010), it would be interesting to test whether mutating residues 
T874 and S933 of lamellipodin influence lamellipodial dynamics in either of these 
contexts.  
 
Secondary Binding Site in EVH1 Domain 
In Chapters 3 and 4, we have identified and performed a preliminary 
characterization of a secondary binding surface on the EVH1 domain of VASP that 
weakly interacts with the same FPPPP motif that is recognized by the primary binding 
site. We have shown that this site is employed in the interaction between VASP-EVH1 
and the proline-rich region of zyxin, which contains four such FPPPP motifs. 
Remarkably, when zyxin is in excess, the fourth and second FPPPP motifs 
simultaneously bind VASP-EVH1 in two orientations, either with the second motif in 
the primary site and the fourth in the secondary site, or visa-versa. Furthermore, the 
Y39D mutation of EVH1, meant to mimic Abl-induced phosphorylation of VASP-
EVH1 (Maruoka et al., 2012), appears to abolish this secondary interaction.  
Future work should include more complete characterization of the possible 
binding orientations between VASP-EVH1 and the proline-rich region of zyxin. We 
mutated motif M3 (F104A) because it appeared to bind weakly relative to the other 
motifs, but it nonetheless must be considered in the complete picture. Likewise, we 
mutated motif M1 (F71A) somewhat arbitrarily, motivated simply to reduce the 
complexity of the interaction. It will be important to test whether motifs M1 and M4, 
or M1 and M2, can similarly bind simultaneously on the two faces of VASP-EVH1. 
It is possible that this secondary interaction serves to strengthen VASP binding 
to zyxin, and that phosphorylation of Y39 is a mechanism to selectively weaken 
VASP binding to zyxin but not other proteins that do not bind in this manner. 
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Alternately, this secondary interaction may not contribute significantly to the affinity 
of VASP-EVH1 for zyxin. To address this, future experiments should include precise 
quantification of the affinity of zyxin for wild-type and Y39D VASP-EVH1, possibly 
using fluorescence anisotropy or SPR. However, given the highly complex multi-state 
interaction between these proteins, care must be taken to account for the different 
possible stoichiometries and binding orientations in such an experiment. Furthermore, 
because the LIM domains of zyxin also contribute to binding to VASP (Moody et al., 
2009), usage of the full-length sequences of VASP and zyxin  may be warranted. 
Importantly, the use of tetrameric VASP over monomeric EVH1 may well bias the 
interaction towards a 1:4 stoichiometry, rendering the secondary binding site 
unimportant. 
 Given that the proteins lamellipodin and ActA similarly contain multiple 
FPPPP motifs, it is reasonable to ask whether VASP-EVH1 binds these proteins in a 
similar manner. The longer length of the proline-rich sequences in these proteins may 
make NMR a less attractive technique to address this. It may be sufficient to simply 
monitor global binding of wild-type and Y39D VASP to infer whether the secondary 
site is employed.  
In characterizing this secondary binding site, we only report chemical shift 
perturbations, which cannot substitute for an atomic-resolution structure. Given the 
possible conservation of this binding site in the EVH1 domains of multiple protein 
families, it makes sense to pursue an NMR or crystal structure. It may be relatively 
straightforward to obtain a structure of VASP-EVH1 with a zyxin sequence bound in 
this site. By producing a fusion protein with the sequence of zyxin residues 85-123 
joined via a short flexible linker to the C-terminus of VASP-EVH1, it should be 
possible to obtain a solution structure of the complex, in analogy to the method used in 
(Volkman et al., 2002). This would provide the added benefit of producing the first 
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VASP-EVH1/peptide complex structure, as only a structure of the EVH1 domain of 
Mena has been solved with a peptide bound.  
 
Novel Zinc-Binding Sequence in IRAK1-UD 
During the course of characterizing the VASP-binding sequence in the UD of 
IRAK1, we observed that the cis and trans side-chain peaks of W200 decreased in 
intensity over time and were replaced by new peaks with distinct chemical shifts. This 
was reversible by addition of 5 mM TCEP, suggesting that the chemical shift change 
was due to a disulfide linkage forming between the flanking cysteine residues C199 
and C203. The addition of a small amount of protease inhibitor cocktail in DMSO, 
which promotes disulfide bond formation, may have contributed to this. Interestingly, 
disulfide formation caused the cis/trans ratio to shift significantly, from 25% cis 
reduced to as much as 77% cis when oxidized, assuming from relative peak positions 
that the new major population was the cis isomer. This assumption is supported by a 
report (Shi et al., 2006) showing that short proline-containing peptides substantially 
increase their population of cis upon cyclization by disulfides when the number of 
residues between the two cysteines is either five or three, as in our sequence 
(199CWPLC203).  
Zinc has been shown to inhibit IRAK1 kinase activity (Wellinghausen et al., 
1997). Based on the conservation of either histidine or cysteine residues at IRAK1 
positions 199, 203, and 210 in mammals, we wondered whether IRAK1 directly binds 
zinc with these residues. Furthermore we speculated that the tendency of these 
cysteine residues to disulfide bond reflected a conformation preordered to bind zinc. 
This would predict that IRAK1 binding to zinc would be specific for the cis isomer, or 
preferentially stabilize the cis isomer. To test this, we measured the intrinsic 
tryptophan fluorescence from W200 while zinc was added to IRAK1-UD. We found 
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that IRAK1-UD indeed binds zinc, with an affinity between 5-30 nM at pH 7.5. 
Furthermore, adding zinc to IRAK1-UD caused a slow change in fluorescence signal 
that was accelerated by cyclophilin A, confirming the expectation that zinc binding 
would display some isomer specificity. We showed that the mutations C199S, P201V, 
C203S, and H210F all decreased binding, and that the double mutant C199S/C203S 
completely abolished it (Appendix Figure 6.1). 
We attempted to use NMR spectroscopy to characterize this interaction with 
zinc using a short peptide with the sequence KPFCWPLCEISRGTHNFK-amide. This 
sequence contained N- and C-terminal lysine residues to increase solubility, because a 
peptide with the similar wt sequence (196FPFCWPLCEISRGTHNFS213) was insoluble 
at neutral pH. We were able to obtain 
1
H-
1
H TOCSY of this peptide bound to zinc at 
pH 8.0. Zinc binding appeared to induce hydrogen bond formation, based on zinc-
induced protection of some backbone amide protons. However, the aliphatic region of 
the spectrum indicated that the H210 peaks did not respond to the presence of zinc, 
and that by contrast the extreme N-terminus seemed to be highly sensitive to it. We 
took this to mean that the N-terminal lysine or extreme N-terminus was preventing 
H210 from coordinating zinc, possibly by forming some secondary interaction with 
E204. 
These zinc-binding peptide experiments were hampered by the limited 
solubility of the peptide in the presence of excess zinc. They were similarly hampered 
by the low affinity of the peptide for zinc at acidic pH, which is necessary to observe 
backbone amide peaks. The limited solubility of the peptide, as well as the apparent 
discrepancy between the peptide and the full-length sequence regarding the 
importance of H210 in binding, argue for design of an additional peptide. In addition, 
future experiments should include testing for binding of other metals, possibly of 
physiological relevance or for minimizing aggregation in order to perform NMR. 
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APPENDIX 
 
Appendix Figure 2.1: 
1
H-
1
H TOCSY showing cis and trans isomers of W168-P169 
and S173-P174 peptide bonds in IRAK1
162-180
. Lines are drawn through TOCSY 
strips showing the resolved  and  proton peaks for the cis and trans isomers of 
W168. The NH chemical shift of S173 is sensitive to the isomer states of both W168-
P169 and S173-P174, leading to four distinct strips for S173. Lines are drawn through 
the two strips corresponding to the cis isomer of S173-P174 on the right, and the  
peaks of the trans isomer of S173-P174 are indicated to the left. Peaks are labeled 
with the isomer state of W168-P169 designated first, and if applicable, the isomer state 
of S173-P174 second. Isomer populations of the S173-P174 peptide bond were 
determined by volumes of the β peaks of S173. 
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Appendix Figure 2.2: Temperature dependence of population of cis isomer of 
IRAK1-UD. The population of cis isomer was determined from the diagonal peaks of 
the W168 sidechain in 
1
H-
1
H TOCSY spectra of the peptide IRAK1
162-180
. The slight 
temperature dependence was fit to a straight line and this was used to determine the 
individual isomerization rates CTk  and TCk   from the observed obsk  measured in the 
fluorescence temperature series, in order to fit to equation 2.7. 
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Appendix Figure 2.3: 
1
H-
1
H TOCSY showing cis and trans isomers of F335-P336 
peptide bond in ActA
333-344
. Dashed lines are shown corresponding to the F335 NH 
chemical shifts of the cis and trans isomers of F335-P336. The NH chemical shift of 
T340 is also split due to its sensitivity to the F335-P336 peptide bond, so its  peaks 
are specified.   
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Appendix Figure 2.4: Alignment of IRAK1 residues 130-208 in primates shows 
that W168 is a very recent mutation. In this alignment, apes (above) are separated 
from monkeys and prosimians by a horizontal line. Black background indicates an 
absolutely conserved residue, whereas grey background indicates the major allele of a 
residue not absolutely conserved. Red letters represent amino acids corresponding to 
new mutations that appear in apes. W168 is one of five such amino acids in humans 
for this 78-residue stretch of IRAK1.  
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Appendix Figure 2.5: Structural model rationalizing isomer specificity of IRAK1-
UD/EVH1 interaction. A representation of the solution structure of the VASP-EVH1 
domain (PDB ID code 1EGX (Ball et al., 2000)) with IRAK1 peptide residues 
modeled into the binding site, with W168-169 in either the cis (right) or trans (left) 
state. The surface representation of the EVH1 domain is colored according to chemical 
shift perturbation of the IRAK1
162-180
 titration.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 186 
 
 
Appendix Figure 3.1: Chemical shift perturbation difference analysis indicates a 
single binding orientation of EVH1/IRAK1 complex. The differences in bound 
15
N 
EVH1 chemical shifts between the IRAK1
162-180
 titration and the IRAK1
162-180, W168F
, 
IRAK1
157-180, pS163
, IRAK1
162-180, pS166
, and IRAK1
157-180, pS173
 titrations were mapped to 
the EVH1 structure. The perturbation differences correspond well with the model’s 
positions of the S166, W168, and S173 side chains, supporting the model and 
supporting a single binding orientation for the peptide. (magenta=no difference, 
green=highest difference) 
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Appendix Figure 3.2: 
15
N-EVH1 chemical shift perturbation profiles of IRAK1
162-
180
 and IRAK1
162-180, W168F
. (A) The chemical shift perturbation profiles (Δδ) of 15N 
EVH1 bound to either IRAK1
162-180
 (black) or IRAK1
162-180, W168F
 (red). (B) Chemical 
shift perturbation differences (ΔΔδ) between the 15N EVH1 IRAK1162-180 and 
IRAK1
162-180, W168F
 titration data.  
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Appendix Figure 3.3: Temperature dependence of IRAK1 W168 sidechain 
chemical shift indicates no hydrogen bond with VASP-EVH1. The 
1
H chemical 
shift of the indole sidechain amide peak of IRAK1
162-180
 is plotted as a function of 
temperature in the presence (top) and absence (bottom) of excess EVH1 domain. The 
slope of the curve is identical in each case, indicating there is no hydrogen bond 
formed between the EVH1 domain and the sidechain of W168.  
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Appendix Figure 4.1: Fitting 
15
N zyxin
41-140
/EVH1 binding curves. (A) Models 
used to fit 
15
N zyxin
41-140
/EVH1 titration data. While the F71A/F104A and 
F71A/F104A/F114A mutants were modeled to bind EVH1 domain (orange) in both 
1:1 and 1:2 stoichiometries, the F71A/F104A/F93A mutant was modeled to only bind 
EVH1 domain in a 1:1 complex. Rounded and triangular indentations in the orange 
EVH1 domain represent the primary and secondary binding sites, respectively. (B) 
Fitting of binding data. Symbols represent chemical shift differences in ppm, as 
differences either in the 
1
H dimension or in the 
15
N dimension but scaled by the factor 
0.154. Lines represent fits to the data. Colors (red, green, or blue) represent the motif 
the data is derived from, either the second, third, or fourth respectively.  
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Appendix Figure 4.2: Fitting 
15
N EVH1/zyxin peptide titration data. (A) The 
model used to fit 
15
N EVH1/zyxin peptide titration data, which accounts for both 
primary (rounded indentation) and secondary (triangular indentation) binding sites, 
and treats each peptide (zyxin
99-123
 and zyxin
99-123, F104A
) as having only one binding 
site. The EVH1 domain is shown as an orange box and the peptide is shown as a black 
line. (B) Representative 
15
N EVH1/zyxin peptide titration data (figures) and fits 
(lines). Binding curves reflecting the primary binding site are shown in red, and curves 
representing the secondary binding site are shown in blue. The peptides used in each 
titration are indicated.   
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Appendix Table 4.1: Assignments of zyxin residues 69-126, excluding prolines  
 cispeaks
Residue N NH Hα NOEs N NH Hα NOEs
E69 121.2 8.48 4.19 4.38 121.1 8.52 4.26 4.40
D70 121.7 8.21 4.53 4.18 121.7 8.26 4.56 4.26
F71 122.1 8.05 4.85 4.52 120.3 7.83 4.48 4.56
P72 -
L73 124.7 8.27 4.61 4.42 124.1 8.35 4.51 3.78
P74 -
P75 -
P76 -
P77 -
L78 123.3 8.31 4.31 4.41
A79 126.0 8.35 4.33 4.31
G80 109.4 8.39 3.97 4.33
D81 121.1 8.29 4.64 3.98
G82 109.9 8.42 3.96 4.64
D83 121.4 8.26 4.61 3.96
D84 121.4 8.36 4.59 4.61
A85 125.1 8.23 4.25 4.59
E86 120.1 8.38 4.21 4.25
G87 110.4 8.33 3.92 4.21
A88 124.3 8.11 4.31 3.91
L89 121.5 8.27 4.35 4.29
G90 110.0 8.33 3.95 4.34
G91 109.3 8.16 3.90 * 109.3 8.21 3.96 *
A92 124.0 8.02 4.25 3.90 124.4 8.09 4.31 3.95
F93 120.8 8.13 4.88 4.25 121.2 8.09 4.47 4.31
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Appendix Table 4.1 (Continued) 
cispeaks
Residue N NH Hα NOEs N NH Hα NOEs
P94 -
P95 -
P96 -
P97 -
P98 -
P99 -
I100 122.0 8.22 4.11 4.45
E101 125.8 8.52 4.27 4.11
E102 123.4 8.39 4.23 4.25 123.7 8.44 4.33 4.32
S103 117.8 8.20 4.38 4.23 118.2 8.33 4.43 4.32
F104 123.5 8.25 4.91 4.39 124.0 8.28 4.48 4.44
P105 -
P106 -
A107 126.3 8.33 4.59 4.44 126.1 8.31 4.50 4.36
P108 -
L109 123.6 8.35 4.31 4.40
E110 122.8 8.43 4.27 4.31
E111 122.5 8.37 4.25 4.27
E112 123.5 8.38 4.20 4.25
I113 123.3 8.06 4.09 4.20 123.9 8.15 4.12 4.27
F114 126.5 8.42 4.93 4.08 126.3 8.23 4.64 4.12
P115 -
S116 118.9 8.42 4.75 4.46 118.2 8.46 4.64 3.89
P117 -
P118 -
P119 -
P120 -
P121 -
E122 121.7 8.55 4.24 4.41
E123 122.5 8.45 4.31 4.23
E124 123.4 8.50 4.29 4.31
G125 111.1 8.51 3.99 4.29
G126 109.8 8.18 4.07 3.99  
(-) indicates proline residues, which do not show peaks in 
15
N-
1
H HSQC spectra 
(*) indicates that no NOE was observed.  
“Cis peaks” refers to the isomer of the Phe-Pro peptide bond nearest the residue.    
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Appendix 5 Equations: 
Equilibrium thermodynamic equations for lineshape analysis, where P denotes the 
protein (PPIase) and L denotes the ligand (pAPP659-682): 
 
         (A 5.1) 
 
         (A 5.2A) 
 
         (A 5.2B) 
where 

[P :L] is the concentration of Pin1-PPIase bound to the pAPP659-682 peptide, 
K AppD  is the apparent dissociation constant, 

[P tot] is the concentration of total Pin1-
PPIase, 

[P free] is the concentration of free Pin1-PPIase, 

[Ltot] is the concentration of 
total pAPP659-682 peptide, and 

[Lfree] is the concentration of free pAPP659-682 
peptide. 
  
                                                                                                                        (A 5.3A) 
 
                                                                                                                       
 (A 5.3B) 
 
                                                                                                                        
(A 5.3C) 
 
                     
(A 5.3D) 
 
where 

[Ltrans] is the concentration of free pAPP659-682 peptide in the trans 
conformation, 

[Lcis] is the concentration of free pAPP659-682 peptide in the cis 
conformation, 

[P :Ltrans] is the concentration of Pin1-PPIase bound to pAPP659-682 
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peptide in the trans conformation, 

[P : Lcis] is the concentration of Pin1-PPIase bound 
to pAPP659-682 peptide in the cis conformation, 
eqK  is the ratio of the trans isomer 
to the cis isomer for free pAPP659-682, and 
bound
eqK  is the ratio of the trans isomer to 
the cis isomer for the bound complex of Pin1-PPIase and  pAPP659-682. 
Scalar coupling equations for lineshape analysis: 
         
      
 
 
(A 5.4) 
 
 
 
(A 5.5) 
 
where A D
HHJ
  are the four largest scalar coupling constants for each of the five analyzed 
proton resonances as reported in the literature (Aliev and Courtier-Murias, 2007) and 
reproduced in Appendix Table 5.2 below, i
HHJ  are all the possible linear combinations 
of these coupling constants as defined in equation A5.4,  1 νS  is the spectrum in the 
absence of scalar coupling as defined in equation 5.1E of chapter 5, and  2 νS  is the 
final simulated spectrum in the presence of scalar coupling. 
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Appendix Table 5.1: Impact of variations in constrained parameters on fit  
 
Variation of constrained parameters in Chapter 5: 
Selected constrained parameters were varied within their standard deviations of 
measurement or within reasonable estimates of their values in order to ascertain the 
influence of uncertainty in the values of these parameters on the results and quality of 
the fit. The “best” fit which produced the reported values is on top, with numbers 
underlined. Constrained parameters which have been perturbed from their values in 
the best fit are in bold and italics. Note that although decreasing K AppD or eqK  from 
their measured values slightly improved the fit, this was not deemed significant 
enough to warrant re-evaluating these independently-measured parameters. 
 
 
 
 
 
 
 
 
 
 
 
 
Constrained parameters Fit parameters error 
( )KAppD mM  
1k ( )cisoff s

 
1k ( )transoff s

 2,0 ( )
boundR Hz  eqK  
bound
eqK  1k (
k
)
trans
cat
cis
cat s


 
 
1.3 4000 20000 20 13.6 3.9 1540 0.0711 
1.3 4000 20000 20 12.9 3.9 1560 0.0735 
1.3 4000 20000 20 14.3 3.9 1520 0.0692 
1.3 4000 20000 16 13.6 3.7 1540 0.0712 
1.3 4000 20000 24 13.6 4.1 1530 0.0714 
1.3 400 2000 20 13.6 2.6 3620 0.0784 
1.3 1000 5000 20 13.6 3.3 2480 0.0723 
1.3 40000 200000 20 13.6 4.2 1430 0.0739 
1.0 4000 20000 20 13.6 4.8 1440 0.0700 
1.6 4000 20000 20 13.6 3.3 1640 0.0720 
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Appendix Table 5.2: Scalar coupling values employed in lineshape simulation (Aliev 
and Courtier-Murias, 2007)
†
 
 Hα Hβ1 Hβ2 Hδ1 Hδ2 
( )
A
HH HzJ  8.81 -13.3 -13.3 
-
11.59 
-11.59 
( )
B
HH HzJ  6.61 8.81 7.53 7.52 7.61 
( )
C
HH HzJ  -0.51 7.52 6.78 6.69 6.84 
( )
D
HH HzJ  -0.39 6.74 6.61 -0.46 0.45 
 
†Each column in Appendix Table 5.2 lists the four largest scalar coupling constants  
A D
HHJ
  to a given nucleus, as given in Table 1 of  (Aliev and Courtier-Murias, 2007). 
These coupling constants were used in equations A5.4 and A5.5 to simulate the final 
spectrum.   
 
 
Treatment of scalar coupling in Chapter 5: 
The observed 
1
H lineshapes exhibited small but noticeable splitting due to J-
coupling between the proline ring protons. These were modeled by treating each peak 
as simply a superposition of 16 lorentzians (equations A5.4, A5.5) using the J-
coupling values reported in (Aliev and Courtier-Murias, 2007) (Appendix Table 5.2). 
The line shape analysis of scalar coupled spin systems requires, generally, a more 
sophisticated approach (Binsch, 1969; Rao, 1989)  than that which is used for 
uncoupled systems (McConnell, 1958). However, a number of considerations 
supported use of a conventional classical approach for line shape fitting. First, upon 
peptide binding to the protein, the coupling pattern does not change (the proline ring 
remains chemically intact, spin systems do not change and no couplings are lost). 
Second, the observed coupling constants in the free peptide are in the range of 0.4-13 
Hz. Upon addition of Pin1-PPIase the proline resonances broaden to linewidths on the 
order of FWHH~50 Hz at the highest titration point, where the peptide is still only 
half-saturated. Thus, if any scalar coupling constants change in the bound state (due 
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possibly to stabilization of a ring-pucker conformer or fast mixing between cis and 
trans isomers) it is still unlikely that this would contribute substantially to the overall 
lineshape. To the extent that the J-coupling constants do differ in the bound state, this 
change in overall line shape is absorbed in the 2,0
boundR  parameter, which has very little 
effect on the fit over a range of ±4 Hz (Appendix Table 5.1). Third, the determined 
exchange rates are all fast (k/JHH > 10) compared to scalar coupling, which minimizes 
the error that can arise from a classical approach (Gunther and Schaffhausen, 2002). It 
is important to note that our simplified approach is only a good approximation due to 
the combination of factors mentioned above. In the general case of a coupled spin 
system in exchange, an accurate line shape analysis based on density matrix formalism 
is required (Binsch, 1969; Kaplan, 1958; Rao, 1989).  
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Appendix Figure 6.1: Zinc binding to IRAK1-UD. (A) The sequence of IRAK1-UD 
(G192-G122) shown to bind zinc, with tested mutants shown by arrows pointing from 
mutated residues. (B) Representative raw tryptophan fluoresence data (IRAK1-UD 
E214T/E215T mutant) used to characterize zinc binding. Zinc is titrated into the 
protein and tryptophan fluoresence time courses are collected. Zinc induces a large 
increase in signal intensity which is followed by a slow decrease, which is accelerated 
by CypA. EDTA induces a large decrease in signal intensity, followed by a slow 
increase, which is also accelerated by CypA. (C) Binding parameters obtained by 
fitting the slow phase of fluorescence data (or fast phase for Cys and Pro mutants) to 
the bimolecular binding equation, for various IRAK1-UD mutants.   
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